<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02732145</url>
  </required_header>
  <id_info>
    <org_study_id>PH20111201001</org_study_id>
    <nct_id>NCT02732145</nct_id>
  </id_info>
  <brief_title>Diagnostic Accuracy of &quot;Three Rings Vulvoscopy&quot; for Detection of Vulvar Dermatosis</brief_title>
  <acronym>DATRIV</acronym>
  <official_title>Diagnostic Accuracy of &quot;Three Rings Vulvoscopy&quot; for Detection of Vulvar Dermatosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ginekološka Poliklinika Dr. Vesna Harni</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Klinički Bolnički Centar Zagreb</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Zagreb</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ginekološka Poliklinika Dr. Vesna Harni</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study was to determine sensitivity, specificity and diagnostic accuracy
      of &quot;Three Rings Vulvoscopy&quot; for detection of vulvar dermatosis using histopathology as the
      reference standard.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      &quot;Three Rings Vulvoscopy&quot; (TRIV) is a new, and original technique for performing colposcopy of
      the vulva, taking into account three different skin types and zones as well as morphological
      evaluation of vulvar lesions according to their specificity (non-specific and lesions
      specific for dermatosis). To evaluate the clinical value of TRIV, we designed two index
      tests, a quantitative test called &quot;Vulvoscopy Index&quot; and a semi-quantitative test marked as
      &quot;N-S-P scheme.&quot; The sensitivity, specificity and diagnostic accuracy of both index tests were
      estimated in comparison with histopathology as the reference test in two groups of 164
      consecutive patients with vulvar discomfort (82 patients with vulvar dermatosis and 82
      patients with vulvodynia ) and 164 consecutive patients without vulvar discomfort (82
      patients with &quot;normal vulva&quot; and 82 patients with &quot;impaired vulvar skin&quot;).

      The study was performed stratified, on three levels, whereby the first two levels were
      pre-assignments.

      The first level of the study was an evaluation of vulvar discomfort during the routine
      gynecological care in the clinic &quot;Poliklinika Harni&quot; Zagreb, Croatia, where we searched for
      symptomatic patients; and in the esthetic gynecological unit of the same clinic, where we
      searched for asymptomatic patients. Vulvar discomfort was evaluated anamnestically by the
      &quot;International Society for the Study of Vulvovaginal Disease (ISSVD) Vulvodynia Pattern
      Questionnaire.&quot; On the second level, we performed detailed clinical examination (inspection
      and Cotton-Swab test), searching for non-specific and lesions specific for skin (vulvar)
      dermatosis, and patients with vulvodynia who fulfilled Friedrich's criteria. Patients with
      vulvar infection or pre/malignancy were excluded from the study. Vulvar lesions in patients
      with vulvodynia were not relevant to the diagnosis of vulvodynia.

      Among women without vulvar discomfort, we described those without any clinical findings
      (&quot;normal vulva&quot;) and those with some non-specific findings on the vulva. We called this group
      &quot;impaired vulvar skin.&quot; The results of the clinical examination were collected using &quot;TRIV
      Form Data.&quot; On this way, we identified four groups of patients during the recruitment: vulvar
      dermatosis, vulvodynia, impaired vulvar skin, and normal vulva. For each patient with vulvar
      dermatosis (82 patients), the first consecutive patient with vulvodynia (82), impaired vulvar
      skin (82) and normal vulva (82) were taken for comparison.

      The third level of the study presents the investigation and included diagnostic interventions
      &quot;Three Rings Vulvoscopy&quot; and vulvar biopsy with histopathology. The results of vulvoscopy
      were collected using &quot;TRIV Form Data&quot; and then assessed by &quot;Vulvoscopy Index&quot; and the &quot;N-S-P
      Scheme.&quot; Biopsy of the vulva from the symptomatic patients was taken to confirm/exclude
      vulvar dermatosis. Asymptomatic patients, who were recruited from patients undergoing planned
      labiaplasty, granted vulvar samples to further investigation.

      The statistical tests were made on a personal computer (PC) in the Statistical Package 12.0.
      All qualitative variables are shown in the tables with the absolute number and percentage.
      Quantitative variables are presented with arithmetic mean and standard deviation (if normal
      distribution), and by the median and range (if not a normal distribution).

      A chi-squared test was used to test the difference between qualitative variables among the
      two groups. A chi-squared test with Yates correction was used for 2x2 size tables, and
      Fisher's exact test was used for small values. T-test proportions were used for the
      evaluation of the differences between the two percentages. Variance analysis (ANOVA) and post
      hoc Tukey HSD were used to test quantitative variables with normal distribution between
      multiple groups. Differences between the arithmetic mean of the two groups were tested by
      t-test.

      Variables that did not have normal distribution were tested by nonparametric tests. The
      differences between several groups were tested by Kruskal-Wallis ANOVA and the differences
      between the two groups Mann-Whitney U test.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>We performed the same interventions: Three Rings Vulvoscopy, Vulvar Biopsy and Histopathologically Evaluation in four groups of patients with and without vulvar discomfort, with the aim to detect vulvar dermatosis.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic Accuracy of &quot;Three Rings Vulvoscopy&quot; by the &quot;Vulvoscopy Index&quot; for Detection of Vulvar Dermatosis</measure>
    <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
    <description>The table shows the distribution of patients with and without vulvar dermatosis diagnosed by &quot;Three Rings Vulvoscopy&quot; (TRIV) using the &quot;Vulvoscopy Index&quot; and histopathology as a reference test.
The Vulvoscopy Index as an outcome measure of TRIV is designed as a quantitative test based on five characteristics: vulvar complaints, Marinoff index, Cotton-Swab test, vulvar lesions according to the three vulvar rings and specificity of lesions; with following results: &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points), &quot;Vulvodynia&quot; (12-18 points), and &quot;Vulvar Dermatosis&quot; (19-32 points).
Since histopathology distinguishes only patients with and without vulvar dermatosis, the clinical value the Vulvoscopy Index had been estimated according to these two groups of patients. Patients with vulvoscopy diagnoses: &quot;Normal Vulva,&quot; &quot;Impaired Vulvar Skin&quot; and &quot;Vulvodynia&quot; were classified into the group &quot;Absent Vulvar Dermatosis.&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Distribution of Patients With Vulvar Dermatosis Diagnosed by Vulvoscopy (TRIV) and Histopathology According to Single Categories of the &quot;Vulvoscopy Index&quot;</measure>
    <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
    <description>The table shows the distribution of patients with &quot;Vulvar Dermatosis&quot; diagnosed by &quot;Three Rings Vulvoscopy&quot; and histopathology according to single categories of the &quot;Vulvoscopy Index.&quot;
We described five categories within the Vulvoscopy Index:
Vulvar complaints (present vs. absent),
Marinoff index (positive vs. negative),
Cotton-Swab test (positive vs. negative),
Vulvar lesions according to the vulvar rings (Outer, Middle, and Inner Vulvar Ring Lesion) and
Specificity of lesions (Non-specific and Specific Lesions).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Distribution of Patients With &quot;Absent Vulvar Dermatosis&quot; Diagnosed by Vulvoscopy (TRIV) and Histopathology According to Single Categories of the &quot;Vulvoscopy Index&quot;</measure>
    <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
    <description>The table shows the distribution of patients with &quot;Absent Vulvar Dermatosis&quot; diagnosed by &quot;Three Rings Vulvoscopy&quot; (patients with vulvoscopical diagnoses &quot;Normal Vulva,&quot; Impaired Vulvar Skin &quot;and&quot; Vulvodynia&quot;) and histopathology, according to single categories of the &quot;Vulvoscopy Index.&quot;
The five categories within the Vulvoscopy Index are:
Vulvar complaints (present vs. absent),
Marinoff index (positive vs. negative),
Cotton-Swab test (positive vs. negative),
Vulvar lesions according to the vulvar rings (Outer, Middle, and Inner Vulvar Ring Lesion) and
Specificity of lesions (Non-specific and Specific Lesions).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>&quot;Vulvoscopy Index&quot; (Mean ± SD) in Patients With &quot;Vulvar Dermatosis&quot; Diagnosed by Vulvoscopy (TRIV) and Histopathology</measure>
    <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
    <description>The table shows the results of &quot;Three Rings Vulvoscopy&quot; (TRIV) by single categories of the &quot;Vulvoscopy Index&quot; (mean ± SD) in patients with &quot;Vulvar Dermatosis&quot; diagnosed by TRIV and histopathology.
The Vulvoscopy Index is based on five characteristics:
Vulvar complaints (negative=0; positive=4 points),
Marinoff index (negative=0; positive=3 points),
Cotton-Swab test (negative=0; positive=2 points),
Vulvar lesions according to the vulvar rings (Outer Vulvar Ring Lesions=4 points; Middle Vulvar Ring Lesions=2 points and Inner Vulvar Ring Lesions=1 point) and
Specificity of lesions (Non-Specific Lesions=2 points; Specific Lesions=14 points).
According to the Vulvoscopy Index, we have set the diagnoses: &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points), &quot;Vulvodynia&quot; (12-18 points), and &quot;Vulvar Dermatosis&quot; (19-32 points).
The likelihood of the diagnosis of &quot;Vulvar Dermatosis&quot; was higher as the value of the Vulvoscopy index was higher.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>&quot;Vulvoscopy Index&quot; (Mean ± SD) in Patients With &quot;Absent Vulvar Dermatosis&quot; Diagnosed by Vulvoscopy (TRIV) and Histopathology</measure>
    <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
    <description>The table shows the results of &quot;Three Rings Vulvoscopy&quot; (TRIV) by single categories of the &quot;Vulvoscopy Index&quot; (mean± SD) in patients with &quot;Absent Vulvar Dermatosis&quot; diagnosed by TRIV and histopathology.
According to the Vulvoscopy Index, we have set the diagnoses: &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points), &quot;Vulvodynia&quot; (12-18 points), and &quot;Vulvar Dermatosis&quot; (19-32 points).
Since histopathology can distinguish only patients with and without vulvar dermatosis, the distribution was estimated according to these two groups of patients. Hence, patients with vulvoscopical diagnoses &quot;Normal Vulva,&quot; Impaired Vulvar Skin &quot;and&quot; Vulvodynia&quot; were classified into the one group called &quot;Absent Vulvar Dermatosis.&quot; The likelihood of the diagnosis of &quot;Absent Vulvar Dermatosis&quot; was higher as the value of the Vulvoscopy index was lower.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>&quot;Vulvoscopy Index&quot; (Median | Range) in Patients With &quot;Vulvar Dermatosis&quot; Diagnosed by Vulvoscopy (TRIV) and Histopathology</measure>
    <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
    <description>The table shows the results of &quot;Three Rings Vulvoscopy&quot; (TRIV) by single categories of the &quot;Vulvoscopy Index&quot; (median ± SD) in patients with &quot;Vulvar Dermatosis&quot; diagnosed by TRIV and histopathology.
The Vulvoscopy Index is based on five characteristics:
Vulvar complaints (negative=0; positive=4 points),
Marinoff index (negative=0; positive=3 points),
Cotton-Swab test (negative=0; positive=2 points),
Vulvar lesions according to the vulvar rings (Outer Vulvar Ring Lesions=4 points; Middle Vulvar Ring Lesions=2 points and Inner Vulvar Ring Lesions=1 point) and
Specificity of lesions (Non-specific Lesions=2 points; Specific Lesions=14 points).
According to the Vulvoscopy Index, we have set the diagnoses: &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points), &quot;Vulvodynia&quot; (12-18 points), and &quot;Vulvar Dermatosis&quot; (19-32 points).
The likelihood of the diagnosis of &quot;Vulvar Dermatosis&quot; was higher as the value of the Vulvoscopy index was higher.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>&quot;Vulvoscopy Index&quot; (Median | Range) in Patients With &quot;Absent Vulvar Dermatosis&quot; Diagnosed by Vulvoscopy (TRIV) and Histopathology</measure>
    <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
    <description>The table shows the results of &quot;Three Rings Vulvoscopy&quot; (TRIV) by single categories of the &quot;Vulvoscopy Index&quot; (median ± SD) in patients with &quot;Absent Vulvar Dermatosis&quot; diagnosed by TRIV (patients with vulvoscopical diagnoses &quot;Normal Vulva,&quot; Impaired Vulvar Skin &quot;and&quot; Vulvodynia&quot;) and histopathology.
According to the Vulvoscopy Index, we have set the diagnoses: &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points), &quot;Vulvodynia&quot; (12-18 points), and &quot;Vulvar Dermatosis&quot; (19-32 points).
The likelihood of the diagnosis of &quot;Absent Vulvar Dermatosis&quot; was higher as the value of the Vulvoscopy index was lower.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diagnostic Accuracy of &quot;Three Rings Vulvoscopy&quot; by the &quot;N-S-P Scheme&quot; for Detection of Vulvar Dermatosis</measure>
    <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
    <description>The distribution of patients with and without vulvar dermatosis diagnosed by vulvoscopy (&quot;N-S-P Scheme&quot;) and histopathology.
According to the specificity of lesions, vulvoscopy results were classified as normal &quot;N&quot; (absence of any lesion), suspect &quot;S&quot; (non-specific lesions) and pathologic &quot;P&quot; results (lesion specific to dermatosis); and each of the three vulvar rings is represented by a single result.
The final vulvoscopy result is presented in the form of a three-letter formula, where the first letter indicates the vulvoscopy result in the Outer Vulvar Ring, the mean initial indicates the vulvoscopy result of the Middle Vulvar Ring and the last letter denotes the vulvoscopy result of the Inner Vulvar Ring.
&quot;N-S-P Scheme&quot; divides the results of the vulvoscopy into three groups: &quot;Normal Vulvoscopy,&quot; &quot;Suspect Vulvoscopy&quot; and &quot;Pathological Vulvoscopy.&quot; Diagnosis of vulvar dermatosis was established if one or more vulvar rings showed pathological results (&quot;Pathological Vulvoscopy&quot;).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Distribution of Vulvar Lesions According to the &quot;N-S-P Scheme&quot; in Patients With Vulvar Dermatosis Diagnosed by Vulvoscopy (TRIV) and Histopathology</measure>
    <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
    <description>The table shows the distribution of vulvoscopy lesions in relation to the vulvar rings and their specificity according to the &quot;N-S-P Scheme,&quot; in patients with vulvar dermatosis diagnosed by vulvoscopy (TRIV) and histopathology.
Vulvoscopy findings of each of the three vulvar rings: Outer (first letter in the formula), Middle (second letter), and Inner Vulvar Ring (third letter) were evaluated as normal &quot;N&quot; (absence of any lesions), suspect &quot;S&quot; (non-specific lesions), or pathological &quot;P&quot; (lesions specific for dermatosis).
&quot;Normal vulvoscopy&quot; indicated the absence of any lesion in all three vulvar rings (&quot;N-N-N&quot;).
&quot;Suspect vulvoscopy&quot; was used to mark findings of non-specific lesions (&quot;S-#*-#&quot;; &quot;S-S-#&quot;; &quot;S-S-S&quot;; &quot;S-N-S&quot; etc.).
&quot;Pathological vulvoscopy&quot; spelled out the finding of lesions specific for dermatosis in any of the three vulvar rings (&quot;P-#-#&quot;; &quot;P-P-&quot;; &quot;P-P-P&quot;; &quot;P-N-S&quot; etc.).
is the label for any of the three possibilities: N or S or P.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Distribution of Vulvar Lesions According to the &quot;N-S-P Scheme&quot; in Patients With Absent Vulvar Dermatosis Diagnosed by Vulvoscopy (TRIV) and Histopathology</measure>
    <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
    <description>The table shows the distribution of lesions according to their specificity and vulvar rings in patients without vulvar dermatosis diagnosed by vulvoscopy (TRIV) and histopathology, as a reference test.
According to the &quot;N-S-P scheme,&quot; we have set the diagnoses: &quot;Normal result&quot; (no lesion), &quot;Suspect result&quot; (non-specific lesion in any of the vulvar rings), and &quot;Pathological result&quot; (specific for dermatosis in any of the vulvar rings).
Since histopathology can distinguish only patients with and without dermatosis, the distribution was estimated according to these two groups of patients. Hence, patients with normal and suspect vulvoscopic results were classified into one group called &quot;Absent Vulvar Dermatosis.&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Baseline Characteristics: Age</measure>
    <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
    <description>The table shows the age in four groups of patients with and without vulvar discomfort.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Characteristics: Weight</measure>
    <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
    <description>The table shows the weight in four groups of patients with and without vulvar discomfort.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Characteristics: Height</measure>
    <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
    <description>The table shows the height in four groups of patients with and without vulvar discomfort.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Characteristics: BMI</measure>
    <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
    <description>The table shows the body mass index (Mean ± SD) in four groups of patients with and without vulvar discomfort.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Demographic Data in Patients With and Without Vulvar Discomfort</measure>
    <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
    <description>The table shows demographic data - age: more or less than 65 years, reproductive age, menopause, domicile country as a country of birth, the degree of education (more and less than 12 years), marital status, births, abortions, and using of contraception among four groups of patient.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Various Characteristics and Duration of Vulvar Discomfort in Patients With Vulvar Dermatosis and Vulvodynia</measure>
    <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
    <description>The table shows various characteristics of vulvar pain (complaints) in patients with vulvar dermatosis or vulvodynia.
Generally, we can differentiate between two categories of pain - the dull pain vs. the sharp pain depending on the nerve fibers in the skin, which are involved in the provocation of the pain.
The symptoms of the dull pain are burning, stinging, soreness, irritation, itching, feeling of inflammation and aching.
The symptoms of the sharp pain are a knife-like pain, paper-cuts pain, stabbing and sticking. We do not know, are there some symptoms characteristic for vulvar dermatosis or vulvodynia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual Activity and Abstinence in Patients With and Without Vulvar Discomfort</measure>
    <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
    <description>The table shows sexual activity and sexual abstinence due to dyspareunia or lack of a sexual partner in four groups of patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspareunia and Marinoff Index in Patients With and Without Vulvar Discomfort</measure>
    <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
    <description>The table shows the degree of dyspareunia in sexually active patients with and without vulvar discomfort. We used Marinoff Index as a measure of the degree of dyspareunia.
Negative Marinoff Index (0) is a sign of the absence of dyspareunia.
Four grades of Marionoff Index are:
Marinoff Index 0 = no dyspareunia; Marinoff Index 1= discomfort/pain with intercourse that doesn't interfere with the frequency of sex; Marinoff Index 2= pain with intercourse which sometimes prevents intercourse and Marinoff Index 3= pain with intercourse preventing any intercourse.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aggravation Of Vulvar Complaints Depending On Sexual Intercourse In Patients With Vulvar Dermatosis And Vulvodynia</measure>
    <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
    <description>The relationship between sexual vulvar discomfort and sexual intercourse (provocation and aggravation) in patients with vulvar dermatosis and vulvodynia, as recommended in the ISSVD Questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aggravation of Vulvar Discomfort Through Various Triggers in Patients With Vulvar Dermatosis and Vulvodynia</measure>
    <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
    <description>The table shows the relationship among worsening of vulvar discomfort by using tampons, cycling, wearing tight clothes, menstruation, and urination in patients with vulvar dermatosis and vulvodynia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Problems Associated With Urination and Defecation in Patients With and Without Vulvar Discomfort</measure>
    <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
    <description>The table shows the incidence of the problems with urination and defecation in four groups of patients with and without vulvar discomfort.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other Associated Symptoms and Diseases in Patients With and Without Vulvar Discomfort</measure>
    <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
    <description>The table shows the incidence of the other associated symptoms and diseases in four groups of patients, as recommended in the ISSVD Questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Previous Treatment of Patients With Vulvar Dermatosis and Vulvodynia</measure>
    <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
    <description>The table shows the incidence of the previous treatment in patients with vulvar dermatosis and vulvodynia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cotton Swab Test (Q-Tip) in Patients With and Without Vulvar Discomfort</measure>
    <time_frame>Cotton Swab Test, up to 10 minutes for each participant.</time_frame>
    <description>The table shows the results of Cotton-Swab Test in four groups of patients. Cotton-Swab Test or Q-Tip Testing is part of a multidisciplinary approach to the assessment of sexual pain, especially, vulvodynia or vestibulodynia, in women. ISSVD recommended the Cotton-Swab test for the differential diagnosis of vulvodynia.
The test consists of using a cotton-swab to palpate multiple vulvar and vestibular site while recording the woman's pain.
We performed Cotton-Swab Test by touching the vulva at 6 points (each vulvar ring), organized into locations based on a clock face and marked like the hours on the clock: 2h, 4h, 6h, 8h, 10h, and 12 h.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distribution of Non-Specific and Specific Vulvar Lesions in Relation to The Three Vulvar Rings (TRIV)</measure>
    <time_frame>Three Rings Vulvoscopy, up to 45 minutes for each participant.</time_frame>
    <description>The table shows the distribution of non-specific and specific vulvar lesions in relation to the three vulvar rings (TRIV).
The &quot;OUTER Vulvar Ring&quot; includes vulvar skin, the &quot;MIDDLE Vulvar Ring&quot; encompasses the modified mucosa, and the &quot;INNER Vulvar Ring&quot; is presented with glicogenized mucosa.
&quot;Non-Specific Lesions&quot; include non-specific erythema, punctuations, papillae, paleness and smoothness, fissures or sores in the absence of infection and pre/malignancy in any part of the vulva.
&quot;Specific Lesions&quot; comprise eczematous inflammation with thickened, excoriated skin within chronic lichen simplex; hypopigmented or white lesions, fusion or resorption of the labia minora and clitoral hood, loss of vulvar architecture and sclerotic changes in lichen sclerosis; white reticular pattern to extensive erosion with agglutination or resorption of the labia within lichen planus and psoriatic erythematous papules with silver, scaly plaques.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distribution of Non-Specific and Specific Lesions of the Outer Vulvar Ring According to the &quot;Three Rings Vulvoscopy&quot;</measure>
    <time_frame>Three Rings Vulvoscopy, up to 45 minutes for each participant.</time_frame>
    <description>The table shows the distribution of the non-specific and specific lesions of the vulva according to individual structures of the Outer Vulvar Ring according to the TRIV.
The &quot;OUTER Vulvar Ring&quot; includes vulvar skin with the following structures: mons pubis, labia majora, and the perineum.
&quot;Non-Specific Lesions&quot; include non-specific erythema, punctuations, papillae, paleness and smoothness, fissures or sores in the absence of infection and pre/malignancy in any part of the vulva.
&quot;Specific Lesions&quot; (lesions specific for vulvar dermatosis) comprise eczematous inflammation with thickened, excoriated skin within chronic lichen simplex; hypopigmented or white lesions, fusion or resorption of the labia minora and clitoral hood, loss of vulvar architecture and sclerotic changes in lichen sclerosis; white reticular pattern to extensive erosion with agglutination or resorption of the labia within lichen planus and psoriatic erythematous papules with silver, scaly plaques.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distribution of Non-Specific and Specific Lesions of the Middle Vulvar Ring According to the &quot;Three Rings Vulvoscopy&quot;</measure>
    <time_frame>Three Rings Vulvoscopy, up to 45 minutes for each participant.</time_frame>
    <description>The table shows the distribution of non-specific and specific lesions of the vulva in relation to the individual structures of the Middle vulvar ring according to the &quot;Three Rings Vulvoscopy.&quot; The &quot;MIDDLE vulvar ring&quot; includes the anterior commissure with the prepuce of the clitoris, interlabial sulci, labia minora, and the posterior commissure.
&quot;Non-Specific Lesions&quot; include non-specific erythema, punctuations, papillae, paleness and smoothness, fissures or sores in the absence of infection and pre/malignancy in any part of the vulva.
&quot;Specific Lesions&quot; comprise eczematous inflammation with thickened, excoriated skin within chronic lichen simplex; hypopigmented or white lesions, fusion or resorption of the labia minora and clitoral hood, loss of vulvar architecture and sclerotic changes in lichen sclerosis; white reticular pattern to extensive erosion with agglutination or resorption of the labia within lichen planus and psoriatic erythematous papules with silver, scaly plaques.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distribution of Non-Specific and Specific Lesions of the Inner Vulvar Ring According to the &quot;Three Rings Vulvoscopy&quot;</measure>
    <time_frame>Three Rings Vulvoscopy, up to 45 minutes for each participant.</time_frame>
    <description>The table shows the distribution of non-specific and specific lesions of the vulva in relation to the individual structures of the Inner vulvar ring according to the &quot;Three Rings Vulvoscopy.&quot; The &quot;INNER vulvar ring&quot; includes clitoris, Hart's line, urethral sulcus, urethral meatus, hymenal remnants, Bartholin's gland opening, and the vestibule.
&quot;Non-Specific Lesions&quot; include non-specific erythema, punctuations, papillae, paleness and smoothness, fissures or sores in the absence of infection and pre/malignancy in any part of the vulva.
&quot;Specific Lesions&quot; comprise eczematous inflammation with thickened, excoriated skin within chronic lichen simplex; hypopigmented or white lesions, fusion or resorption of the labia minora and clitoral hood, loss of vulvar architecture and sclerotic changes in lichen sclerosis; white reticular pattern to extensive erosion with agglutination or resorption of the labia within lichen planus and psoriatic erythematous papules with silver, scaly plaques.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aceto-Whitening Reaction (AWR) in Relation to the Three Vulvar Rings</measure>
    <time_frame>Aceto-Whitening Test, up to 10 minutes for each participant.</time_frame>
    <description>The table shows the presence, the quality, and the distribution of the aceto-whitening reaction after 5% acetic acid application (Aceto-Whitening Test), in relation to the three vulvar rings.
The &quot;OUTER Vulvar Ring&quot; includes vulvar skin, the &quot;MIDDLE Vulvar Ring&quot; encompasses the modified mucosa, and the &quot;INNER Vulvar Ring&quot; is presented with glicogenized mucosa.
Acetic acid is thought to cause swelling of the epithelial tissue through reversible coagulation or precipitation of the nuclear proteins and cytokeratins.
Areas of pre-/malignant lesions turn densely white and opaque immediately after application of acetic acid, due to the presence of large numbers of dysplastic cells in the superficial layers of the epithelium.
The acetowhite appearance is not unique to pre-/malignancy; it is also seen in other conditions with increased nuclear protein. The acetowhite reaction varies in intensity, within and between patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Velocity of the Aceto-Whitening Reaction (Mean ± SD)</measure>
    <time_frame>Aceto-Whitening Test, up to 10 minutes for each participant.</time_frame>
    <description>The table shows the velocity (Mean ± SD) of the aceto-whitening occurrence after 5% acetic acid application (AWR - aceto-whitening reaction) in patients with positive AWR classified into four groups based on anamnestic data and clinical examination.
Acetic acid is thought to cause swelling of the epithelial tissue through reversible coagulation or precipitation of the nuclear proteins and cytokeratins.
Areas of pre-/malignant lesions turn densely white and opaque immediately after application of acetic acid, due to their higher concentration of abnormal nuclear protein and the presence of large numbers of dysplastic cells in the superficial layers of the epithelium.
The acetowhite appearance is not unique to pre-/malignancy; it is also seen in other conditions with increased nuclear protein like immature squamous metaplasia, regeneration, inflammation, HPV-infection, hyperkeratosis, etc. The acetowhite reaction varies in intensity, within and between patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Velocity of Aceto-Whitening Reaction (Median | Range)</measure>
    <time_frame>Aceto-Whitening Test, up to 10 minutes for each participant.</time_frame>
    <description>The table shows the velocity (Median | Range) of the aceto-whitening occurrence after 5% acetic acid application (AWR - aceto-whitening reaction) in patients with positive AWR classified into four groups based on anamnestic data and clinical examination.
Acetic acid is thought to cause swelling of the epithelial tissue through reversible coagulation or precipitation of the nuclear proteins and cytokeratins.
Areas of pre-/malignant lesions turn densely white and opaque immediately after application of acetic acid, due to their higher concentration of abnormal nuclear protein and the presence of large numbers of dysplastic cells in the superficial layers of the epithelium.
The acetowhite appearance is not unique to pre-/malignancy; it is also seen in other conditions with increased nuclear protein like immature squamous metaplasia, regeneration, inflammation, HPV-infection, hyperkeratosis, etc. The acetowhite reaction varies in intensity, within and between patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distribution of Aceto-Whitening Reaction in Relation to the Structures of the Outer Vulvar Ring</measure>
    <time_frame>Aceto-Whitening Test, up to 10 minutes for each participant.</time_frame>
    <description>The table shows the distribution of aceto-whitening occurrence (AWR) after 5% acetic acid application in relation to the structures of the Outer Vulvar Ring.
The &quot;OUTER Vulvar Ring&quot; is presented with the following structures: Mons Pubis, Labia Majora, and the Perineum.
Acetic acid is thought to cause swelling of the epithelial tissue through reversible coagulation or precipitation of the nuclear proteins and cytokeratins.
Areas of pre-/malignant lesions turn densely white and opaque immediately after application of acetic acid, due to the presence of large numbers of dysplastic cells in the superficial layers of the epithelium.
The acetowhite appearance is not unique to pre-/malignancy; it is also seen in other conditions with increased nuclear protein. The acetowhite reaction varies in intensity, within and between patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distribution of Aceto-Whitening Reaction in Relation to the Structures of the Middle Vulvar Ring</measure>
    <time_frame>Aceto-Whitening Test, up to 10 minutes for each participant.</time_frame>
    <description>The distribution of aceto-whitening occurrence after 5% acetic acid application (AWR - aceto-whitening reaction) in relation to the structures of the Middle Vulvar Ring.
The &quot;MIDDLE vulvar ring&quot; encompasses the following structures: the anterior commissure with the prepuce of the clitoris, interlabial sulci, labia minora, and the posterior commissure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distribution of Aceto-Whitening Reaction in Relation to the Structures of the Inner Vulvar Ring</measure>
    <time_frame>Aceto-Whitening Test, up to 10 minutes for each participant.</time_frame>
    <description>The table shows the distribution of aceto-whitening reaction (AWR) after 5% acetic acid application (AWR - aceto-whitening reaction) in relation to the structures of the Inner Vulvar Ring.
The &quot;INNER Vulvar Ring&quot; is presented with the following structures: the clitoris, Hart's line, the urethral sulcus, the urethral meatus, hymenal remnants, Bartholin's gland opening, and the vestibule.
Acetic acid is thought to cause swelling of the epithelial tissue through reversible coagulation or precipitation of the nuclear proteins and cytokeratins.
Areas of pre-/malignant lesions turn densely white and opaque immediately after application of acetic acid, due to the presence of large numbers of dysplastic cells in the superficial layers of the epithelium.
The acetowhite appearance is not unique to pre-/malignancy; it is also seen in other conditions with increased nuclear protein. The acetowhite reaction varies in intensity, within and between patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histopathological Characteristics of Vulvar Specimens in Patients With And Without Vulvar Discomfort</measure>
    <time_frame>Histopathological Examination, up to 30 minutes for each vulvar sample.</time_frame>
    <description>The table shows the distribution of histopathological findings of vulvar epidermis among patients with and without vulvar discomfort, classified into four groups based on anamnestic data, clinical examination and &quot;Three Rings Vulvoscopy.&quot; Histopathological characteristics of vulvar epidermis included hyperkeratosis, parakeratosis, acanthosis, and epidermal atrophy. In the vulvar dermis, there were evaluated presence of inflammatory infiltrates (monocytes, lymphocytes, mastocytes), collagen fibers, hyalinization, hyperpigmentation, elongated dermal papillae, blood vessels, sebaceous glands, and nerve fibers.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histopathological Features of the Vulvar Epidermis and Vulvar Discomfort in Patients With Vulvar Dermatosis</measure>
    <time_frame>Histopathological Examination, up to 30 minutes for each vulvar sample.</time_frame>
    <description>The table shows the relationship between histopathological features of the vulvar epidermis (normal versus abnormal) and single vulvar symptoms from the categories of the dull (&quot;slow&quot;) and sharp (&quot;fast&quot;) pain of the vulva in 82 patients with vulvar dermatosis.
The dull pain comprises sensations of burning, stinging, soreness, irritation,itching, inflammation and aching.
The fast pain includes sensations like sticking and stabbing, paper-cut or knife-like pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histopathological Features of the Vulvar Epidermis and Vulvar Complaints in Patients With Vulvodynia</measure>
    <time_frame>Histopathological Examination, up to 30 minutes for each vulvar sample.</time_frame>
    <description>The table shows the relationship between histopathological features of the vulvar epidermis (normal versus abnormal), and single vulvar symptoms from the categories of the dull (&quot;slow&quot;) and sharp (&quot;fast&quot;) pain of the vulva in 82 patients with vulvodynia diagnosed anamnestically and clinically following Friedrich's criteria.
The &quot;dull&quot; pain comprises sensations of burning, stinging, soreness, irritation, itching, inflammation and aching. The &quot;fast&quot; pain includes sensations like sticking and stabbing, paper-cut or knife-like pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histopathological Features of Vulvar Dermis in Patients With Vulvar Dermatosis Depending On The Duration of Vulvar Discomfort</measure>
    <time_frame>Histopathological Examination, up to 30 minutes for each vulvar sample.</time_frame>
    <description>The table shows the relationship between histopathological features of the vulvar dermis depending on the duration of vulvar discomfort (less or more than 24 months) in 82 consecutive patients with vulvar dermatosis.
Histopathological characteristics of vulvar dermis included inflammatory infiltrates (mononuclear, lymphocytes, mastocytes), collagen fibers, hyalinization, hyperpigmentation, elongated dermal papillae, blood vessels, sebaceous glands, and nerve fibers.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histopathological Features of the Vulvar Dermis in Patients With Vulvodynia Depending on The Duration of Vulvar Discomfort</measure>
    <time_frame>Histopathological Examination, up to 30 minutes for each vulvar sample.</time_frame>
    <description>The table shows the relationship between histopathological features of the vulvar dermis depending on the duration of vulvar discomfort (less or more than 24 months) in 82 patients with vulvodynia, diagnosed anamnestically and clinically following Friedrich's criteria.
Histopathological characteristics of vulvar dermis included inflammatory infiltrates (mononuclear, lymphocytes, mastocytes), collagen fibers, hyalinization, hyperpigmentation, elongated dermal papillae, blood vessels, sebaceous glands, and nerve fibers.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">328</enrollment>
  <condition>Lichen Sclerosus</condition>
  <condition>Lichen Planus</condition>
  <condition>Lichen Simplex Chronicus</condition>
  <condition>Vulvodynia</condition>
  <arm_group>
    <arm_group_label>Normal vulva</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The &quot;Normal vulva&quot; group consisted of patients without vulvar discomfort (ISSVD Questionnaire), and without any vulvar lesion (Clinical examination) undergoing planned labioplasty. For each patient with vulvar dermatosis, the first consecutive patient with normal vulva was taken for comparison.
Interventions: Three Rings Vulvoscopy, Vulvar Biopsy, and Histopathology.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Impaired vulvar skin</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The group of &quot;Impaired vulvar skin&quot; was formed by the patients without vulvar symptoms (ISSVD Questionnaire), but with some non-specific vulvar lesions (Clinical examination) undergoing planned labioplasty, before surgery. For each patient with vulvar dermatosis, the first consecutive patient with impaired vulvar skin was taken for comparison.
Interventions: Three Rings Vulvoscopy, Vulvar Biopsy, and Histopathology.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vulvodynia</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The &quot;Vulvodynia&quot; group consisted of patients with vulvar discomfort (ISSVD Questionnaire), who fulfilled Friedrich's criteria (Clinical examination). Non-specific lesions found with TRIV were not relevant for the diagnosis of vulvodynia. For each patient with vulvar dermatosis, the first consecutive patient with vulvodynia was taken for comparison.
Interventions: Three Rings Vulvoscopy, Vulvar Biopsy, and Histopathology.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vulvar dermatosis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The group of &quot;Vulvar Dermatosis&quot; was formed by the patients with vulvar discomfort (ISSVD Questionnaire) and vulvar lesion specific for dermatosis (Clinical examination).
Interventions: Three Rings Vulvoscopy, Vulvar Biopsy, and Histopathology.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>&quot;Three Rings Vulvoscopy&quot; (TRIV)</intervention_name>
    <description>Mapping of the vulvar lesions according to the three vulvar rings and specificity of the lesions during &quot;Three Rings Vulvoscopy&quot; technique (TRIV Form Data). Assessing of the data by the &quot;Vulvoscopy Index&quot; and the &quot;N-S-P Scheme&quot;.</description>
    <arm_group_label>Impaired vulvar skin</arm_group_label>
    <arm_group_label>Normal vulva</arm_group_label>
    <arm_group_label>Vulvar dermatosis</arm_group_label>
    <arm_group_label>Vulvodynia</arm_group_label>
    <other_name>Colposcopy of the Vulva</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Histopathology</intervention_name>
    <description>Biopsy of the vulva in symptomatic patients, vulvar samples after labiaplasty in asymptomatic patients.</description>
    <arm_group_label>Impaired vulvar skin</arm_group_label>
    <arm_group_label>Normal vulva</arm_group_label>
    <arm_group_label>Vulvar dermatosis</arm_group_label>
    <arm_group_label>Vulvodynia</arm_group_label>
    <other_name>Biopsy of the Vulva</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        &quot;Three Rings Vulvoscopy&quot; performed at Poliklinika Harni, during the period from December
        2011 - December 2016.

        Ability to provide Informed Consent and complete Questionnaire.

        Exclusion Criteria:

        Incomplete medical records. Lack of histopathology. Vulvo-vaginal infection. Benign tumors
        of the vulva. Pre-/malignant conditions of the vulva.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vesna Harni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Poliklinika Harni, Bukovacka 1, HR-10000 Zagreb, Croatia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Poliklinika Harni</name>
      <address>
        <city>Zagreb</city>
        <zip>HR-10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <reference>
    <citation>Moyal-Barracco M, Wendling J. Vulvar dermatosis. Best Pract Res Clin Obstet Gynaecol. 2014 Oct;28(7):946-58. doi: 10.1016/j.bpobgyn.2014.07.005. Epub 2014 Jul 18. Review.</citation>
    <PMID>25132276</PMID>
  </reference>
  <reference>
    <citation>Doyen J, Demoulin S, Delbecque K, Goffin F, Kridelka F, Delvenne P. Vulvar skin disorders throughout lifetime: about some representative dermatoses. Biomed Res Int. 2014;2014:595286. doi: 10.1155/2014/595286. Epub 2014 Jan 8. Review.</citation>
    <PMID>24511539</PMID>
  </reference>
  <reference>
    <citation>Ball SB, Wojnarowska F. Vulvar dermatoses: lichen sclerosus, lichen planus, and vulval dermatitis/lichen simplex chronicus. Semin Cutan Med Surg. 1998 Sep;17(3):182-8.</citation>
    <PMID>9759675</PMID>
  </reference>
  <reference>
    <citation>McKay M. Vulvar dermatoses: common problems in dermatological and gynaecological practice. Br J Clin Pract Suppl. 1990 Sep;71:5-10. Review.</citation>
    <PMID>2091734</PMID>
  </reference>
  <reference>
    <citation>O'Keefe RJ, Scurry JP, Dennerstein G, Sfameni S, Brenan J. Audit of 114 non-neoplastic vulvar biopsies. Br J Obstet Gynaecol. 1995 Oct;102(10):780-6.</citation>
    <PMID>7547733</PMID>
  </reference>
  <reference>
    <citation>Cooper SM, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol. 2008 Nov;144(11):1432-5. doi: 10.1001/archderm.144.11.1432.</citation>
    <PMID>19015417</PMID>
  </reference>
  <reference>
    <citation>Raspollini MR, Asirelli G, Moncini D, Taddei GL. A comparative analysis of lichen sclerosus of the vulva and lichen sclerosus that evolves to vulvar squamous cell carcinoma. Am J Obstet Gynecol. 2007 Dec;197(6):592.e1-5. Epub 2007 Aug 21.</citation>
    <PMID>17714682</PMID>
  </reference>
  <reference>
    <citation>Shier M, El-Khatib S. Vulvar lichen sclerosus. J Obstet Gynaecol Can. 2010 Oct;32(10):929-30. English, French.</citation>
    <PMID>21176300</PMID>
  </reference>
  <reference>
    <citation>Petersen CD, Kristensen E, Lundvall L, Giraldi A. A retrospective study of relevant diagnostic procedures in vulvodynia. J Reprod Med. 2009 May;54(5):281-7.</citation>
    <PMID>19517691</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>March 15, 2016</study_first_submitted>
  <study_first_submitted_qc>April 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2016</study_first_posted>
  <results_first_submitted>October 2, 2018</results_first_submitted>
  <results_first_submitted_qc>October 7, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">October 30, 2019</results_first_posted>
  <last_update_submitted>October 7, 2019</last_update_submitted>
  <last_update_submitted_qc>October 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ginekološka Poliklinika Dr. Vesna Harni</investigator_affiliation>
    <investigator_full_name>Vesna Harni</investigator_full_name>
    <investigator_title>Dr. med. Vesna Harni</investigator_title>
  </responsible_party>
  <keyword>Three-Vulvar-Rings</keyword>
  <keyword>Three-Rings-Vulvoscopy</keyword>
  <keyword>N-S-P scheme</keyword>
  <keyword>Vulvoscopy Index</keyword>
  <keyword>Vulvar Dermatosis</keyword>
  <keyword>Vulvar Lichen Sclerosus</keyword>
  <keyword>Lichen Planus</keyword>
  <keyword>Lichen Simplex Chronicus</keyword>
  <keyword>Vulvodynia</keyword>
  <keyword>Provoked Vestibulodynia</keyword>
  <keyword>Vulvar Vestibulitis</keyword>
  <keyword>Vulvar Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vulvodynia</mesh_term>
    <mesh_term>Lichen Planus</mesh_term>
    <mesh_term>Skin Diseases</mesh_term>
    <mesh_term>Lichen Sclerosus et Atrophicus</mesh_term>
    <mesh_term>Neurodermatitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_id>ISBN:978-1-63484-507-6</doc_id>
      <doc_type>Chapter/Commentary</doc_type>
      <doc_url>https://novapublishers.com/shop/cryosurgery-and-colposcopy-practices-outcomes-and-potential-complications/</doc_url>
      <doc_comment>Harni V, Babic D, Barisic D. &quot;Three Rings Vulvoscopy&quot; - A New Approach to the Vulva. In: Cryosurgery and Colposcopy: Practices, Outcomes and Potential Complications, Editor: Lillian Watson. Publisher: Nova Science Publishers Inc, NewYork, USA, 2016.</doc_comment>
    </study_doc>
  </study_docs>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were recruited at &quot;Poliklinika Harni,&quot; Zagreb, Croatia, during routine gynecological care, and from esthetic unit to obtain vulvar specimens from patients with the normal vulva.
For each patient with vulvar dermatosis, the first consecutive patient with vulvodynia, impaired vulvar skin, and normal vulva was taken for comparison.</recruitment_details>
      <pre_assignment_details>Vulvar discomfort was evaluated with the ISSVD Vulvodynia Pattern Questionnaire (1. level of the investigation/pre-assignment), and vulvar lesions were assessed by clinical examination and Cotton-Swab test (2. level of the study/pre-assignment).
Patients with vulvar infection and pre/malignancy were excluded from further investigation.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Normal Vulva</title>
          <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and finding any vulvar lesion (Clinical Examination and Cotton-Swab Test); undergoing planned labioplasty, who granted vulvar specimens for further investigation.</description>
        </group>
        <group group_id="P2">
          <title>Impaired Vulvar Skin</title>
          <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire), but with some non-specific vulvar lesions (Clinical Examination and Cotton-Swab Test); undergoing planned labioplasty, who granted vulvar specimens for further investigation.</description>
        </group>
        <group group_id="P3">
          <title>Vulvodynia</title>
          <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria (Clinical Examination and Cotton-Swab Test). Non-specific lesions found with TRIV were not relevant for the diagnosis of vulvodynia.</description>
        </group>
        <group group_id="P4">
          <title>Vulvar Dermatosis</title>
          <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and vulvar lesions specific for dermatosis (Clinical Examination and Cotton-Swab Test).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="82"/>
                <participants group_id="P2" count="82"/>
                <participants group_id="P3" count="82"/>
                <participants group_id="P4" count="82"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="82"/>
                <participants group_id="P2" count="82"/>
                <participants group_id="P3" count="82"/>
                <participants group_id="P4" count="82"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Normal Vulva</title>
          <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and finding any vulvar lesion (Clinical Examination and Cotton-Swab Test); undergoing planned labioplasty, who granted vulvar specimens for further investigation.</description>
        </group>
        <group group_id="B2">
          <title>Impaired Vulvar Skin</title>
          <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire), but with some non-specific vulvar lesions (Clinical Examination and Cotton-Swab Test); undergoing planned labioplasty, who granted vulvar specimens for further investigation.</description>
        </group>
        <group group_id="B3">
          <title>Vulvodynia</title>
          <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria (Clinical Examination and Cotton-Swab Test). Non-specific lesions found with TRIV were not relevant for the diagnosis of vulvodynia.</description>
        </group>
        <group group_id="B4">
          <title>Vulvar Dermatosis</title>
          <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and vulvar lesions specific for dermatosis (Clinical Examination and Cotton-Swab Test).</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="82"/>
            <count group_id="B2" value="82"/>
            <count group_id="B3" value="82"/>
            <count group_id="B4" value="82"/>
            <count group_id="B5" value="328"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="81"/>
                    <measurement group_id="B2" value="79"/>
                    <measurement group_id="B3" value="82"/>
                    <measurement group_id="B4" value="66"/>
                    <measurement group_id="B5" value="308"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="15"/>
                    <measurement group_id="B5" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.21" spread="10.01"/>
                    <measurement group_id="B2" value="34.44" spread="9.37"/>
                    <measurement group_id="B3" value="35.71" spread="7.97"/>
                    <measurement group_id="B4" value="51.11" spread="16.21"/>
                    <measurement group_id="B5" value="38.87" spread="10.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="82"/>
                    <measurement group_id="B2" value="82"/>
                    <measurement group_id="B3" value="82"/>
                    <measurement group_id="B4" value="82"/>
                    <measurement group_id="B5" value="328"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="82"/>
                    <measurement group_id="B2" value="82"/>
                    <measurement group_id="B3" value="82"/>
                    <measurement group_id="B4" value="82"/>
                    <measurement group_id="B5" value="328"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Croatia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="82"/>
                    <measurement group_id="B2" value="82"/>
                    <measurement group_id="B3" value="82"/>
                    <measurement group_id="B4" value="82"/>
                    <measurement group_id="B5" value="328"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Diagnostic Accuracy of &quot;Three Rings Vulvoscopy&quot; by the &quot;Vulvoscopy Index&quot; for Detection of Vulvar Dermatosis</title>
        <description>The table shows the distribution of patients with and without vulvar dermatosis diagnosed by &quot;Three Rings Vulvoscopy&quot; (TRIV) using the &quot;Vulvoscopy Index&quot; and histopathology as a reference test.
The Vulvoscopy Index as an outcome measure of TRIV is designed as a quantitative test based on five characteristics: vulvar complaints, Marinoff index, Cotton-Swab test, vulvar lesions according to the three vulvar rings and specificity of lesions; with following results: &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points), &quot;Vulvodynia&quot; (12-18 points), and &quot;Vulvar Dermatosis&quot; (19-32 points).
Since histopathology distinguishes only patients with and without vulvar dermatosis, the clinical value the Vulvoscopy Index had been estimated according to these two groups of patients. Patients with vulvoscopy diagnoses: &quot;Normal Vulva,&quot; &quot;Impaired Vulvar Skin&quot; and &quot;Vulvodynia&quot; were classified into the group &quot;Absent Vulvar Dermatosis.&quot;</description>
        <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
        <population>Vulvar dermatosis was diagnosed in 82 patients by vulvoscopy and 72 patients by histopathology. Absent vulvar dermatosis was found in 246 patients by vulvoscopy and 256 patients by histopathology. The likelihood of vulvar dermatosis was higher as the value of the Vulvoscopy index was higher.</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvoscopy: Vulvar Dermatosis</title>
            <description>Patients with vulvoscopy diagnosis &quot;Vulvar Dermatosis&quot; according to the &quot;Vulvoscopy Index&quot; (19-32 points).</description>
          </group>
          <group group_id="O2">
            <title>Vulvoscopy: Absent Vulvar Dermatosis</title>
            <description>Patients with vulvoscopy diagnoses &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points) and &quot;Vulvodynia&quot; (12-18 points) according to the &quot;Vulvoscopy Index&quot;, who were classified into one group labeled by the term&quot; Absent Vulvar Dermatosis&quot;.</description>
          </group>
        </group_list>
        <measure>
          <title>Diagnostic Accuracy of &quot;Three Rings Vulvoscopy&quot; by the &quot;Vulvoscopy Index&quot; for Detection of Vulvar Dermatosis</title>
          <description>The table shows the distribution of patients with and without vulvar dermatosis diagnosed by &quot;Three Rings Vulvoscopy&quot; (TRIV) using the &quot;Vulvoscopy Index&quot; and histopathology as a reference test.
The Vulvoscopy Index as an outcome measure of TRIV is designed as a quantitative test based on five characteristics: vulvar complaints, Marinoff index, Cotton-Swab test, vulvar lesions according to the three vulvar rings and specificity of lesions; with following results: &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points), &quot;Vulvodynia&quot; (12-18 points), and &quot;Vulvar Dermatosis&quot; (19-32 points).
Since histopathology distinguishes only patients with and without vulvar dermatosis, the clinical value the Vulvoscopy Index had been estimated according to these two groups of patients. Patients with vulvoscopy diagnoses: &quot;Normal Vulva,&quot; &quot;Impaired Vulvar Skin&quot; and &quot;Vulvodynia&quot; were classified into the group &quot;Absent Vulvar Dermatosis.&quot;</description>
          <population>Vulvar dermatosis was diagnosed in 82 patients by vulvoscopy and 72 patients by histopathology. Absent vulvar dermatosis was found in 246 patients by vulvoscopy and 256 patients by histopathology. The likelihood of vulvar dermatosis was higher as the value of the Vulvoscopy index was higher.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="246"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Histopathology: Vulvar Dermatosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Histopathology: Absent Vulvar Dermatosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="246"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: Sensitivity of &quot;Three Rings Vulvoscopy&quot; for detection of vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Question: Determination of sensitivity of the &quot;Vulvoscopy Index&quot; as a measure of the sensitivity of &quot;Three Rings Vulvoscopy&quot; in comparison to the histopathological diagnosis of vulvar dermatosis.</non_inferiority_desc>
            <param_type>Sensitivity (2x2 Table)</param_type>
            <param_value>1.0000</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.0000</ci_lower_limit>
            <ci_upper_limit>1.0000</ci_upper_limit>
            <estimate_desc>The Sensitivity of the &quot;Vulvoscopy Index&quot; for Detection of Vulvar Dermatosis was 1.000 (Range: 1.0000 – 1.0000).</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: Specificity of &quot;Three Rings Vulvoscopy&quot; for detection of vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Question: Determination of specificity of the &quot;Vulvoscopy index&quot; as a measure of the specificity of &quot;Three Rings Vulvoscopy&quot; in comparison to the histopathological diagnosis of vulvar dermatosis.</non_inferiority_desc>
            <param_type>Specificity (2x2 Table)</param_type>
            <param_value>0.9609</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.5794</ci_lower_limit>
            <ci_upper_limit>1.0000</ci_upper_limit>
            <estimate_desc>The Specificity of the &quot;Vulvoscopy Index&quot; for Detection of Vulvar Dermatosis was 0.9609 (Range: 0.5794 – 1.0000)</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: Diagnostic accuracy of &quot;Three Rings Vulvoscopy&quot; for detection of vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Question: Determination of diagnostic accuracy of the &quot;Vulvoscopy index&quot; as a measure of the diagnostic value of &quot;Three Rings Vulvoscopy&quot; in comparison to the histopathological diagnosis of vulvar dermatosis.</non_inferiority_desc>
            <param_type>Diagnostic Accuracy (2x2 Table)</param_type>
            <param_value>0.9695</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.6313</ci_lower_limit>
            <ci_upper_limit>1.0000</ci_upper_limit>
            <estimate_desc>The Diagnostic accuracy of the &quot;Vulvoscopy Index&quot; for Detection of Vulvar Dermatosis was 0.9695 (Range: 0.6313 – 1.0000)</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: Positive predictive value of &quot;Three Rings Vulvoscopy&quot; for detection of vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Determination of positive predictive value of the &quot;Vulvoscopy index&quot; for detection of vulvar dermatosis in comparison to the histopathology results.</non_inferiority_desc>
            <param_type>PPV (2x2 Table)</param_type>
            <param_value>0.8780</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.2270</ci_lower_limit>
            <ci_upper_limit>1.0000</ci_upper_limit>
            <estimate_desc>Positive predictive value of the &quot;Vulvoscopy Index&quot; for Detection of Vulvar Dermatosis was 0.8780 (Range: 0.2270 - 1.0000).</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: Negative predictive value of &quot;Three Rings Vulvoscopy&quot; for detection of vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Question: Determination of negative predictive value of the &quot;Vulvoscopy index&quot; for detection of vulvar dermatosis in comparison to the histopathology results.</non_inferiority_desc>
            <param_type>NPV (2x2 Table)</param_type>
            <param_value>1.0000</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.0000</ci_lower_limit>
            <ci_upper_limit>1.0000</ci_upper_limit>
            <estimate_desc>Negative predictive value of the &quot;Vulvoscopy Index&quot; for Detection of Vulvar Dermatosis was 1.0000 (Range: 1.0000 - 1.0000).</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the diagnostic accuracy between TRIV using the &quot;Vulvoscopy Index&quot; and histopathology for detection of vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the diagnostic accuracy of the &quot;Vulvoscopy Index&quot; as an outcome measure of the diagnostic value of &quot;Three Rings Vulvoscopy,&quot; and histopathology?</non_inferiority_desc>
            <p_value>0.6108</p_value>
            <method>t-test proportion</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Distribution of Patients With Vulvar Dermatosis Diagnosed by Vulvoscopy (TRIV) and Histopathology According to Single Categories of the &quot;Vulvoscopy Index&quot;</title>
        <description>The table shows the distribution of patients with &quot;Vulvar Dermatosis&quot; diagnosed by &quot;Three Rings Vulvoscopy&quot; and histopathology according to single categories of the &quot;Vulvoscopy Index.&quot;
We described five categories within the Vulvoscopy Index:
Vulvar complaints (present vs. absent),
Marinoff index (positive vs. negative),
Cotton-Swab test (positive vs. negative),
Vulvar lesions according to the vulvar rings (Outer, Middle, and Inner Vulvar Ring Lesion) and
Specificity of lesions (Non-specific and Specific Lesions).</description>
        <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
        <population>Vulvar dermatosis was diagnosed in 82 patients by vulvoscopy and 72 patients by histopathology. The likelihood of vulvar dermatosis was higher as the value of the Vulvoscopy index was higher.</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvoscopy: Vulvar Dermatosis</title>
            <description>Patients with vulvoscopy diagnosis &quot;Vulvar Dermatosis&quot; according to the &quot;Vulvoscopy Index&quot; (19-32 points).</description>
          </group>
          <group group_id="O2">
            <title>Histopathology: Vulvar Dermatosis</title>
            <description>Histopathological diagnosis &quot;Vulvar Dermatosis&quot; from the vulvar specimens of 328 women was set in 72 patients.</description>
          </group>
        </group_list>
        <measure>
          <title>Distribution of Patients With Vulvar Dermatosis Diagnosed by Vulvoscopy (TRIV) and Histopathology According to Single Categories of the &quot;Vulvoscopy Index&quot;</title>
          <description>The table shows the distribution of patients with &quot;Vulvar Dermatosis&quot; diagnosed by &quot;Three Rings Vulvoscopy&quot; and histopathology according to single categories of the &quot;Vulvoscopy Index.&quot;
We described five categories within the Vulvoscopy Index:
Vulvar complaints (present vs. absent),
Marinoff index (positive vs. negative),
Cotton-Swab test (positive vs. negative),
Vulvar lesions according to the vulvar rings (Outer, Middle, and Inner Vulvar Ring Lesion) and
Specificity of lesions (Non-specific and Specific Lesions).</description>
          <population>Vulvar dermatosis was diagnosed in 82 patients by vulvoscopy and 72 patients by histopathology. The likelihood of vulvar dermatosis was higher as the value of the Vulvoscopy index was higher.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="72"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Vulvar Complaints</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82"/>
                    <measurement group_id="O2" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Marinoff Index</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                    <measurement group_id="O2" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Cotton-Swab</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lesions In Any Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82"/>
                    <measurement group_id="O2" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Outer Vulvar Ring Lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77"/>
                    <measurement group_id="O2" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Middle Vulvar Ring Lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82"/>
                    <measurement group_id="O2" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inner Vulvar Ring Lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74"/>
                    <measurement group_id="O2" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-Specific Lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71"/>
                    <measurement group_id="O2" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82"/>
                    <measurement group_id="O2" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of vulvar complaints in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of vulvar complaints among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of positive Marinoff Index in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of positive Marinoff Index among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.9628</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of the positive Cotton-Swab test in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of the positive Cotton-Swab test among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.9152</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of any lesion in any vulvar ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of any lesion in any vulvar ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of any vulvar lesion of the Outer Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of any vulvar lesion of the Outer Vulvar Ring among the patients with vulvar dermatosis diagnosed with vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.8862</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of any vulvar lesion of the Middle Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of any vulvar lesion of the Middle Vulvar Ring among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of any vulvar lesion of the Inner Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of any vulvar lesion of the Inner Vulvar Ring among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.3319</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of non-specific vulvar lesions in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of non-specific vulvar lesions among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.8662</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of vulvar lesions specific for dermatosis in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of specific vulvar lesions among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Distribution of Patients With &quot;Absent Vulvar Dermatosis&quot; Diagnosed by Vulvoscopy (TRIV) and Histopathology According to Single Categories of the &quot;Vulvoscopy Index&quot;</title>
        <description>The table shows the distribution of patients with &quot;Absent Vulvar Dermatosis&quot; diagnosed by &quot;Three Rings Vulvoscopy&quot; (patients with vulvoscopical diagnoses &quot;Normal Vulva,&quot; Impaired Vulvar Skin &quot;and&quot; Vulvodynia&quot;) and histopathology, according to single categories of the &quot;Vulvoscopy Index.&quot;
The five categories within the Vulvoscopy Index are:
Vulvar complaints (present vs. absent),
Marinoff index (positive vs. negative),
Cotton-Swab test (positive vs. negative),
Vulvar lesions according to the vulvar rings (Outer, Middle, and Inner Vulvar Ring Lesion) and
Specificity of lesions (Non-specific and Specific Lesions).</description>
        <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
        <population>&quot;Absent Vulvar Dermatosis&quot; was diagnosed in 246 patients by vulvoscopy and 256 patients by histopathology. The likelihood of absent vulvar dermatosis was higher as the value of the Vulvoscopy index was lower.</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvoscopy: Absent Vulvar Dermatosis</title>
            <description>Patients with vulvoscopy diagnoses &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points) and &quot;Vulvodynia&quot; (12-18 points) according to the &quot;Vulvoscopy Index&quot;, who were classified into one group labeled by the term&quot; Absent Vulvar Dermatosis&quot;.</description>
          </group>
          <group group_id="O2">
            <title>Histopathology: Absent Vulvar Dermatosis</title>
            <description>Histopathological diagnosis &quot;Normal Vulva&quot; or absent vulvar dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Distribution of Patients With &quot;Absent Vulvar Dermatosis&quot; Diagnosed by Vulvoscopy (TRIV) and Histopathology According to Single Categories of the &quot;Vulvoscopy Index&quot;</title>
          <description>The table shows the distribution of patients with &quot;Absent Vulvar Dermatosis&quot; diagnosed by &quot;Three Rings Vulvoscopy&quot; (patients with vulvoscopical diagnoses &quot;Normal Vulva,&quot; Impaired Vulvar Skin &quot;and&quot; Vulvodynia&quot;) and histopathology, according to single categories of the &quot;Vulvoscopy Index.&quot;
The five categories within the Vulvoscopy Index are:
Vulvar complaints (present vs. absent),
Marinoff index (positive vs. negative),
Cotton-Swab test (positive vs. negative),
Vulvar lesions according to the vulvar rings (Outer, Middle, and Inner Vulvar Ring Lesion) and
Specificity of lesions (Non-specific and Specific Lesions).</description>
          <population>&quot;Absent Vulvar Dermatosis&quot; was diagnosed in 246 patients by vulvoscopy and 256 patients by histopathology. The likelihood of absent vulvar dermatosis was higher as the value of the Vulvoscopy index was lower.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="246"/>
                <count group_id="O2" value="256"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Vulvar Complaints</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82"/>
                    <measurement group_id="O2" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Marinoff Index</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74"/>
                    <measurement group_id="O2" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Cotton-Swab</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="104"/>
                    <measurement group_id="O2" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Vulvar Ring Lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="163"/>
                    <measurement group_id="O2" value="173"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Outer Vulvar Ring Lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Middle Vulvar Ring Lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="115"/>
                    <measurement group_id="O2" value="125"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inner Vulvar Ring Lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="156"/>
                    <measurement group_id="O2" value="162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-Specific Lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="163"/>
                    <measurement group_id="O2" value="171"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of vulvar complaints in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of vulvar complaints among the patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.5399</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of positive Marinoff Index in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of positive Marinoff Index among the patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.9248</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of the positive Cotton-Swab test in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of the positive Cotton-Swab test among the patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.9839</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of any lesion in any vulvar ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of any lesion in any vulvar ring among the patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.7537</p_value>
            <method>t</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of any vulvar lesion of the Outer Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of any vulvar lesion of the Outer Vulvar Ring among the patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.2054</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of any vulvar lesion of the Middle Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of any vulvar lesion of the Middle Vulvar Ring among the patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.6409</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of any vulvar lesion of the Inner Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of any vulvar lesion of the Inner Vulvar Ring among the patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.9753</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of non-specific vulvar lesions in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of non-specific vulvar lesions among the patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.8986</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of vulvar lesions specific for dermatosis in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology (first biopsy).</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of specific vulvar lesions among the patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology (first biopsy)?</non_inferiority_desc>
            <p_value>0.0017</p_value>
            <method>t-test proportion</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>&quot;Vulvoscopy Index&quot; (Mean ± SD) in Patients With &quot;Vulvar Dermatosis&quot; Diagnosed by Vulvoscopy (TRIV) and Histopathology</title>
        <description>The table shows the results of &quot;Three Rings Vulvoscopy&quot; (TRIV) by single categories of the &quot;Vulvoscopy Index&quot; (mean ± SD) in patients with &quot;Vulvar Dermatosis&quot; diagnosed by TRIV and histopathology.
The Vulvoscopy Index is based on five characteristics:
Vulvar complaints (negative=0; positive=4 points),
Marinoff index (negative=0; positive=3 points),
Cotton-Swab test (negative=0; positive=2 points),
Vulvar lesions according to the vulvar rings (Outer Vulvar Ring Lesions=4 points; Middle Vulvar Ring Lesions=2 points and Inner Vulvar Ring Lesions=1 point) and
Specificity of lesions (Non-Specific Lesions=2 points; Specific Lesions=14 points).
According to the Vulvoscopy Index, we have set the diagnoses: &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points), &quot;Vulvodynia&quot; (12-18 points), and &quot;Vulvar Dermatosis&quot; (19-32 points).
The likelihood of the diagnosis of &quot;Vulvar Dermatosis&quot; was higher as the value of the Vulvoscopy index was higher.</description>
        <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
        <population>Vulvar dermatosis was diagnosed in 82 patients by vulvoscopy and 72 patients by histopathology. The likelihood of vulvar dermatosis was higher as the value of the Vulvoscopy index was higher.</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvoscopy: Vulvar Dermatosis</title>
            <description>Patients with vulvoscopy diagnosis &quot;Vulvar Dermatosis&quot; according to the &quot;Vulvoscopy Index&quot; (19-32 points).</description>
          </group>
          <group group_id="O2">
            <title>Histopathology: Vulvar Dermatosis</title>
            <description>Histopathological diagnosis &quot;Vulvar Dermatosis&quot; from the vulvar specimens of 328 women was set in 72 patients.</description>
          </group>
        </group_list>
        <measure>
          <title>&quot;Vulvoscopy Index&quot; (Mean ± SD) in Patients With &quot;Vulvar Dermatosis&quot; Diagnosed by Vulvoscopy (TRIV) and Histopathology</title>
          <description>The table shows the results of &quot;Three Rings Vulvoscopy&quot; (TRIV) by single categories of the &quot;Vulvoscopy Index&quot; (mean ± SD) in patients with &quot;Vulvar Dermatosis&quot; diagnosed by TRIV and histopathology.
The Vulvoscopy Index is based on five characteristics:
Vulvar complaints (negative=0; positive=4 points),
Marinoff index (negative=0; positive=3 points),
Cotton-Swab test (negative=0; positive=2 points),
Vulvar lesions according to the vulvar rings (Outer Vulvar Ring Lesions=4 points; Middle Vulvar Ring Lesions=2 points and Inner Vulvar Ring Lesions=1 point) and
Specificity of lesions (Non-Specific Lesions=2 points; Specific Lesions=14 points).
According to the Vulvoscopy Index, we have set the diagnoses: &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points), &quot;Vulvodynia&quot; (12-18 points), and &quot;Vulvar Dermatosis&quot; (19-32 points).
The likelihood of the diagnosis of &quot;Vulvar Dermatosis&quot; was higher as the value of the Vulvoscopy index was higher.</description>
          <population>Vulvar dermatosis was diagnosed in 82 patients by vulvoscopy and 72 patients by histopathology. The likelihood of vulvar dermatosis was higher as the value of the Vulvoscopy index was higher.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="72"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Vulvar Complaints (0-4 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="0.0"/>
                    <measurement group_id="O2" value="4.0" spread="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Marinoff Index (0-3 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.28" spread="1.49"/>
                    <measurement group_id="O2" value="1.29" spread="1.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cotton-Swab (0-2 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.68" spread="0.95"/>
                    <measurement group_id="O2" value="0.67" spread="0.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Vulvar Ring Lesions (0-7 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.66" spread="1.08"/>
                    <measurement group_id="O2" value="6.72" spread="1.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Outer Vulvar Ring Lesions (0-4 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.76" spread="0.96"/>
                    <measurement group_id="O2" value="3.78" spread="0.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Middle Vulvar Ring Lesions (0-2 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="0.0"/>
                    <measurement group_id="O2" value="2.0" spread="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inner Vulvar Ring Lesions (0-1 Point)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.90" spread="0.30"/>
                    <measurement group_id="O2" value="0.94" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specificity of Lesions (0-16)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.73" spread="0.69"/>
                    <measurement group_id="O2" value="15.75" spread="0.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-Specific Lesions (0-2 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.73" spread="0.69"/>
                    <measurement group_id="O2" value="1.75" spread="0.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions (0-14 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.0" spread="0.0"/>
                    <measurement group_id="O2" value="14.0" spread="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sum (0-32 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.35" spread="2.46"/>
                    <measurement group_id="O2" value="28.43" spread="2.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for vulvar complaints (mean) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for vulvar complaints (mean) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for Marinoff Index (mean) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for Marinoff Index (mean) among patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.9899</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for the Cotton-Swab test (mean) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for the Cotton-Swab test (mean) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.9686</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for any lesion in any vulvar ring (mean) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for any lesion in any vulvar ring (mean) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.7055</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for any vulvar lesion of the Outer Vulvar Ring (mean) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for any vulvar lesion of the Outer Vulvar Ring (mean) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.8852</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for any vulvar lesion of the Middle Vulvar Ring (mean) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for any vulvar lesion of the Middle Vulvar Ring (mean) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for any vulvar lesion of the Inner Vulvar Ring (mean) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for any vulvar lesion of the Inner Vulvar Ring (mean) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.3351</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for the specificity of vulvar lesions (mean) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for the specificity of vulvar lesions (mean) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.8673</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for non-specific vulvar lesions (mean) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for non-specific vulvar lesions (mean) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.8673</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for specific vulvar lesions (mean) with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for specific vulvar lesions (mean) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the overall sum of points for the &quot;Vulvoscopy Index&quot; (mean) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the overall sum of points for the &quot;Vulvoscopy Index&quot; (mean) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.8472</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>&quot;Vulvoscopy Index&quot; (Mean ± SD) in Patients With &quot;Absent Vulvar Dermatosis&quot; Diagnosed by Vulvoscopy (TRIV) and Histopathology</title>
        <description>The table shows the results of &quot;Three Rings Vulvoscopy&quot; (TRIV) by single categories of the &quot;Vulvoscopy Index&quot; (mean± SD) in patients with &quot;Absent Vulvar Dermatosis&quot; diagnosed by TRIV and histopathology.
According to the Vulvoscopy Index, we have set the diagnoses: &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points), &quot;Vulvodynia&quot; (12-18 points), and &quot;Vulvar Dermatosis&quot; (19-32 points).
Since histopathology can distinguish only patients with and without vulvar dermatosis, the distribution was estimated according to these two groups of patients. Hence, patients with vulvoscopical diagnoses &quot;Normal Vulva,&quot; Impaired Vulvar Skin &quot;and&quot; Vulvodynia&quot; were classified into the one group called &quot;Absent Vulvar Dermatosis.&quot; The likelihood of the diagnosis of &quot;Absent Vulvar Dermatosis&quot; was higher as the value of the Vulvoscopy index was lower.</description>
        <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
        <population>&quot;Absent Vulvar Dermatosis&quot; was diagnosed in 246 patients by vulvoscopy and 256 patients by histopathology.</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvoscopy: Absent Vulvar Dermatosis</title>
            <description>Patients with vulvoscopy diagnoses &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points) and &quot;Vulvodynia&quot; (12-18 points) according to the &quot;Vulvoscopy Index&quot;, who were classified into one group labeled by the term&quot; Absent Vulvar Dermatosis&quot;.</description>
          </group>
          <group group_id="O2">
            <title>Histopathology: Absent Vulvar Dermatosis</title>
            <description>Histopathological diagnosis: &quot;Normal Vulva&quot; or absent vulvar dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>&quot;Vulvoscopy Index&quot; (Mean ± SD) in Patients With &quot;Absent Vulvar Dermatosis&quot; Diagnosed by Vulvoscopy (TRIV) and Histopathology</title>
          <description>The table shows the results of &quot;Three Rings Vulvoscopy&quot; (TRIV) by single categories of the &quot;Vulvoscopy Index&quot; (mean± SD) in patients with &quot;Absent Vulvar Dermatosis&quot; diagnosed by TRIV and histopathology.
According to the Vulvoscopy Index, we have set the diagnoses: &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points), &quot;Vulvodynia&quot; (12-18 points), and &quot;Vulvar Dermatosis&quot; (19-32 points).
Since histopathology can distinguish only patients with and without vulvar dermatosis, the distribution was estimated according to these two groups of patients. Hence, patients with vulvoscopical diagnoses &quot;Normal Vulva,&quot; Impaired Vulvar Skin &quot;and&quot; Vulvodynia&quot; were classified into the one group called &quot;Absent Vulvar Dermatosis.&quot; The likelihood of the diagnosis of &quot;Absent Vulvar Dermatosis&quot; was higher as the value of the Vulvoscopy index was lower.</description>
          <population>&quot;Absent Vulvar Dermatosis&quot; was diagnosed in 246 patients by vulvoscopy and 256 patients by histopathology.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="246"/>
                <count group_id="O2" value="256"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Vulvar Complaints (0-4 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.33" spread="1.89"/>
                    <measurement group_id="O2" value="1.44" spread="1.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Marinoff Index (0-3 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.90" spread="1.38"/>
                    <measurement group_id="O2" value="0.91" spread="1.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cotton-Swab (0-2 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.85" spread="0.99"/>
                    <measurement group_id="O2" value="0.84" spread="0.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Vulvar Ring Lesions (0-7 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.86" spread="1.92"/>
                    <measurement group_id="O2" value="2.03" spread="2.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Outer Vulvar Ring Lesions (0-4 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" spread="1.04"/>
                    <measurement group_id="O2" value="0.49" spread="1.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Middle Vulvar Ring Lesions (0-2 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.93" spread="1.00"/>
                    <measurement group_id="O2" value="0.98" spread="1.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inner Vulvar Ring Lesions (0-1 Point)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.63" spread="0.48"/>
                    <measurement group_id="O2" value="0.63" spread="0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specificity of Lesions (0-16 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.33" spread="0.95"/>
                    <measurement group_id="O2" value="1.88" spread="2.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-Specific Lesions (0-2 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.33" spread="0.95"/>
                    <measurement group_id="O2" value="1.34" spread="094"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions (0-14 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" spread="0.0"/>
                    <measurement group_id="O2" value="0.55" spread="2.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sum (0-32 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.27" spread="5.89"/>
                    <measurement group_id="O2" value="7.11" spread="7.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>&quot;Vulvoscopy Index&quot; (Median | Range) in Patients With &quot;Vulvar Dermatosis&quot; Diagnosed by Vulvoscopy (TRIV) and Histopathology</title>
        <description>The table shows the results of &quot;Three Rings Vulvoscopy&quot; (TRIV) by single categories of the &quot;Vulvoscopy Index&quot; (median ± SD) in patients with &quot;Vulvar Dermatosis&quot; diagnosed by TRIV and histopathology.
The Vulvoscopy Index is based on five characteristics:
Vulvar complaints (negative=0; positive=4 points),
Marinoff index (negative=0; positive=3 points),
Cotton-Swab test (negative=0; positive=2 points),
Vulvar lesions according to the vulvar rings (Outer Vulvar Ring Lesions=4 points; Middle Vulvar Ring Lesions=2 points and Inner Vulvar Ring Lesions=1 point) and
Specificity of lesions (Non-specific Lesions=2 points; Specific Lesions=14 points).
According to the Vulvoscopy Index, we have set the diagnoses: &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points), &quot;Vulvodynia&quot; (12-18 points), and &quot;Vulvar Dermatosis&quot; (19-32 points).
The likelihood of the diagnosis of &quot;Vulvar Dermatosis&quot; was higher as the value of the Vulvoscopy index was higher.</description>
        <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
        <population>Vulvar dermatosis was diagnosed in 82 patients by vulvoscopy and 72 patients by histopathology.</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvoscopy: Vulvar Dermatosis</title>
            <description>Patients with vulvoscopy diagnosis &quot;Vulvar Dermatosis&quot; according to the &quot;Vulvoscopy Index&quot; (19-32 points).</description>
          </group>
          <group group_id="O2">
            <title>Histopathology: Vulvar Dermatosis</title>
            <description>Histopathological diagnosis &quot;Vulvar Dermatosis&quot; from the vulvar specimens of 328 women was set in 72 patients.</description>
          </group>
        </group_list>
        <measure>
          <title>&quot;Vulvoscopy Index&quot; (Median | Range) in Patients With &quot;Vulvar Dermatosis&quot; Diagnosed by Vulvoscopy (TRIV) and Histopathology</title>
          <description>The table shows the results of &quot;Three Rings Vulvoscopy&quot; (TRIV) by single categories of the &quot;Vulvoscopy Index&quot; (median ± SD) in patients with &quot;Vulvar Dermatosis&quot; diagnosed by TRIV and histopathology.
The Vulvoscopy Index is based on five characteristics:
Vulvar complaints (negative=0; positive=4 points),
Marinoff index (negative=0; positive=3 points),
Cotton-Swab test (negative=0; positive=2 points),
Vulvar lesions according to the vulvar rings (Outer Vulvar Ring Lesions=4 points; Middle Vulvar Ring Lesions=2 points and Inner Vulvar Ring Lesions=1 point) and
Specificity of lesions (Non-specific Lesions=2 points; Specific Lesions=14 points).
According to the Vulvoscopy Index, we have set the diagnoses: &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points), &quot;Vulvodynia&quot; (12-18 points), and &quot;Vulvar Dermatosis&quot; (19-32 points).
The likelihood of the diagnosis of &quot;Vulvar Dermatosis&quot; was higher as the value of the Vulvoscopy index was higher.</description>
          <population>Vulvar dermatosis was diagnosed in 82 patients by vulvoscopy and 72 patients by histopathology.</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="72"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Vulvar Complaints (0-4 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="4" upper_limit="4"/>
                    <measurement group_id="O2" value="4" lower_limit="4" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Marinoff Index (0-3 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cotton-Swab (0-2 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Vulvar Ring Lesions (0-7 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="2" upper_limit="7"/>
                    <measurement group_id="O2" value="7" lower_limit="2" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Outer Vulvar Ring Lesions (0-4 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="4" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Middle Vulvar Ring Lesions (0-2 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="2" upper_limit="2"/>
                    <measurement group_id="O2" value="2" lower_limit="2" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inner Vulvar Ring Lesions (0-1 Point)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specificity of Lesions, in total (0-16 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" lower_limit="14" upper_limit="16"/>
                    <measurement group_id="O2" value="16" lower_limit="14" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-Specific Lesions (0-2 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="2" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions (0-14 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14" lower_limit="14" upper_limit="14"/>
                    <measurement group_id="O2" value="14" lower_limit="14" upper_limit="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sum (0-32 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.5" lower_limit="21" upper_limit="32"/>
                    <measurement group_id="O2" value="28.5" lower_limit="21" upper_limit="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for vulvar complaints (median) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for vulvar complaints (median) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for Marinoff Index (median) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for Marinoff Index (median) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.9629</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for the Cotton-Swab test (median) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for the Cotton-Swab test (median) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.9155</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for any lesion in any vulvar ring (median) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for any lesion in any vulvar ring (median) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.4913</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for any vulvar lesion of the Outer Vulvar Ring (median) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for any vulvar lesion of the Outer Vulvar Ring (median) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.8866</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for any vulvar lesion of the Middle Vulvar Ring (median) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for any vulvar lesion of the Middle Vulvar Ring (median) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for any vulvar lesion of the Inner Vulvar Ring (median) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for any vulvar lesion of the Inner Vulvar Ring (median) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.3335</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for the specificity of vulvar lesions (median) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for the specificity of vulvar lesions (median) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.8666</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for non-specific vulvar lesions (median) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for non-specific vulvar lesions (median) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.8666</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for specific vulvar lesions (median) with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for specific vulvar lesions (median) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the overall sum of points for the &quot;Vulvoscopy Index&quot; (median) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the overall sum of points for the &quot;Vulvoscopy Index&quot; (median) among the patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.8144</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>&quot;Vulvoscopy Index&quot; (Median | Range) in Patients With &quot;Absent Vulvar Dermatosis&quot; Diagnosed by Vulvoscopy (TRIV) and Histopathology</title>
        <description>The table shows the results of &quot;Three Rings Vulvoscopy&quot; (TRIV) by single categories of the &quot;Vulvoscopy Index&quot; (median ± SD) in patients with &quot;Absent Vulvar Dermatosis&quot; diagnosed by TRIV (patients with vulvoscopical diagnoses &quot;Normal Vulva,&quot; Impaired Vulvar Skin &quot;and&quot; Vulvodynia&quot;) and histopathology.
According to the Vulvoscopy Index, we have set the diagnoses: &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points), &quot;Vulvodynia&quot; (12-18 points), and &quot;Vulvar Dermatosis&quot; (19-32 points).
The likelihood of the diagnosis of &quot;Absent Vulvar Dermatosis&quot; was higher as the value of the Vulvoscopy index was lower.</description>
        <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
        <population>&quot;Absent Vulvar Dermatosis&quot; was diagnosed in 246 patients by vulvoscopy and 256 patients by histopathology.</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvoscopy: Absent Vulvar Dermatosis</title>
            <description>Patients with vulvoscopy diagnoses &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points) and &quot;Vulvodynia&quot; (12-18 points) according to the &quot;Vulvoscopy Index&quot;, who were classified into one group labeled by the term&quot; Absent Vulvar Dermatosis&quot;.</description>
          </group>
          <group group_id="O2">
            <title>Histopathology: Absent Vulvar Dermatosis</title>
            <description>Histopathological diagnosis: &quot;Normal Vulva&quot; or absent vulvar dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>&quot;Vulvoscopy Index&quot; (Median | Range) in Patients With &quot;Absent Vulvar Dermatosis&quot; Diagnosed by Vulvoscopy (TRIV) and Histopathology</title>
          <description>The table shows the results of &quot;Three Rings Vulvoscopy&quot; (TRIV) by single categories of the &quot;Vulvoscopy Index&quot; (median ± SD) in patients with &quot;Absent Vulvar Dermatosis&quot; diagnosed by TRIV (patients with vulvoscopical diagnoses &quot;Normal Vulva,&quot; Impaired Vulvar Skin &quot;and&quot; Vulvodynia&quot;) and histopathology.
According to the Vulvoscopy Index, we have set the diagnoses: &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points), &quot;Vulvodynia&quot; (12-18 points), and &quot;Vulvar Dermatosis&quot; (19-32 points).
The likelihood of the diagnosis of &quot;Absent Vulvar Dermatosis&quot; was higher as the value of the Vulvoscopy index was lower.</description>
          <population>&quot;Absent Vulvar Dermatosis&quot; was diagnosed in 246 patients by vulvoscopy and 256 patients by histopathology.</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="246"/>
                <count group_id="O2" value="256"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Vulvar Complaints (0-4 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Marinoff Index (0-3 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cotton-Swab (0-2 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Vulvar Ring Lesions (0-7 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="7"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Outer Vulvar Ring Lesions (0-4 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Middle Vulvar Ring Lesions (0-2 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inner Vulvar Ring Lesions (0-1 Point)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specificity of Lesions, in total (0-16 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="2" lower_limit="0" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-Specific Lesions (0-2 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="2" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions (0-14 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sum (0-32 Points)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="0" upper_limit="18"/>
                    <measurement group_id="O2" value="5" lower_limit="0" upper_limit="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for vulvar complaints (median) in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for vulvar complaints in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.5403</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for Marinoff Index (median) in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for Marinoff Index in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.9248</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for the Cotton-Swab test (median) in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for the Cotton-Swab test in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.9839</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for any lesion in any vulvar ring (median) in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for any lesion in any vulvar ring (median) in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.5124</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for any vulvar lesion of the Outer Vulvar Ring (median) in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for any vulvar lesion of the Outer Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.2058</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for any vulvar lesion of the Middle Vulvar Ring (median) in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for any vulvar lesion of the Middle Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.6412</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for any vulvar lesion of the Inner Vulvar Ring (median) in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for any vulvar lesion of the Inner Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.9753</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for the specificity of vulvar lesions (median) in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for the specificity of vulvar lesions in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.3621</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for non-specific vulvar lesions (median) in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for non-specific vulvar lesions in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.8987</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the score for vulvar lesions specific for dermatosis (median) in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology (first biopsy).</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the score for specific vulvar lesions in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology (first biopsy)?</non_inferiority_desc>
            <p_value>0.0018</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the overall sum of points for the &quot;Vulvoscopy Index&quot; (median) in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the overall sum of points for the &quot;Vulvoscopy Index&quot; in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.4409</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Diagnostic Accuracy of &quot;Three Rings Vulvoscopy&quot; by the &quot;N-S-P Scheme&quot; for Detection of Vulvar Dermatosis</title>
        <description>The distribution of patients with and without vulvar dermatosis diagnosed by vulvoscopy (&quot;N-S-P Scheme&quot;) and histopathology.
According to the specificity of lesions, vulvoscopy results were classified as normal &quot;N&quot; (absence of any lesion), suspect &quot;S&quot; (non-specific lesions) and pathologic &quot;P&quot; results (lesion specific to dermatosis); and each of the three vulvar rings is represented by a single result.
The final vulvoscopy result is presented in the form of a three-letter formula, where the first letter indicates the vulvoscopy result in the Outer Vulvar Ring, the mean initial indicates the vulvoscopy result of the Middle Vulvar Ring and the last letter denotes the vulvoscopy result of the Inner Vulvar Ring.
&quot;N-S-P Scheme&quot; divides the results of the vulvoscopy into three groups: &quot;Normal Vulvoscopy,&quot; &quot;Suspect Vulvoscopy&quot; and &quot;Pathological Vulvoscopy.&quot; Diagnosis of vulvar dermatosis was established if one or more vulvar rings showed pathological results (&quot;Pathological Vulvoscopy&quot;).</description>
        <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
        <population>Histopathology distinguishes two groups of patients with and without vulvar dermatosis. Therefore the accuracy of the &quot;N-S-P Scheme&quot; had been estimated according to these two groups of patients.</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvoscopy: Vulvar Dermatosis</title>
            <description>Patients with vulvoscopy diagnosis &quot;Vulvar Dermatosis&quot; according to the &quot;Vulvoscopy Index&quot; (19-32 points).</description>
          </group>
          <group group_id="O2">
            <title>Vulvoscopy: Absent Vulvar Dermatosis</title>
            <description>Patients with vulvoscopy diagnoses &quot;Normal Vulva&quot; (0-2 points), &quot;Impaired Vulvar Skin&quot; (3-11 points) and &quot;Vulvodynia&quot; (12-18 points) according to the &quot;Vulvoscopy Index&quot;, who were classified into one group labeled by the term&quot; Absent Vulvar Dermatosis&quot;.</description>
          </group>
        </group_list>
        <measure>
          <title>Diagnostic Accuracy of &quot;Three Rings Vulvoscopy&quot; by the &quot;N-S-P Scheme&quot; for Detection of Vulvar Dermatosis</title>
          <description>The distribution of patients with and without vulvar dermatosis diagnosed by vulvoscopy (&quot;N-S-P Scheme&quot;) and histopathology.
According to the specificity of lesions, vulvoscopy results were classified as normal &quot;N&quot; (absence of any lesion), suspect &quot;S&quot; (non-specific lesions) and pathologic &quot;P&quot; results (lesion specific to dermatosis); and each of the three vulvar rings is represented by a single result.
The final vulvoscopy result is presented in the form of a three-letter formula, where the first letter indicates the vulvoscopy result in the Outer Vulvar Ring, the mean initial indicates the vulvoscopy result of the Middle Vulvar Ring and the last letter denotes the vulvoscopy result of the Inner Vulvar Ring.
&quot;N-S-P Scheme&quot; divides the results of the vulvoscopy into three groups: &quot;Normal Vulvoscopy,&quot; &quot;Suspect Vulvoscopy&quot; and &quot;Pathological Vulvoscopy.&quot; Diagnosis of vulvar dermatosis was established if one or more vulvar rings showed pathological results (&quot;Pathological Vulvoscopy&quot;).</description>
          <population>Histopathology distinguishes two groups of patients with and without vulvar dermatosis. Therefore the accuracy of the &quot;N-S-P Scheme&quot; had been estimated according to these two groups of patients.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="246"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Histopathology: Vulvar Dermatosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Histopathology: Absent Vulvar Dermatosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="246"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: Sensitivity of &quot;Three Rings Vulvoscopy&quot; for detection of vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Question: Determination of sensitivity of the &quot;N-S-P Scheme&quot; as a measure of the sensitivity of &quot;Three Rings Vulvoscopy&quot;, in comparison to the histopathological diagnosis of vulvar dermatosis.</non_inferiority_desc>
            <param_type>Sensitivity (2x2 Table)</param_type>
            <param_value>1.0000</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.0000</ci_lower_limit>
            <ci_upper_limit>1.0000</ci_upper_limit>
            <estimate_desc>The Sensitivity of the &quot;N-S-P Scheme&quot; for Detection of Vulvar Dermatosis was 1.0000 (Range: 1.0000 – 1.0000).</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: Specificity of &quot;Three Rings Vulvoscopy&quot; for detection of vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Question: Determination of specificity of the &quot;N-S-P Scheme&quot; as a measure of the specificity of &quot;Three Rings Vulvoscopy&quot;, in comparison to the histopathological diagnosis of vulvar dermatosis.</non_inferiority_desc>
            <param_type>Specificity (2x2 Table)</param_type>
            <param_value>0.9609</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.5794</ci_lower_limit>
            <ci_upper_limit>1.0000</ci_upper_limit>
            <estimate_desc>The Specificity of the &quot;N-S-P Scheme&quot; for Detection of Vulvar Dermatosis was 0.9609 (Range: 0.5794 – 1.0000).</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: Diagnostic accuracy of &quot;Three Rings Vulvoscopy&quot; for detection of vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Question: Determination of diagnostic accuracy of the &quot;N-S-P Scheme&quot; as a measure of the diagnostic value of the &quot;Three Rings Vulvoscopy&quot;, in relation to the histopathological diagnosis of vulvar dermatosis.</non_inferiority_desc>
            <param_type>Diagnostic Accuracy (2x2 Table)</param_type>
            <param_value>0.9695</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.6313</ci_lower_limit>
            <ci_upper_limit>1.0000</ci_upper_limit>
            <estimate_desc>The Diagnostic accuracy of the &quot;N-S-P Scheme&quot; for Detection of Vulvar Dermatosis was 0.9695 (Range: 0.6313 – 1.0000).</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: Positive predictive value of &quot;Three Rings Vulvoscopy&quot; for detection of vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Question: Determination of positive predictive value of the &quot;N-S-P Scheme&quot; for detection of vulvar dermatosis in comparison to the histopathology results.</non_inferiority_desc>
            <param_type>PPV (2x2 Table)</param_type>
            <param_value>0.8780</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.2270</ci_lower_limit>
            <ci_upper_limit>1.0000</ci_upper_limit>
            <estimate_desc>Positive predictive value of the &quot;N-S-P Scheme&quot; for Detection of Vulvar Dermatosis was 0.8780 (Range: 0.2270 - 1.0000).</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: Negative predictive value of &quot;Three Rings Vulvoscopy&quot; for detection of vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Question: Determination of negative predictive value of the &quot;N-S-P Scheme&quot; for detection of vulvar dermatosis in comparison to the histopathology results.</non_inferiority_desc>
            <param_type>NPV (2x2 Table)</param_type>
            <param_value>1.0000</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.0000</ci_lower_limit>
            <ci_upper_limit>1.0000</ci_upper_limit>
            <estimate_desc>Negative predictive value of the &quot;N-S-P Scheme&quot; for Detection of Vulvar Dermatosis was 1.0000 (Range: 1.0000 - 1.0000).</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the diagnostic accuracy between TRIV using the &quot;N-S-P Scheme&quot; and histopathology for detection of vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the diagnostic accuracy of the &quot;N-S-P Scheme&quot; as an outcome measure of the diagnostic value of &quot;Three Rings Vulvoscopy,&quot; and histopathology?</non_inferiority_desc>
            <p_value>0.6108</p_value>
            <method>t-test proportion</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Distribution of Vulvar Lesions According to the &quot;N-S-P Scheme&quot; in Patients With Vulvar Dermatosis Diagnosed by Vulvoscopy (TRIV) and Histopathology</title>
        <description>The table shows the distribution of vulvoscopy lesions in relation to the vulvar rings and their specificity according to the &quot;N-S-P Scheme,&quot; in patients with vulvar dermatosis diagnosed by vulvoscopy (TRIV) and histopathology.
Vulvoscopy findings of each of the three vulvar rings: Outer (first letter in the formula), Middle (second letter), and Inner Vulvar Ring (third letter) were evaluated as normal &quot;N&quot; (absence of any lesions), suspect &quot;S&quot; (non-specific lesions), or pathological &quot;P&quot; (lesions specific for dermatosis).
&quot;Normal vulvoscopy&quot; indicated the absence of any lesion in all three vulvar rings (&quot;N-N-N&quot;).
&quot;Suspect vulvoscopy&quot; was used to mark findings of non-specific lesions (&quot;S-#*-#&quot;; &quot;S-S-#&quot;; &quot;S-S-S&quot;; &quot;S-N-S&quot; etc.).
&quot;Pathological vulvoscopy&quot; spelled out the finding of lesions specific for dermatosis in any of the three vulvar rings (&quot;P-#-#&quot;; &quot;P-P-&quot;; &quot;P-P-P&quot;; &quot;P-N-S&quot; etc.).
is the label for any of the three possibilities: N or S or P.</description>
        <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
        <population>Vulvar dermatosis was diagnosed in 82 patients by vulvoscopy and 72 patients by histopathology. The likelihood of vulvar dermatosis was higher as one or more of the vulvar rings were assessed as &quot;P.&quot;</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvoscopy: Vulvar Dermatosis</title>
            <description>Patients with vulvoscopy diagnosis &quot;Vulvar Dermatosis&quot; according to the &quot;Vulvoscopy Index&quot; (19-32 points).</description>
          </group>
          <group group_id="O2">
            <title>Histopathology: Vulvar Dermatosis</title>
            <description>Histopathological diagnosis &quot;Vulvar Dermatosis&quot; from the vulvar specimens of 328 women was set in 72 patients.</description>
          </group>
        </group_list>
        <measure>
          <title>Distribution of Vulvar Lesions According to the &quot;N-S-P Scheme&quot; in Patients With Vulvar Dermatosis Diagnosed by Vulvoscopy (TRIV) and Histopathology</title>
          <description>The table shows the distribution of vulvoscopy lesions in relation to the vulvar rings and their specificity according to the &quot;N-S-P Scheme,&quot; in patients with vulvar dermatosis diagnosed by vulvoscopy (TRIV) and histopathology.
Vulvoscopy findings of each of the three vulvar rings: Outer (first letter in the formula), Middle (second letter), and Inner Vulvar Ring (third letter) were evaluated as normal &quot;N&quot; (absence of any lesions), suspect &quot;S&quot; (non-specific lesions), or pathological &quot;P&quot; (lesions specific for dermatosis).
&quot;Normal vulvoscopy&quot; indicated the absence of any lesion in all three vulvar rings (&quot;N-N-N&quot;).
&quot;Suspect vulvoscopy&quot; was used to mark findings of non-specific lesions (&quot;S-#*-#&quot;; &quot;S-S-#&quot;; &quot;S-S-S&quot;; &quot;S-N-S&quot; etc.).
&quot;Pathological vulvoscopy&quot; spelled out the finding of lesions specific for dermatosis in any of the three vulvar rings (&quot;P-#-#&quot;; &quot;P-P-&quot;; &quot;P-P-P&quot;; &quot;P-N-S&quot; etc.).
is the label for any of the three possibilities: N or S or P.</description>
          <population>Vulvar dermatosis was diagnosed in 82 patients by vulvoscopy and 72 patients by histopathology. The likelihood of vulvar dermatosis was higher as one or more of the vulvar rings were assessed as &quot;P.&quot;</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="72"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Outer Vulvar Ring: No Lesion | N-#-#</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Outer Vulvar Ring: Non-Specific Lesions | S-#-#</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Outer Vulvar Ring: Specific Lesions | P-#-#</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73"/>
                    <measurement group_id="O2" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Middle Vulvar Ring: No Lesion | #-N-#</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Middle Vulvar Ring: Non-Specific Lesions | #-S-#</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Middle Vulvar Ring: Specific Lesions | #-P-#</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73"/>
                    <measurement group_id="O2" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inner Vulvar Ring: No Lesion | #-#-N</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inner Vulvar Ring: Non-Specific Lesions | #-#-S</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                    <measurement group_id="O2" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inner Vulvar Ring: Specific Lesions | #-#-P</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All Three Vulvar Rings: No Lesion N-N-N</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Vulvar Ring: Non-Specific Lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67"/>
                    <measurement group_id="O2" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Vulvar Ring: Specific Lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82"/>
                    <measurement group_id="O2" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;N-#-#&quot; result (no lesions) of the Outer Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;N-#-#&quot; result (no lesions) of the Outer Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.9286</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;S-#-#&quot; result (non-specific lesions) of the Outer Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;S-#-#&quot; result (non-specific lesions) of the Outer Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.8618</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;P-#-#&quot; result (specific lesions) of the Outer Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;P-#-#&quot; result (specific lesions) of the Outer Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.9786</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;#-N-#&quot; result (no lesions) of the Middle Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;#-N-#&quot; result (no lesions) of the Middle Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;#-S-#&quot; result (non-specific lesions) of the Middle Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;#-S-#&quot; result (non-specific lesions) of the Middle Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.8634</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;#-P-#&quot; result (specific lesions) of the Middle Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;#-P-#&quot; result (specific lesions) of the Middle Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.7992</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;#-#-N&quot; result (no lesions) of the Inner Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;#-#-N&quot; result (no lesions) of the Inner Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.3912</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;#-#-S&quot; result (non-specific lesions) of the Inner Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;#-#-S&quot; result (non-specific lesions) of the Inner Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.6152</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;#-#-P&quot; result (specific lesions) of the Inner Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;#-#-P&quot; result (specific lesions) of the Inner Vulvar Ring in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.6108</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;N-N-N&quot; result (no lesions) in any of the Three Vulvar Rings in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;N-N-N&quot; result (no lesions) in any of the Three Vulvar Rings in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;S&quot; result (non-specific lesions) in any of the Three Vulvar Rings (&quot;S-#-#&quot;; &quot;S-S-#&quot;; &quot;S-S-S&quot;; &quot;S-N-S&quot; etc.) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;S&quot; result (non-specific lesions) in any of the Three Vulvar Rings (&quot;S-#-#&quot;; &quot;S-S-#&quot;; &quot;S-S-S&quot;; &quot;S-N-S&quot; etc.) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.7912</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;P&quot; result (specific lesions) in any of the Three Vulvar Rings (&quot;P-#-#&quot;; &quot;P-P-&quot;; &quot;P-P-P&quot;; &quot;P-N-S&quot; etc.) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;P&quot; result (specific lesions) in any of the Three Vulvar Rings (&quot;P-#-#&quot;; &quot;P-P-&quot;; &quot;P-P-P&quot;; &quot;P-N-S&quot; etc.) in patients with vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Distribution of Vulvar Lesions According to the &quot;N-S-P Scheme&quot; in Patients With Absent Vulvar Dermatosis Diagnosed by Vulvoscopy (TRIV) and Histopathology</title>
        <description>The table shows the distribution of lesions according to their specificity and vulvar rings in patients without vulvar dermatosis diagnosed by vulvoscopy (TRIV) and histopathology, as a reference test.
According to the &quot;N-S-P scheme,&quot; we have set the diagnoses: &quot;Normal result&quot; (no lesion), &quot;Suspect result&quot; (non-specific lesion in any of the vulvar rings), and &quot;Pathological result&quot; (specific for dermatosis in any of the vulvar rings).
Since histopathology can distinguish only patients with and without dermatosis, the distribution was estimated according to these two groups of patients. Hence, patients with normal and suspect vulvoscopic results were classified into one group called &quot;Absent Vulvar Dermatosis.&quot;</description>
        <time_frame>ISSVD Questionnaire and TRIV, up to 75 minutes for each participant.</time_frame>
        <population>&quot;Absent Vulvar Dermatosis&quot; was diagnosed in 246 patients by vulvoscopy and 256 patients by histopathology. The likelihood of absent vulvar dermatosis was higher as none of the vulvar rings were assessed as &quot;P.&quot;</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvoscopy: Absent Vulvar Dermatosis</title>
            <description>Patients with vulvoscopy diagnoses: &quot;Normal Vulva&quot;, &quot;Impaired Vulvar Skin&quot; and &quot;Vulvodynia&quot; according to the &quot;N-S-P Scheme&quot;, who were classified into one group marked by the term&quot; Absent Vulvar Dermatosis&quot;.</description>
          </group>
          <group group_id="O2">
            <title>Histopathology: Absent Vulvar Dermatosis</title>
            <description>Histopathological diagnosis &quot;Normal Vulva&quot; or absent vulvar dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Distribution of Vulvar Lesions According to the &quot;N-S-P Scheme&quot; in Patients With Absent Vulvar Dermatosis Diagnosed by Vulvoscopy (TRIV) and Histopathology</title>
          <description>The table shows the distribution of lesions according to their specificity and vulvar rings in patients without vulvar dermatosis diagnosed by vulvoscopy (TRIV) and histopathology, as a reference test.
According to the &quot;N-S-P scheme,&quot; we have set the diagnoses: &quot;Normal result&quot; (no lesion), &quot;Suspect result&quot; (non-specific lesion in any of the vulvar rings), and &quot;Pathological result&quot; (specific for dermatosis in any of the vulvar rings).
Since histopathology can distinguish only patients with and without dermatosis, the distribution was estimated according to these two groups of patients. Hence, patients with normal and suspect vulvoscopic results were classified into one group called &quot;Absent Vulvar Dermatosis.&quot;</description>
          <population>&quot;Absent Vulvar Dermatosis&quot; was diagnosed in 246 patients by vulvoscopy and 256 patients by histopathology. The likelihood of absent vulvar dermatosis was higher as none of the vulvar rings were assessed as &quot;P.&quot;</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="246"/>
                <count group_id="O2" value="256"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Outer Vulvar Ring: No Lesion | N-#-#</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="227"/>
                    <measurement group_id="O2" value="228"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Outer Vulvar Ring: Non-Specific Lesions | S-#-#</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Outer Vulvar Ring: Specific Lesions | P-#-#</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Middle Vulvar Ring: No Lesion | #-N-#</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="131"/>
                    <measurement group_id="O2" value="131"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Middle Vulvar Ring: Non-Specific Lesions | #-S-#</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="115"/>
                    <measurement group_id="O2" value="121"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Middle Vulvar Ring: Specific Lesions | #-P-#</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inner Vulvar Ring: No Lesion | #-#-N</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89"/>
                    <measurement group_id="O2" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inner Vulvar Ring: Non-Specific Lesions | #-#-S</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="157"/>
                    <measurement group_id="O2" value="161"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inner Vulvar Ring: Specific Lesions | #-#-P</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All Three Vulvar Rings: No Lesion N-N-N</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83"/>
                    <measurement group_id="O2" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Vulvar Ring: Non-Specific Lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="163"/>
                    <measurement group_id="O2" value="170"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Vulvar Ring: Specific Lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;N-#-#&quot; result (no lesions) of the Outer Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;N-#-#&quot; result (no lesions) of the Outer Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.2530</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;S-#-#&quot; result (non-specific lesions) of the Outer Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;S-#-#&quot; result (non-specific lesions) of the Outer Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.8338</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;P-#-#&quot; result (specific lesions) of the Outer Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;P-#-#&quot; result (specific lesions) of the Outer Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.0019</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;#-N-#&quot; result (no lesions) of the Middle Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;#-N-#&quot; result (no lesions) of the Middle Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.6541</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;#-S-#&quot; result (non-specific lesions) of the Middle Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;#-S-#&quot; result (non-specific lesions) of the Middle Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.8224</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;#-P-#&quot; result (specific lesions) of the Middle Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;#-P-#&quot; result (specific lesions) of the Middle Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.0064</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;#-#-N&quot; result (no lesions) of the Inner Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;#-#-N&quot; result (no lesions) of the Inner Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.9723</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;#-#-S&quot; result (non-specific lesions) of the Inner Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;#-#-S&quot; result (non-specific lesions) of the Inner Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.8161</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;#-#-P&quot; result (specific lesions) of the Inner Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;#-#-P&quot; result (specific lesions) of the Inner Vulvar Ring in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.1165</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;N-N-N&quot; result (no lesions) in any of the Three Vulvar Rings in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;N-N-N&quot; result (no lesions) in any of the Three Vulvar Rings in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.6339</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;S&quot; result (non-specific lesions) in any of the Three Vulvar Rings (&quot;S-#-#&quot;; &quot;S-S-#&quot;; &quot;S-S-S&quot;; &quot;S-N-S&quot; etc.) in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;S&quot; result (non-specific lesions) in any of the Three Vulvar Rings (&quot;S-#-#&quot;; &quot;S-S-#&quot;; &quot;S-S-S&quot;; &quot;S-N-S&quot; etc.) in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.9724</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of &quot;P&quot; result (specific lesions) in any of the Three Vulvar Rings (&quot;P-#-#&quot;; &quot;P-P-&quot;; &quot;P-P-P&quot;; &quot;P-N-S&quot; etc.) in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of &quot;P&quot; result (specific lesions) in any of the Three Vulvar Rings (&quot;P-#-#&quot;; &quot;P-P-&quot;; &quot;P-P-P&quot;; &quot;P-N-S&quot; etc.) in patients with absent vulvar dermatosis diagnosed by vulvoscopy and histopathology?</non_inferiority_desc>
            <p_value>0.0016</p_value>
            <method>t-test proportion</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Characteristics: Age</title>
        <description>The table shows the age in four groups of patients with and without vulvar discomfort.</description>
        <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
        <population>Baseline characteristics were assessed by anamnestic data (ISSVD Vulvodynia Pattern Questionnaire) and clinical examination.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Characteristics: Age</title>
          <description>The table shows the age in four groups of patients with and without vulvar discomfort.</description>
          <population>Baseline characteristics were assessed by anamnestic data (ISSVD Vulvodynia Pattern Questionnaire) and clinical examination.</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.2" spread="10.0"/>
                    <measurement group_id="O2" value="34.4" spread="9.4"/>
                    <measurement group_id="O3" value="34.2" spread="10.0"/>
                    <measurement group_id="O4" value="51.1" spread="16.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the age of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the age of patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Characteristics: Weight</title>
        <description>The table shows the weight in four groups of patients with and without vulvar discomfort.</description>
        <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
        <population>Baseline characteristics were assessed by anamnestic data (ISSVD Vulvodynia Pattern Questionnaire) and clinical examination.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Characteristics: Weight</title>
          <description>The table shows the weight in four groups of patients with and without vulvar discomfort.</description>
          <population>Baseline characteristics were assessed by anamnestic data (ISSVD Vulvodynia Pattern Questionnaire) and clinical examination.</population>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.9" spread="8.3"/>
                    <measurement group_id="O2" value="63.3" spread="10.9"/>
                    <measurement group_id="O3" value="61.1" spread="9.2"/>
                    <measurement group_id="O4" value="71.3" spread="12.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>The difference in the weight of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Is there a difference in the weight of patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Characteristics: Height</title>
        <description>The table shows the height in four groups of patients with and without vulvar discomfort.</description>
        <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
        <population>Baseline characteristics were assessed by anamnestic data (ISSVD Vulvodynia Pattern Questionnaire) and clinical examination.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Characteristics: Height</title>
          <description>The table shows the height in four groups of patients with and without vulvar discomfort.</description>
          <population>Baseline characteristics were assessed by anamnestic data (ISSVD Vulvodynia Pattern Questionnaire) and clinical examination.</population>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="169.1" spread="6.0"/>
                    <measurement group_id="O2" value="168.7" spread="6.3"/>
                    <measurement group_id="O3" value="166.7" spread="6.7"/>
                    <measurement group_id="O4" value="167.5" spread="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>The difference in the height of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Is there a difference in the height of patients from different groups.</non_inferiority_desc>
            <p_value>0.0557</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Characteristics: BMI</title>
        <description>The table shows the body mass index (Mean ± SD) in four groups of patients with and without vulvar discomfort.</description>
        <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
        <population>Baseline characteristics were assessed by anamnestic data (ISSVD Vulvodynia Pattern Questionnaire) and clinical examination.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Characteristics: BMI</title>
          <description>The table shows the body mass index (Mean ± SD) in four groups of patients with and without vulvar discomfort.</description>
          <population>Baseline characteristics were assessed by anamnestic data (ISSVD Vulvodynia Pattern Questionnaire) and clinical examination.</population>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.6" spread="2.5"/>
                    <measurement group_id="O2" value="22.3" spread="3.6"/>
                    <measurement group_id="O3" value="22.0" spread="2.9"/>
                    <measurement group_id="O4" value="25.4" spread="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>The difference in the body mass index of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Is there a difference in the body mass index of patients from different groups.</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Demographic Data in Patients With and Without Vulvar Discomfort</title>
        <description>The table shows demographic data - age: more or less than 65 years, reproductive age, menopause, domicile country as a country of birth, the degree of education (more and less than 12 years), marital status, births, abortions, and using of contraception among four groups of patient.</description>
        <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
        <population>We assesses demographic data by ISSVD Vulvodynia Pattern Questionnaire (anamnestic).</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding of any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Demographic Data in Patients With and Without Vulvar Discomfort</title>
          <description>The table shows demographic data - age: more or less than 65 years, reproductive age, menopause, domicile country as a country of birth, the degree of education (more and less than 12 years), marital status, births, abortions, and using of contraception among four groups of patient.</description>
          <population>We assesses demographic data by ISSVD Vulvodynia Pattern Questionnaire (anamnestic).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Age: ≥ 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Age: &lt; 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82"/>
                    <measurement group_id="O2" value="81"/>
                    <measurement group_id="O3" value="82"/>
                    <measurement group_id="O4" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Reproductive Age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77"/>
                    <measurement group_id="O2" value="79"/>
                    <measurement group_id="O3" value="76"/>
                    <measurement group_id="O4" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Menopausal age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Domicile country (Croatia) as a Country of Birth</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68"/>
                    <measurement group_id="O2" value="62"/>
                    <measurement group_id="O3" value="68"/>
                    <measurement group_id="O4" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Education: &gt;12 Years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="58"/>
                    <measurement group_id="O3" value="52"/>
                    <measurement group_id="O4" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Education: ≤12 Years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="24"/>
                    <measurement group_id="O3" value="30"/>
                    <measurement group_id="O4" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Married</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="39"/>
                    <measurement group_id="O3" value="44"/>
                    <measurement group_id="O4" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nuliparious</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="52"/>
                    <measurement group_id="O3" value="44"/>
                    <measurement group_id="O4" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Multiparous (3 and more births)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abortion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Contraception</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="20"/>
                    <measurement group_id="O4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of patients older than 65 years between different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of patients older than 65 years in different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of menopausal patients among different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of menopausal patients among different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of domicile country (Croatia) as a country of birth among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of domicile country (Croatia) as a country of birth among patients from different groups.</non_inferiority_desc>
            <p_value>0.3708</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of patients educated equally or less than 12 years among different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of patients educated equally or less than 12 years among different groups?</non_inferiority_desc>
            <p_value>0.0180</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of marital status among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in marital status among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the nulliparity among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the nulliparity among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the multiparity among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the multiparity among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the number of abortions among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the number of abortions among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the using of contraception among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the using of contraception among patients from different groups?</non_inferiority_desc>
            <p_value>0.1323</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Various Characteristics and Duration of Vulvar Discomfort in Patients With Vulvar Dermatosis and Vulvodynia</title>
        <description>The table shows various characteristics of vulvar pain (complaints) in patients with vulvar dermatosis or vulvodynia.
Generally, we can differentiate between two categories of pain - the dull pain vs. the sharp pain depending on the nerve fibers in the skin, which are involved in the provocation of the pain.
The symptoms of the dull pain are burning, stinging, soreness, irritation, itching, feeling of inflammation and aching.
The symptoms of the sharp pain are a knife-like pain, paper-cuts pain, stabbing and sticking. We do not know, are there some symptoms characteristic for vulvar dermatosis or vulvodynia.</description>
        <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
        <population>Vulvar discomfort was evaluated anamnestically by the &quot;ISSVD Vulvodynia Pattern Questionnaire&quot;.</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
          <group group_id="O2">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
        </group_list>
        <measure>
          <title>Various Characteristics and Duration of Vulvar Discomfort in Patients With Vulvar Dermatosis and Vulvodynia</title>
          <description>The table shows various characteristics of vulvar pain (complaints) in patients with vulvar dermatosis or vulvodynia.
Generally, we can differentiate between two categories of pain - the dull pain vs. the sharp pain depending on the nerve fibers in the skin, which are involved in the provocation of the pain.
The symptoms of the dull pain are burning, stinging, soreness, irritation, itching, feeling of inflammation and aching.
The symptoms of the sharp pain are a knife-like pain, paper-cuts pain, stabbing and sticking. We do not know, are there some symptoms characteristic for vulvar dermatosis or vulvodynia.</description>
          <population>Vulvar discomfort was evaluated anamnestically by the &quot;ISSVD Vulvodynia Pattern Questionnaire&quot;.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dull / Slow Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82"/>
                    <measurement group_id="O2" value="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Burning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stinging</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65"/>
                    <measurement group_id="O2" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Soreness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Irritation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                    <measurement group_id="O2" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Itching</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79"/>
                    <measurement group_id="O2" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inflammation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aching</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sharp / Fast Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Knife-Like Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Paper-Cuts Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stabbing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sticking</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Association Of Symptoms</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Duration Of Discomfort &gt;24 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                    <measurement group_id="O2" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Duration Of Discomfort &gt;12 monts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Duration Of Discomfort &gt;6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of symptoms of the dull pain of the vulva (burning, stinging, soreness, irritation, itching, inflammation, aching) among patients with vulvar discomfort.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of symptoms of the dull pain of the vulva among patients with vulvar discomfort?</non_inferiority_desc>
            <p_value>0.3158</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of symptoms of the sharp pain in the vulva (stabbing, sticking, knife-like pain, paper-cuts pain) among patients with vulvar discomfort.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of symptoms of the sharp pain of the vulva among patients with vulvar discomfort?</non_inferiority_desc>
            <p_value>0.0007</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of symptoms of the dull pain versus the sharp pain of the vulva in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the dull pain versus the sharp pain of the vulva in the patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of symptoms of the dull pain versus the sharp pain of the vulva in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the dull pain versus the sharp pain of the vulva in the patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar burning among patients with vulvar discomfort.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar burning among patients with vulvar discomfort?</non_inferiority_desc>
            <p_value>0.0147</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar stinging among patients with vulvar discomfort.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stinging among patients with vulvar discomfort?</non_inferiority_desc>
            <p_value>0.8456</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar soreness among patients with vulvar discomfort.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar soreness among patients with vulvar discomfort?</non_inferiority_desc>
            <p_value>0.0076</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of irritation of the vulva among patients with vulvar discomfort.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of irritation of the vulva among the patients with vulvar discomfort?</non_inferiority_desc>
            <p_value>0.0423</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the knife-like pain in the vulva among patients with vulvar discomfort.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the knife-like pain in the vulva among the patients with vulvar discomfort?</non_inferiority_desc>
            <p_value>0.0457</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the paper-cuts pain of the vulva among patients with vulvar discomfort.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the paper-cuts pain of the vulva among the patients with vulvar discomfort?</non_inferiority_desc>
            <p_value>0.0430</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the stabbing of the vulva among patients with vulvar discomfort.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the stabbing of the vulva among the patients with vulvar discomfort?</non_inferiority_desc>
            <p_value>0.0134</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of sticking of the vulva among patients with vulvar discomfort.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of sticking of the vulva among the patients with vulvar discomfort?</non_inferiority_desc>
            <p_value>0.0581</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of itching of the vulva among patients with vulvar discomfort.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of itching of the vulva among the patients with vulvar discomfort?</non_inferiority_desc>
            <p_value>0.0002</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the feeling of inflammation of the vulva among patients with vulvar discomfort.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the feeling of inflammation of the vulva among the patients with vulvar discomfort?</non_inferiority_desc>
            <p_value>0.0852</p_value>
            <method>Chi-squared</method>
            <param_type>t-test proportion</param_type>
            <param_value>0.0000</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aching of the vulva among patients with vulvar discomfort.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aching of the vulva among the patients with vulvar discomfort?</non_inferiority_desc>
            <p_value>0.0001</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of association of different vulvar symptoms among patients with vulvar discomfort.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the association of different symptoms of the vulva among the patients with vulvar discomfort?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar itching versus burning in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar itching versus burning in the patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar itching versus stinging in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar itching versus stinging in the patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0008</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar itching versus soreness in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar itching versus soreness in the patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar itching versus irritation in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar itching versus irritation in the patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar itching versus the feeling of inflammation in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0000</p_value>
            <p_value_desc>There was a statistically significant difference at p&lt;0.001. Patients with vulvar dermatosis had significantly more often itching than the feeling of inflammation of the vulva.</p_value_desc>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar itching versus aching in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar itching versus aching in the patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar stinging versus burning in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stinging versus burning in the patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar stinging versus soreness in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stinging versus soreness in the patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar stinging versus irritation in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stinging versus irritation in the patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar stinging versus the feeling of inflammation in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stinging versus the feeling of inflammation in the patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar stinging versus aching in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stinging versus aching in the patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar aching versus burning in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar aching versus burning in the patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.8591</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar aching versus soreness in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar aching versus soreness in the patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0090</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar aching versus irritation in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar aching versus irritation in the patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0212</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar aching versus the feeling of inflammation in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar aching versus the feeling of inflammation in the patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0057</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar sticking versus knife-like pain in patients with vulvar dermatosis who had sharp vulvar pain.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar sticking versus knife-like pain in the patients with vulvar dermatosis who had sharp pain?</non_inferiority_desc>
            <p_value>0.0977</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar sticking versus paper-cuts pain in patients with vulvar dermatosis who had sharp vulvar pain.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar sticking versus paper-cuts pain in the patients with vulvar dermatosis who had sharp pain?</non_inferiority_desc>
            <p_value>0.0143</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar sticking versus stabbing in patients with vulvar dermatosis who had sharp vulvar pain.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar sticking versus stabbing in the patients with vulvar dermatosis who had sharp pain?</non_inferiority_desc>
            <p_value>0.2059</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar stabbing versus knife-like pain in patients with vulvar dermatosis who had sharp vulvar pain.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stabbing versus knife-like pain in the patients with vulvar dermatosis who had sharp pain?</non_inferiority_desc>
            <p_value>0.6820</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar stabbing versus paper-cuts pain in patients with vulvar dermatosis who had sharp vulvar pain.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stabbing versus paper-cuts pain in the patients with vulvar dermatosis who had sharp pain?</non_inferiority_desc>
            <p_value>0.2059</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar stinging versus burning in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stinging versus burning in the patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar stinging versus soreness in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stinging versus soreness in the patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0344</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar stinging versus irritation in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stinging versus irritation in the patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0023</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar stinging versus itching in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stinging versus itching in the patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.5675</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar stinging versus the feeling of inflammation in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stinging versus the feeling of inflammation in the patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0037</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar stinging versus aching in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stinging versus aching in the patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0005</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar itching versus burning in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar itching versus burning in the patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar itching versus soreness in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar itching versus soreness in the patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.1201</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar itching versus irritation in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar itching versus irritation in the patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0123</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar itching versus the feeling of inflammation in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar itching versus the feeling of inflammation in the patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0188</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar itching versus aching in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar itching versus aching in the patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0030</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar aching versus burning in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar aching versus burning in the patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.2155</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar aching versus soreness in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar aching versus soreness in the patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.1508</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar aching versus irritation in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar aching versus irritation in the patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.6364</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar aching versus the feeling of inflammation in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar aching versus the feeling of inflammation in the patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.5277</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar sticking versus knife-like pain in patients with vulvodynia who had sharp vulvar pain.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar sticking versus knife-like pain in the patients with vulvodynia who had sharp vulvar pain?</non_inferiority_desc>
            <p_value>0.2041</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar sticking versus paper-cuts pain in patients with vulvodynia who had sharp vulvar pain.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar sticking versus paper-cuts pain in the patients with vulvodynia who had sharp vulvar pain?</non_inferiority_desc>
            <p_value>0.0412</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar sticking versus stabbing in patients with vulvodynia who had sharp vulvar pain.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar sticking versus stabbing in the patients with vulvodynia who had sharp vulvar pain?</non_inferiority_desc>
            <p_value>0.7978</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar stabbing versus knife-like pain in patients with vulvodynia who had sharp vulvar pain.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stabbing versus knife-like pain in the patients with vulvodynia who had sharp vulvar pain?</non_inferiority_desc>
            <p_value>0.3094</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar stabbing versus paper-cuts pain in patients with vulvodynia who had sharp vulvar pain.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stabbing versus paper-cuts pain in the patients with vulvodynia who had sharp vulvar pain?</non_inferiority_desc>
            <p_value>0.0730</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the duration of vulvar complaints for more than 24 months among patients with vulvar dermatosis or vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the duration of vulvar complaints for more than 24 months among patients with vulvar dermatosis and vulvodynia?</non_inferiority_desc>
            <p_value>0.4038</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the duration of vulvar complaints for more than 12 months among patients with vulvar dermatosis or vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the duration of vulvar complaints for more than 12 months among patients with vulvar dermatosis and vulvodynia?</non_inferiority_desc>
            <p_value>0.7299</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the duration of vulvar complaints for more than six months among patients with vulvar dermatosis or vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the duration of vulvar complaints for more than six months among patients with vulvar dermatosis and vulvodynia?</non_inferiority_desc>
            <p_value>0.7241</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sexual Activity and Abstinence in Patients With and Without Vulvar Discomfort</title>
        <description>The table shows sexual activity and sexual abstinence due to dyspareunia or lack of a sexual partner in four groups of patients.</description>
        <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
        <population>Sexual activity was evaluated anamnestically by the &quot;ISSVD Vulvodynia Pattern Questionnaire.&quot;</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV (some non-specific lesions of the vulva) were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Sexual Activity and Abstinence in Patients With and Without Vulvar Discomfort</title>
          <description>The table shows sexual activity and sexual abstinence due to dyspareunia or lack of a sexual partner in four groups of patients.</description>
          <population>Sexual activity was evaluated anamnestically by the &quot;ISSVD Vulvodynia Pattern Questionnaire.&quot;</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Sexually Active Patients</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81"/>
                    <measurement group_id="O2" value="77"/>
                    <measurement group_id="O3" value="73"/>
                    <measurement group_id="O4" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No sexual activity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sexual Abstinence Due To Dyspareunia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dyspareunia And Lack Of Partner</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the sexual activity among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the sexual activity among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of dyspareunia as a cause of sexual inactivity among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of dyspareunia as a cause of sexual inactivity among patients from different groups?</non_inferiority_desc>
            <p_value>0.0006</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of sexual inactivity due to dyspareunia and lack of a sexual partner among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of sexual inactivity due to dyspareunia and lack of a sexual partner among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dyspareunia and Marinoff Index in Patients With and Without Vulvar Discomfort</title>
        <description>The table shows the degree of dyspareunia in sexually active patients with and without vulvar discomfort. We used Marinoff Index as a measure of the degree of dyspareunia.
Negative Marinoff Index (0) is a sign of the absence of dyspareunia.
Four grades of Marionoff Index are:
Marinoff Index 0 = no dyspareunia; Marinoff Index 1= discomfort/pain with intercourse that doesn't interfere with the frequency of sex; Marinoff Index 2= pain with intercourse which sometimes prevents intercourse and Marinoff Index 3= pain with intercourse preventing any intercourse.</description>
        <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
        <population>Dyspareunia and Marinoff Index were evaluated anamnestically by the &quot;ISSVD Vulvodynia Pattern Questionnaire&quot;. We assessed the degree of dyspareunia only in sexually active patients.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV (some non-specific lesions of the vulva) were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Dyspareunia and Marinoff Index in Patients With and Without Vulvar Discomfort</title>
          <description>The table shows the degree of dyspareunia in sexually active patients with and without vulvar discomfort. We used Marinoff Index as a measure of the degree of dyspareunia.
Negative Marinoff Index (0) is a sign of the absence of dyspareunia.
Four grades of Marionoff Index are:
Marinoff Index 0 = no dyspareunia; Marinoff Index 1= discomfort/pain with intercourse that doesn't interfere with the frequency of sex; Marinoff Index 2= pain with intercourse which sometimes prevents intercourse and Marinoff Index 3= pain with intercourse preventing any intercourse.</description>
          <population>Dyspareunia and Marinoff Index were evaluated anamnestically by the &quot;ISSVD Vulvodynia Pattern Questionnaire&quot;. We assessed the degree of dyspareunia only in sexually active patients.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="81"/>
                <count group_id="O2" value="77"/>
                <count group_id="O3" value="73"/>
                <count group_id="O4" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dyspareunia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="73"/>
                    <measurement group_id="O4" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Marinoff Index 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                    <measurement group_id="O2" value="76"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Marinoff Index 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Marinoff Index 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="40"/>
                    <measurement group_id="O4" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Marinoff Index 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of dyspareunia among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of dyspareunia among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the degree of dyspareunia (Marinoff Index) among sexually active patients with vulvodynia or vulvar dermatosis who had dyspareunia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Parameter: The difference in the degree of dyspareunia (Marinoff Index) among sexually active patients with vulvodynia or vulvar dermatosis who had dyspareunia.</non_inferiority_desc>
            <p_value>0.2999</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Aggravation Of Vulvar Complaints Depending On Sexual Intercourse In Patients With Vulvar Dermatosis And Vulvodynia</title>
        <description>The relationship between sexual vulvar discomfort and sexual intercourse (provocation and aggravation) in patients with vulvar dermatosis and vulvodynia, as recommended in the ISSVD Questionnaire.</description>
        <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
        <population>Provocation and aggravation of vulvar discomfort depending on sexual intercourse were evaluated anamnestically by the &quot;ISSVD Vulvodynia Pattern Questionnaire.&quot;</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
          <group group_id="O2">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
        </group_list>
        <measure>
          <title>Aggravation Of Vulvar Complaints Depending On Sexual Intercourse In Patients With Vulvar Dermatosis And Vulvodynia</title>
          <description>The relationship between sexual vulvar discomfort and sexual intercourse (provocation and aggravation) in patients with vulvar dermatosis and vulvodynia, as recommended in the ISSVD Questionnaire.</description>
          <population>Provocation and aggravation of vulvar discomfort depending on sexual intercourse were evaluated anamnestically by the &quot;ISSVD Vulvodynia Pattern Questionnaire.&quot;</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Sexually active patients</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Intercourse aggravates vulvar discomfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Penetration aggravates vulvar complaints</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vulvar complaints during intercourse</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vulvar complaints after intercourse</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of vulvar discomfort provoked through the intercourse in patients with vulvodynia and vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the frequency of vulvar discomfort provoked through the intercourse in patients with vulvodynia and vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of vulvar discomfort provoked through the penetration in patients with vulvodynia and vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of vulvar discomfort provoked through the penetration in patients with vulvodynia and vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0347</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of vulvar discomfort aggravated through sexual intercourse in patients with vulvodynia and vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of vulvar discomfort aggravated through sexual intercourse in patients with vulvodynia and vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.7068</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of vulvar discomfort aggravated after sexual intercourse in patients with vulvodynia and vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of vulvar discomfort aggravated after sexual intercourse in patients with vulvodynia and vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0025</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Aggravation of Vulvar Discomfort Through Various Triggers in Patients With Vulvar Dermatosis and Vulvodynia</title>
        <description>The table shows the relationship among worsening of vulvar discomfort by using tampons, cycling, wearing tight clothes, menstruation, and urination in patients with vulvar dermatosis and vulvodynia.</description>
        <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
        <population>Worsening of vulvar discomfort by the using of tampons, cycling, wearing tight clothes, menstruation and urination in symptomatic patients were evaluated anamnestically by the &quot;ISSVD Vulvodynia Pattern Questionnaire&quot;.</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
          <group group_id="O2">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
        </group_list>
        <measure>
          <title>Aggravation of Vulvar Discomfort Through Various Triggers in Patients With Vulvar Dermatosis and Vulvodynia</title>
          <description>The table shows the relationship among worsening of vulvar discomfort by using tampons, cycling, wearing tight clothes, menstruation, and urination in patients with vulvar dermatosis and vulvodynia.</description>
          <population>Worsening of vulvar discomfort by the using of tampons, cycling, wearing tight clothes, menstruation and urination in symptomatic patients were evaluated anamnestically by the &quot;ISSVD Vulvodynia Pattern Questionnaire&quot;.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Using of tampons</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tampon aggravates vulvar complaints</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycling</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycling aggravates vulvar complaints</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Wearing tight clothes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tight clothes aggravates vulvar complaints</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Menstrual cycle</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Influence of menstrual cycle on symptoms</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Worsening before menstrual bleeding</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Worsening during menstrual bleeding</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Worsening after menstrual bleeding</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Worsening between menstrual bleeding</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Worsening during urination</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Worsening during urination after intercourse</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of use of vaginal tampon among patients with vulvodynia and vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of use of vaginal tampon among patients with vulvodynia and vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of worsening of vulvar discomfort due to the use of vaginal tampon in symptomatic patients, who use vaginal tampons.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of worsening of vulvar discomfort due to the use of vaginal tampon in symptomatic patients, who use vaginal tampons?</non_inferiority_desc>
            <p_value>0.6552</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of cycling among patients with vulvodynia and vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of cycling among patients with vulvodynia and vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0002</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of worsening of vulvar discomfort due to the cycling in symptomatic patients, who ride a bicycle.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of worsening of vulvar discomfort due to the cycling in symptomatic patients, who ride a bicycle?</non_inferiority_desc>
            <p_value>0.2877</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of wearing tight clothes among patients with vulvar dermatosis and vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of wearing tight clothes among patients with vulvar dermatosis and vulvodynia?</non_inferiority_desc>
            <p_value>0.0001</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of worsening of vulvar discomfort due to wearing of tight clothes in symptomatic patients, who wear tight clothes.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of worsening of vulvar discomfort due to wearing of tight clothes in symptomatic patients, who wear tight clothes?</non_inferiority_desc>
            <p_value>0.4754</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of worsening of vulvar discomfort depending on the menstrual cycle in symptomatic patients of reproductive age.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of worsening of vulvar discomfort depending on the menstrual cycle in symptomatic patients of reproductive age?</non_inferiority_desc>
            <p_value>0.1082</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of worsening of vulvar discomfort before starting menstrual bleeding in symptomatic patients of reproductive age.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of worsening of vulvar discomfort before starting menstrual bleeding in symptomatic patients of reproductive age?</non_inferiority_desc>
            <p_value>0.0179</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of worsening of vulvar discomfort during menstrual bleeding in symptomatic patients of reproductive age.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of worsening of vulvar discomfort during menstrual bleeding in symptomatic patients of reproductive age?</non_inferiority_desc>
            <p_value>0.5722</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of worsening of vulvar discomfort after menstrual bleeding in symptomatic patients of reproductive age.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of worsening of vulvar discomfort after menstrual bleeding in symptomatic patients of reproductive age?</non_inferiority_desc>
            <p_value>0.6148</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of worsening of vulvar discomfort between two menstrual bleeding in symptomatic patients of reproductive age.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of worsening of vulvar discomfort between two menstrual bleeding in symptomatic patients of reproductive age?</non_inferiority_desc>
            <p_value>0.5307</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of worsening of vulvar discomfort during urination.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of worsening of vulvar discomfort during urination?</non_inferiority_desc>
            <p_value>0.1546</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of worsening of vulvar complaints during urination after sexual intercourse in symptomatic patients, who are sexually active.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of worsening of vulvar complaints during urination after sexual intercourse in symptomatic patients, who are sexually active?</non_inferiority_desc>
            <p_value>0.1019</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Problems Associated With Urination and Defecation in Patients With and Without Vulvar Discomfort</title>
        <description>The table shows the incidence of the problems with urination and defecation in four groups of patients with and without vulvar discomfort.</description>
        <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
        <population>Problems with urination and defecation were evaluated anamnestically by the &quot;ISSVD Vulvodynia Pattern Questionnaire&quot;.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Problems Associated With Urination and Defecation in Patients With and Without Vulvar Discomfort</title>
          <description>The table shows the incidence of the problems with urination and defecation in four groups of patients with and without vulvar discomfort.</description>
          <population>Problems with urination and defecation were evaluated anamnestically by the &quot;ISSVD Vulvodynia Pattern Questionnaire&quot;.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any Problem With Urinating and Defecation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54"/>
                    <measurement group_id="O2" value="47"/>
                    <measurement group_id="O3" value="74"/>
                    <measurement group_id="O4" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dysuria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="36"/>
                    <measurement group_id="O4" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Intermittent Dysuria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="26"/>
                    <measurement group_id="O4" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Frequent Dysuria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Urinary Incontinence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Intermittent Urinary Incontinence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Frequent Urinary Incontinence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Difficulties At Starting Urination</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Intermittent Diff. At Starting Urination</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Frequent Diff. At Starting Urination</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Urgency</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Intermittent Urgency</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Frequent Urgency</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nocturia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="40"/>
                    <measurement group_id="O4" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Intermittent Nocturia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="31"/>
                    <measurement group_id="O4" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Frequent Nocturia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Recurrent Cystitis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Constipation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="27"/>
                    <measurement group_id="O4" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Intermittent Constipation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="20"/>
                    <measurement group_id="O4" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Frequent Constipation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Intermittent Diarrhea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Frequent Diarrhea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Irritable Colon</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of problems associated with urination and defecation between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of problems associated with urination and defecation between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of dysuria between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of dysuria between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of intermittent dysuria between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of intermittent dysuria between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of frequent dysuria between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of frequent dysuria between patients from different groups?</non_inferiority_desc>
            <p_value>0.0003</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of urinary incontinence between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of urinary incontinence between patients from different groups?</non_inferiority_desc>
            <p_value>0.0010</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of intermittent urinary incontinence between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of intermittent urinary incontinence between patients from different groups?</non_inferiority_desc>
            <p_value>0.1859</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of frequent urinary incontinence between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of frequent urinary incontinence between patients from different groups?</non_inferiority_desc>
            <p_value>0.0003</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of difficulties at starting urination between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of difficulties at starting urination between patients from different groups?</non_inferiority_desc>
            <p_value>0.0015</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of intermittent difficulties at starting urination between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of intermittent difficulties at starting urination between patients from different groups?</non_inferiority_desc>
            <p_value>0.0013</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of frequent difficulties at starting urination between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of frequent difficulties at starting urination between patients from different groups?</non_inferiority_desc>
            <p_value>0.5673</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of urgency between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of urgency between patients from different groups?</non_inferiority_desc>
            <p_value>0.0065</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of intermittent urgency between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of intermittent urgency between patients from different groups?</non_inferiority_desc>
            <p_value>0.0830</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of frequent urgency between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of frequent urgency between patients from different groups?</non_inferiority_desc>
            <p_value>0.0001</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of nocturia between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of nocturia between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of intermittent nocturia between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of intermittent nocturia between patients from different groups?</non_inferiority_desc>
            <p_value>0.2315</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of frequent nocturia between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of frequent nocturia between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of recurrent cystitis between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of recurrent cystitis between patients from different groups?</non_inferiority_desc>
            <p_value>0.0539</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of constipation between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of constipation between patients from different groups?</non_inferiority_desc>
            <p_value>0.0379</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of intermittent constipation between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of intermittent constipation between patients from different groups?</non_inferiority_desc>
            <p_value>0.1485</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of frequent constipation between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of frequent constipation between patients from different groups?</non_inferiority_desc>
            <p_value>0.4155</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of diarrhea between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of diarrhea between patients from different groups?</non_inferiority_desc>
            <p_value>0.0092</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of intermittent diarrhea between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of intermittent diarrhea between patients from different groups?</non_inferiority_desc>
            <p_value>0.0192</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of frequent diarrhea between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of frequent diarrhea between patients from different groups?</non_inferiority_desc>
            <p_value>0.5253</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the irritable colon between patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the irritable colon between patients from different groups?</non_inferiority_desc>
            <p_value>0.0060</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Other Associated Symptoms and Diseases in Patients With and Without Vulvar Discomfort</title>
        <description>The table shows the incidence of the other associated symptoms and diseases in four groups of patients, as recommended in the ISSVD Questionnaire.</description>
        <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
        <population>Other associated symptoms and diseases were evaluated anamnestically by the &quot;ISSVD Vulvodynia Pattern Questionnaire&quot;.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Other Associated Symptoms and Diseases in Patients With and Without Vulvar Discomfort</title>
          <description>The table shows the incidence of the other associated symptoms and diseases in four groups of patients, as recommended in the ISSVD Questionnaire.</description>
          <population>Other associated symptoms and diseases were evaluated anamnestically by the &quot;ISSVD Vulvodynia Pattern Questionnaire&quot;.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Other Symptoms and Diseases</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="58"/>
                    <measurement group_id="O3" value="79"/>
                    <measurement group_id="O4" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Recurrent Headache</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="21"/>
                    <measurement group_id="O4" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chronic Fatigue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="28"/>
                    <measurement group_id="O4" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lumbar Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="24"/>
                    <measurement group_id="O3" value="40"/>
                    <measurement group_id="O4" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fibromyalgia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="31"/>
                    <measurement group_id="O4" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Energy Loss</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="50"/>
                    <measurement group_id="O4" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sleep Disorders</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="23"/>
                    <measurement group_id="O4" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pelvic Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="28"/>
                    <measurement group_id="O4" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unintended Weight Loss</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Endometriosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&quot;D-D-D Triad&quot;</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypertension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Angina pectoris</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diabetes mellitus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Genital Herpes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thyroid Disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Drug Allergy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Recurrent Attacs of Sinusitis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="23"/>
                    <measurement group_id="O4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HPV Testing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="36"/>
                    <measurement group_id="O3" value="45"/>
                    <measurement group_id="O4" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Human Papillomavirus (HPV) test</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal Papanicolaou (PAP) Smear</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="25"/>
                    <measurement group_id="O4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Genital Warts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Conization | LETZ (Loop Excis. of the Trans. Zone)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of any associated symptom or disease among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of any associated symptom or disease among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of a frequent headache among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of a frequent headache among patients from different groups?</non_inferiority_desc>
            <p_value>0.3957</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of chronic fatigue among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of chronic fatigue among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of lumbar pain among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of lumbar pain among patients from different groups?</non_inferiority_desc>
            <p_value>0.0001</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of fibromyalgia among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of fibromyalgia among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of energy loss among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of energy loss among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of sleep disorders among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of sleep disorders among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of pelvic pain among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of pelvic pain among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of unintended weight loss among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of unintended weight loss among patients from different groups?</non_inferiority_desc>
            <p_value>0.1764</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of endometriosis among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of endometriosis among patients from different groups?</non_inferiority_desc>
            <p_value>0.3127</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the difference in the incidence of &quot;D-D-D Triad&quot; (Dysmenorrhoea-Dyspareunia-Dysuria) among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of &quot;D-D-D Triad&quot; among patients from different groups?</non_inferiority_desc>
            <p_value>0.0028</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of hypertension among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of hypertension among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of genital herpes among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of genital herpes among patients from different groups?</non_inferiority_desc>
            <p_value>0.9323</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of thyroid disease among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of thyroid disease among patients from different groups?</non_inferiority_desc>
            <p_value>0.0011</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of drug allergy among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of drug allergy among patients from different groups?</non_inferiority_desc>
            <p_value>0.2756</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of recurrent attacks of sinusitis among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of recurrent attacks of sinusitis among patients from different groups?</non_inferiority_desc>
            <p_value>0.0105</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of HPV infection among patients from different groups, who were tested for HPV.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of HPV infection among patients from different groups, who were tested for HPV?</non_inferiority_desc>
            <p_value>0.2128</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of abnormal PAP smear among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of abnormal PAP smear among patients from different groups?</non_inferiority_desc>
            <p_value>0.0018</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of genital warts among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of genital warts among patients from different groups?</non_inferiority_desc>
            <p_value>0.2524</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of conization or LETZ among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of conization or LETZ among patients from different groups?</non_inferiority_desc>
            <p_value>0.2452</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Previous Treatment of Patients With Vulvar Dermatosis and Vulvodynia</title>
        <description>The table shows the incidence of the previous treatment in patients with vulvar dermatosis and vulvodynia.</description>
        <time_frame>ISSVD Questionnaire, up to 30 minutes for each participant.</time_frame>
        <population>Previous treatment was evaluated anamnestically by the &quot;ISSVD Vulvodynia Pattern Questionnaire&quot;.</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
          <group group_id="O2">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
        </group_list>
        <measure>
          <title>Previous Treatment of Patients With Vulvar Dermatosis and Vulvodynia</title>
          <description>The table shows the incidence of the previous treatment in patients with vulvar dermatosis and vulvodynia.</description>
          <population>Previous treatment was evaluated anamnestically by the &quot;ISSVD Vulvodynia Pattern Questionnaire&quot;.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any prior treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antifungals Local</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antifungals Systemic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antibiotics Local</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antibiotics Systemic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Corticosteroids Local</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Corticosteroids Systemic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antidepressants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of any previous treatment between patients with vulvar dermatosis and vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of any previous treatment between patients with vulvar dermatosis and vulvodynia?</non_inferiority_desc>
            <p_value>0.1583</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of previous local treatment with antifungals among patients with vulvar dermatosis and vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of previous local treatment with antifungals between the patients with vulvar dermatosis and vulvodynia?</non_inferiority_desc>
            <p_value>0.0380</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of previous systemic treatment with antifungals among patients with vulvar dermatosis and vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of previous systemic treatment with antifungals between the patients with vulvar dermatosis and vulvodynia?</non_inferiority_desc>
            <p_value>0.6468</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of previous local treatment with antibiotics among patients with vulvar dermatosis and vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of previous local treatment with antibiotics between the patients with vulvar dermatosis and vulvodynia?</non_inferiority_desc>
            <p_value>0.4670</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of previous systemic treatment with antibiotics among patients with vulvar dermatosis and vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of previous systemic treatment with antibiotics between the patients with vulvar dermatosis and vulvodynia?</non_inferiority_desc>
            <p_value>0.2131</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of previous local treatment with corticoids among patients with vulvar dermatosis and vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of previous local treatment with corticosteroids between the patients with vulvar dermatosis and vulvodynia?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the frequency of previous systemic treatment with antidepressant among patients with vulvar dermatosis and vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of previous systemic treatment with antidepressant between the patients with vulvar dermatosis and vulvodynia?</non_inferiority_desc>
            <p_value>0.0962</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cotton Swab Test (Q-Tip) in Patients With and Without Vulvar Discomfort</title>
        <description>The table shows the results of Cotton-Swab Test in four groups of patients. Cotton-Swab Test or Q-Tip Testing is part of a multidisciplinary approach to the assessment of sexual pain, especially, vulvodynia or vestibulodynia, in women. ISSVD recommended the Cotton-Swab test for the differential diagnosis of vulvodynia.
The test consists of using a cotton-swab to palpate multiple vulvar and vestibular site while recording the woman's pain.
We performed Cotton-Swab Test by touching the vulva at 6 points (each vulvar ring), organized into locations based on a clock face and marked like the hours on the clock: 2h, 4h, 6h, 8h, 10h, and 12 h.</description>
        <time_frame>Cotton Swab Test, up to 10 minutes for each participant.</time_frame>
        <population>Cotton-Swab test was evaluated by clinical examination of the Inner Vulvar Ring (&quot;TRIV Data Form&quot;).</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Cotton Swab Test (Q-Tip) in Patients With and Without Vulvar Discomfort</title>
          <description>The table shows the results of Cotton-Swab Test in four groups of patients. Cotton-Swab Test or Q-Tip Testing is part of a multidisciplinary approach to the assessment of sexual pain, especially, vulvodynia or vestibulodynia, in women. ISSVD recommended the Cotton-Swab test for the differential diagnosis of vulvodynia.
The test consists of using a cotton-swab to palpate multiple vulvar and vestibular site while recording the woman's pain.
We performed Cotton-Swab Test by touching the vulva at 6 points (each vulvar ring), organized into locations based on a clock face and marked like the hours on the clock: 2h, 4h, 6h, 8h, 10h, and 12 h.</description>
          <population>Cotton-Swab test was evaluated by clinical examination of the Inner Vulvar Ring (&quot;TRIV Data Form&quot;).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Positive Cotton Swab Test, generally (any point)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="73"/>
                    <measurement group_id="O4" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Cotton Swab at the point of 2h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="34"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Cotton Swab at the point of 4h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="58"/>
                    <measurement group_id="O4" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Cotton Swab at the point of 6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="62"/>
                    <measurement group_id="O4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Cotton Swab at the point of 8h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="59"/>
                    <measurement group_id="O4" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Cotton Swab at the point of 10h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="42"/>
                    <measurement group_id="O4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Cotton Swab at the point of 12h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="38"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of a positive Cotton-Swab test of the vulva among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of a positive Cotton-Swab test of the vulva among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of a positive Cotton-Swab test at the point marked as 2h among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of a positive Cotton-Swab test at the point marked as 2h among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of a positive Cotton-Swab test at the point marked as 4h among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of a positive Cotton-Swab test at the point marked as 4h among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of a positive Cotton-Swab test at the point marked as 6h among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of a positive Cotton-Swab test at the point marked as 6h among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of a positive Cotton-Swab test at the point marked as 8h among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of a positive Cotton-Swab test at the point marked as 8h among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of a positive Cotton-Swab test at the point marked as 10h among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of a positive Cotton-Swab test at the point marked as 10h among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of a positive Cotton-Swab test at the point marked as 12h among patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of a positive Cotton-Swab test at the point marked as 12h among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of a positive Cotton-Swab test of the vulva in patients with vulvar dermatosis versus normal vulva.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of a positive Cotton-Swab test of the vulva in patients with vulvar dermatosis versus normal vulva?</non_inferiority_desc>
            <p_value>0.0009</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of a positive Cotton-Swab test at the point marked as 2h in patients with vulvar dermatosis versus normal vulva.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of a positive Cotton-Swab test at the point marked as 2h in patients with vulvar dermatosis versus normal vulva?</non_inferiority_desc>
            <p_value>0.0289</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of a positive Cotton-Swab test at the point marked as 4h in patients with vulvar dermatosis and normal vulva.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of a positive Cotton-Swab test at the point marked as 4h in patients with vulvar dermatosis versus normal vulva?</non_inferiority_desc>
            <p_value>0.0134</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of a positive Cotton-Swab test at the point marked as 6h in patients with vulvar dermatosis and normal vulva.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of a positive Cotton-Swab test at the point marked as 6h in patients with vulvar dermatosis versus normal vulva?</non_inferiority_desc>
            <p_value>0.0037</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of a positive Cotton-Swab test at the point marked as 8h in patients with vulvar dermatosis and normal vulva.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of a positive Cotton-Swab test at the point marked as 8h in patients with vulvar dermatosis and normal vulva?</non_inferiority_desc>
            <p_value>0.0080</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of a positive Cotton-Swab test at the point marked as 10h in patients with vulvar dermatosis and normal vulva.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of a positive Cotton-Swab test at the point marked as 10h in patients with vulvar dermatosis versus normal vulva?</non_inferiority_desc>
            <p_value>0.0579</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of a positive Cotton-Swab test at the point marked as 12h in patients with vulvar dermatosis and normal vulva.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of a positive Cotton-Swab test at the point marked as 12h in patients with vulvar dermatosis versus normal vulva?</non_inferiority_desc>
            <p_value>0.0720</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Distribution of Non-Specific and Specific Vulvar Lesions in Relation to The Three Vulvar Rings (TRIV)</title>
        <description>The table shows the distribution of non-specific and specific vulvar lesions in relation to the three vulvar rings (TRIV).
The &quot;OUTER Vulvar Ring&quot; includes vulvar skin, the &quot;MIDDLE Vulvar Ring&quot; encompasses the modified mucosa, and the &quot;INNER Vulvar Ring&quot; is presented with glicogenized mucosa.
&quot;Non-Specific Lesions&quot; include non-specific erythema, punctuations, papillae, paleness and smoothness, fissures or sores in the absence of infection and pre/malignancy in any part of the vulva.
&quot;Specific Lesions&quot; comprise eczematous inflammation with thickened, excoriated skin within chronic lichen simplex; hypopigmented or white lesions, fusion or resorption of the labia minora and clitoral hood, loss of vulvar architecture and sclerotic changes in lichen sclerosis; white reticular pattern to extensive erosion with agglutination or resorption of the labia within lichen planus and psoriatic erythematous papules with silver, scaly plaques.</description>
        <time_frame>Three Rings Vulvoscopy, up to 45 minutes for each participant.</time_frame>
        <population>&quot;Three Rings Vulvoscopy&quot; was performed in 328 patients, classified into four groups based on anamnestic data and clinical examination. Localization and specificity of the lesions were mapped into the &quot;TRIV Form Data.&quot; Vulvar lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia which was made by Friedrich's criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Distribution of Non-Specific and Specific Vulvar Lesions in Relation to The Three Vulvar Rings (TRIV)</title>
          <description>The table shows the distribution of non-specific and specific vulvar lesions in relation to the three vulvar rings (TRIV).
The &quot;OUTER Vulvar Ring&quot; includes vulvar skin, the &quot;MIDDLE Vulvar Ring&quot; encompasses the modified mucosa, and the &quot;INNER Vulvar Ring&quot; is presented with glicogenized mucosa.
&quot;Non-Specific Lesions&quot; include non-specific erythema, punctuations, papillae, paleness and smoothness, fissures or sores in the absence of infection and pre/malignancy in any part of the vulva.
&quot;Specific Lesions&quot; comprise eczematous inflammation with thickened, excoriated skin within chronic lichen simplex; hypopigmented or white lesions, fusion or resorption of the labia minora and clitoral hood, loss of vulvar architecture and sclerotic changes in lichen sclerosis; white reticular pattern to extensive erosion with agglutination or resorption of the labia within lichen planus and psoriatic erythematous papules with silver, scaly plaques.</description>
          <population>&quot;Three Rings Vulvoscopy&quot; was performed in 328 patients, classified into four groups based on anamnestic data and clinical examination. Localization and specificity of the lesions were mapped into the &quot;TRIV Form Data.&quot; Vulvar lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia which was made by Friedrich's criteria.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Non-specific Findings of the Outer Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-specific Findings of the Middle Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="71"/>
                    <measurement group_id="O3" value="79"/>
                    <measurement group_id="O4" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-specific Findings of the Inner Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="79"/>
                    <measurement group_id="O3" value="81"/>
                    <measurement group_id="O4" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema of the Outer Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema of the Middle Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="41"/>
                    <measurement group_id="O3" value="62"/>
                    <measurement group_id="O4" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema of the Inner Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="61"/>
                    <measurement group_id="O3" value="76"/>
                    <measurement group_id="O4" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Excoriations of the Outer Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fissures of the Middle Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fissures of the Inner Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rhagades of the Outer Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Smoothness of the Middle Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Smoothness of the Inner Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="41"/>
                    <measurement group_id="O4" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ischemia of the Middle Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ischemia of the Inner Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="36"/>
                    <measurement group_id="O3" value="40"/>
                    <measurement group_id="O4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Punctuation of the Middle Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Punctuation of the Inner Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="36"/>
                    <measurement group_id="O3" value="45"/>
                    <measurement group_id="O4" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Papillae of the Inner Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="21"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions of the Outer Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions of the Middle Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions of the Inner Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of the Outer Vulvar Ring in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Outer Vulvar Ring between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of the Middle Vulvar Ring in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy&quot;. Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Middle Vulvar Ring between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of the Inner Vulvar Ring in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Inner Vulvar Ring between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of erythema of the Outer Vulvar Ring in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of erythema of the Outer Vulvar Ring between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of erythema of the Middle Vulvar Ring in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of erythema of the Middle Vulvar Ring between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of erythema of the Inner Vulvar Ring in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of erythema of the Inner Vulvar Ring between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of excoriations of the Outer Vulvar Ring in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of excoriations of the Outer Vulvar Ring between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of fissures of the Middle Vulvar Ring in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of fissures the Middle Vulvar Ring between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of rhagades of the Outer Vulvar Ring in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of rhagades of the Outer Vulvar Ring between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of smoothness of the Middle Vulvar Ring in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of smoothness of the Middle Vulvar Ring between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of smoothness of the Inner Vulvar Ring in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of smoothness of the Inner Vulvar Ring between patients within different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of ischemia of the Middle Vulvar Ring in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of ischemia of the Middle Vulvar Ring between patients from different groups?</non_inferiority_desc>
            <p_value>0.0632</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of ischemia of the Inner Vulvar Ring in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of ischemia of the Inner Vulvar Ring between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of punctuation of the Middle Vulvar Ring in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of punctuation of the Middle Vulvar Ring between patients within different groups?</non_inferiority_desc>
            <p_value>0.0043</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of punctuation of the Inner Vulvar Ring in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Typ), evaluated with &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of punctuation of the Inner Vulvar Ring between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of papillae of the Inner Vulvar Ring in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of papillae of the Inner Vulvar Ring between patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Outer versus non-specific lesions of the Middle Vulvar Ring in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Outer versus non-specific lesions of the Middle Vulvar Ring in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0697</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Outer versus non-specific lesions of the Inner Vulvar Ring in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Outer versus non-specific lesions of the Inner Vulvar Ring in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0319</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Middle versus non-specific lesions of the Inner Vulvar Ring in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Middle versus non-specific lesions of the Inner Vulvar Ring in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.7273</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Outer versus non-specific lesions of the Middle Vulvar Ring in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Outer versus non-specific lesions of the Middle Vulvar Ring in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Outer versus non-specific lesions of the Inner Vulvar Ring in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Outer versus non-specific lesions of the Middle Vulvar Ring in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Middle versus non-specific lesions of the Inner Vulvar Ring in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Middle versus non-specific lesions of the Inner Vulvar Ring in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.2203</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Outer versus non-specific lesions of the Middle Vulvar Ring in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Outer versus non-specific lesions of the Middle Vulvar Ring in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Outer versus non-specific lesions of the Inner Vulvar Ring in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Outer versus non-specific lesions of the Inner Vulvar Ring in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of the Middle versus non-specific lesions of the Inner Vulvar Ring in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Middle versus non-specific lesions of the Inner Vulvar Ring in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.1456</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of the Outer versus specific lesions of the Middle Vulvar Ring in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesions of the Outer versus specific lesions of the Middle Vulvar Ring in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.1133</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of the Outer versus specific lesions of the Inner Vulvar Ring in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesions of the Outer versus specific lesions of the Inner Vulvar Ring in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of the Middle versus specific lesions of the Inner Vulvar Ring in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesions of the Middle versus specific lesions of the Inner Vulvar Ring in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0058</p_value>
            <method>t-test proportion</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Distribution of Non-Specific and Specific Lesions of the Outer Vulvar Ring According to the &quot;Three Rings Vulvoscopy&quot;</title>
        <description>The table shows the distribution of the non-specific and specific lesions of the vulva according to individual structures of the Outer Vulvar Ring according to the TRIV.
The &quot;OUTER Vulvar Ring&quot; includes vulvar skin with the following structures: mons pubis, labia majora, and the perineum.
&quot;Non-Specific Lesions&quot; include non-specific erythema, punctuations, papillae, paleness and smoothness, fissures or sores in the absence of infection and pre/malignancy in any part of the vulva.
&quot;Specific Lesions&quot; (lesions specific for vulvar dermatosis) comprise eczematous inflammation with thickened, excoriated skin within chronic lichen simplex; hypopigmented or white lesions, fusion or resorption of the labia minora and clitoral hood, loss of vulvar architecture and sclerotic changes in lichen sclerosis; white reticular pattern to extensive erosion with agglutination or resorption of the labia within lichen planus and psoriatic erythematous papules with silver, scaly plaques.</description>
        <time_frame>Three Rings Vulvoscopy, up to 45 minutes for each participant.</time_frame>
        <population>&quot;Three Rings Vulvoscopy&quot; was performed in 328 patients, classified into four groups based on anamnestic data and clinical examination. Localization and specificity of the lesions were mapped into the &quot;TRIV Form Data&quot;. Vulvar lesions in patients with vulvodynia were not relevant for the diagnosis of vulvodynia which was made by Friedrich's criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Distribution of Non-Specific and Specific Lesions of the Outer Vulvar Ring According to the &quot;Three Rings Vulvoscopy&quot;</title>
          <description>The table shows the distribution of the non-specific and specific lesions of the vulva according to individual structures of the Outer Vulvar Ring according to the TRIV.
The &quot;OUTER Vulvar Ring&quot; includes vulvar skin with the following structures: mons pubis, labia majora, and the perineum.
&quot;Non-Specific Lesions&quot; include non-specific erythema, punctuations, papillae, paleness and smoothness, fissures or sores in the absence of infection and pre/malignancy in any part of the vulva.
&quot;Specific Lesions&quot; (lesions specific for vulvar dermatosis) comprise eczematous inflammation with thickened, excoriated skin within chronic lichen simplex; hypopigmented or white lesions, fusion or resorption of the labia minora and clitoral hood, loss of vulvar architecture and sclerotic changes in lichen sclerosis; white reticular pattern to extensive erosion with agglutination or resorption of the labia within lichen planus and psoriatic erythematous papules with silver, scaly plaques.</description>
          <population>&quot;Three Rings Vulvoscopy&quot; was performed in 328 patients, classified into four groups based on anamnestic data and clinical examination. Localization and specificity of the lesions were mapped into the &quot;TRIV Form Data&quot;. Vulvar lesions in patients with vulvodynia were not relevant for the diagnosis of vulvodynia which was made by Friedrich's criteria.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Non-specific Lesions of Mons Pubis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-specific Lesions of Labia Majora</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-specific Lesions of the Perineum</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema of Mons Pubis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema of Labia Majora</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema of the Perineum</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Excoriations of Mons Pubis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Excoriations of Labia Majora</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Excoriations of the Perineum</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rhagades of Mons Pubis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rhagades of Labia Majora</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rhagades of the Perineum</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions of Mons Pubis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions of Labia Majora</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions of the Perineum</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of Mons pubis in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant for the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Mons Pubis among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of Labia Majora in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant for the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Labia Majora among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of the Perineum in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant for the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Perineum among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of erythema of Mons Pubis in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant for the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of erythema of Mons Pubis among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of erythema of Labia Majora in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant for the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of erythema of Labia Majora among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of erythema of the Perineum in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant for the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of erythema of the Perineum among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of excoriations of Mons Pubis in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant for the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of excoriations of Mons Pubis among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of excoriations of Labia Majora in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant for the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of excoriations of Labia Majora among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of excoriations of the Perineum in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant for the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of excoriations of the Perineum among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of rhagades of Mons Pubis in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant for the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of rhagades of Mons Pubis among patients from different groups?</non_inferiority_desc>
            <p_value>0.0016</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of rhagades of Labia Majora in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant for the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of rhagades of Labia Majora among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of rhagades of the Perineum in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant for the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of rhagades of the Perineum among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Mons Pubis versus non-specific lesions of Labia Majora in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Mons Pubis versus non-specific lesions of Labia Majora in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0014</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Mons Pubis versus non-specific lesions of the Perineum in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Mons Pubis versus non-specific lesions of the Perineum in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesion of Labia Majora versus non-specific lesions of the Perineum in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Labia Majora versus non-specific lesions of the Perineum in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0414</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Mons Pubis versus non-specific lesions of Labia Majora in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Mons Pubis versus non-specific lesions of Labia Majora in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0898</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Mons Pubis versus non-specific lesions of the Perineum in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Mons Pubis versus non-specific lesions of the Perineum in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0008</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Labia Majora versus non-specific lesions of the Perineum in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Labia Majora versus non-specific lesions of the Perineum in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0587</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Mons Pubis versus non-specific lesions of Labia Majora in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Mons Pubis versus non-specific lesions of Labia Majora in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Mons Pubis versus non-specific lesions of the Perineum in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Mons Pubis versus non-specific lesions of the Perineum in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.1352</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesion of Labia Majora versus non-specific lesions of the Perineum in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Labia Majora versus non-specific lesions of the Perineum in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.1352</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of Mons Pubis versus specific lesions of Labia Majora in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesions of Mons Pubis versus specific lesions of Labia Majora in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0002</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of Mons Pubis versus specific lesions of the Perineum in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesions of Mons Pubis versus specific lesions of the Perineum in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of Labia Majora versus specific lesions of the Perineum in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesions of Labia Majora versus specific lesions of the Perineum in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0854</p_value>
            <method>t-test proportion</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Distribution of Non-Specific and Specific Lesions of the Middle Vulvar Ring According to the &quot;Three Rings Vulvoscopy&quot;</title>
        <description>The table shows the distribution of non-specific and specific lesions of the vulva in relation to the individual structures of the Middle vulvar ring according to the &quot;Three Rings Vulvoscopy.&quot; The &quot;MIDDLE vulvar ring&quot; includes the anterior commissure with the prepuce of the clitoris, interlabial sulci, labia minora, and the posterior commissure.
&quot;Non-Specific Lesions&quot; include non-specific erythema, punctuations, papillae, paleness and smoothness, fissures or sores in the absence of infection and pre/malignancy in any part of the vulva.
&quot;Specific Lesions&quot; comprise eczematous inflammation with thickened, excoriated skin within chronic lichen simplex; hypopigmented or white lesions, fusion or resorption of the labia minora and clitoral hood, loss of vulvar architecture and sclerotic changes in lichen sclerosis; white reticular pattern to extensive erosion with agglutination or resorption of the labia within lichen planus and psoriatic erythematous papules with silver, scaly plaques.</description>
        <time_frame>Three Rings Vulvoscopy, up to 45 minutes for each participant.</time_frame>
        <population>&quot;Three Rings Vulvoscopy&quot; was performed in 328 patients, classified into four groups based on anamnestic data and clinical examination. Localization and specificity of the lesions were mapped into the &quot;TRIV Form Data&quot;. Vulvar lesions in patients with vulvodynia were not relevant for the diagnosis of vulvodynia which was made by Friedrich's criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Distribution of Non-Specific and Specific Lesions of the Middle Vulvar Ring According to the &quot;Three Rings Vulvoscopy&quot;</title>
          <description>The table shows the distribution of non-specific and specific lesions of the vulva in relation to the individual structures of the Middle vulvar ring according to the &quot;Three Rings Vulvoscopy.&quot; The &quot;MIDDLE vulvar ring&quot; includes the anterior commissure with the prepuce of the clitoris, interlabial sulci, labia minora, and the posterior commissure.
&quot;Non-Specific Lesions&quot; include non-specific erythema, punctuations, papillae, paleness and smoothness, fissures or sores in the absence of infection and pre/malignancy in any part of the vulva.
&quot;Specific Lesions&quot; comprise eczematous inflammation with thickened, excoriated skin within chronic lichen simplex; hypopigmented or white lesions, fusion or resorption of the labia minora and clitoral hood, loss of vulvar architecture and sclerotic changes in lichen sclerosis; white reticular pattern to extensive erosion with agglutination or resorption of the labia within lichen planus and psoriatic erythematous papules with silver, scaly plaques.</description>
          <population>&quot;Three Rings Vulvoscopy&quot; was performed in 328 patients, classified into four groups based on anamnestic data and clinical examination. Localization and specificity of the lesions were mapped into the &quot;TRIV Form Data&quot;. Vulvar lesions in patients with vulvodynia were not relevant for the diagnosis of vulvodynia which was made by Friedrich's criteria.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Non-specific Lesions of the Anterior Commissure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-specific Lesions of Interlabial Sulci</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="32"/>
                    <measurement group_id="O3" value="41"/>
                    <measurement group_id="O4" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-specific Lesions of Labia Minora</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="25"/>
                    <measurement group_id="O3" value="48"/>
                    <measurement group_id="O4" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-specific Lesions of the Posterior Commissure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="56"/>
                    <measurement group_id="O3" value="76"/>
                    <measurement group_id="O4" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema of the Anterior Commissure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema of Interlabial Sulci</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="28"/>
                    <measurement group_id="O3" value="35"/>
                    <measurement group_id="O4" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema of Labia Minora</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="25"/>
                    <measurement group_id="O4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema of the Posterior Commissure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="48"/>
                    <measurement group_id="O4" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fissures of the Anterior Commissure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fissures of Interlabial Sulci</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fissures of Labia Minora</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fissures of the Posterior Commissure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Smoothness of the Anterior Commissure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Smoothness of Interlabial Sulci</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Smoothness of Labia Minora</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Smoothness of the Posterior Commissure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions of the Anterior Commissure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions of Interlabial Sulci</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions of Labia Minora</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions of the Posterior Commissure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of the Anterior Commissure in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Anterior Commissure among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of Interlabial Sulci in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Interlabial Sulci among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of Labia Minora in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Labia Minora among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of the Posterior Commissure in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot;. Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Posterior Commissure among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of erythema of the Anterior Commissure in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q- Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of erythema of the Anterior Commissure among patients from different groups?</non_inferiority_desc>
            <p_value>0.0199</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of erythema of Interlabial Sulci in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q- Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of erythema of Interlabial Sulci among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of erythema of Labia Minora in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q- Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of erythema of Labia Minora among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of erythema of the Posterior Commissure in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q- Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of erythema of the Posterior Commissure among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of fissures of Interlabial Sulci in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q- Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of fissures of Interlabial Sulci among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of fissures of the Posterior Commissure in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q- Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of fissures of the Posterior Commissure among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of smoothness of the Anterior Commissure in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of smoothness of the Anterior Commissure among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of smoothness of Interlabial Sulci in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q- Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of smoothness of Interlabial Sulci among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The frequency of smoothness of Labia Minora in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q- Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the frequency of smoothness of Labia Minora among patients from different groups?</non_inferiority_desc>
            <p_value>0.0024</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of smoothness of the Posterior Commissure in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q- Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of smoothness of the Posterior Commissure among patients from different groups?</non_inferiority_desc>
            <p_value>0.0205</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Anterior Commissure versus non-specific lesions of Interlabial Sulci in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Anterior Commissure versus non-specific lesions of Interlabial Sulci in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0158</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Anterior Commissure versus non-specific lesions of the Posterior Commissure in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Anterior Commissure versus non-specific lesions of the Posterior Commissure in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0001</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Labia Minora versus non-specific lesions of the Posterior Commissure in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Labia Minora versus non-specific lesions of the Posterior Commissure in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0280</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Anterior Commissure versus non-specific lesions of Interlabial Sulci in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Anterior Commissure versus non-specific lesions of Interlabial Sulci in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Anterior Commissure versus non-specific lesions of Labia Minora in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Anterior Commissure versus non-specific lesions of Labia Minora in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Anterior Commissure versus non-specific lesions of the Posterior Commissure in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Anterior Commissure versus non-specific lesions of the Posterior Commissure in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Interlabial Sulci versus non-specific lesions of the Posterior Commissure in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Interlabial Sulci versus non-specific lesions of the Posterior Commissure in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Labia Minora versus non-specific lesions of the Posterior Commissure in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Labia Minora versus non-specific lesions of the Posterior Commissure in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Anterior Commissure versus non-specific lesions of Interlabial Sulci in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Anterior Commissure versus non-specific lesions of Interlabial Sulci in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Anterior Commissure versus non-specific lesions of Labia Minora in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Anterior Commissure versus non-specific lesions of Labia Minora in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0006</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Anterior Commissure versus non-specific lesions of the Posterior Commissure in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Anterior Commissure versus non-specific lesions of the Posterior Commissure in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Interlabial Sulci versus non-specific lesions of the Posterior Commissure in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Interlabial Sulci versus non-specific lesions of the Posterior Commissure in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0003</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Labia Minora versus non-specific lesions of the Posterior Commissure in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Labia Minora versus non-specific lesions of the Posterior Commissure in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of the Anterior Commissure versus specific lesions of Interlabial Sulci in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesion of the Anterior Commissure versus specific lesions of Interlabial Sulci in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.3053</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of the Anterior Commissure versus specific lesions of Labia Minora in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesion of the Anterior Commissure versus specific lesions of Labia Minora in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.7758</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of the Anterior Commissure versus specific lesions of the Posterior Commissure in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesion of the Anterior Commissure versus specific lesions of the Posterior Commissure in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.6676</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of Interlabial Sulci versus specific lesions of Labia Minora in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesion of Interlabial Sulci versus specific lesions of Labia Minora in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.4577</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of Interlabial Sulci versus specific lesions of the Posterior Commissure in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesion of Interlabial Sulci versus specific lesions of the Posterior Commissure in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.1681</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of Labia Minora versus specific lesions of the Posterior Commissure in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesion of Labia Minora versus specific lesions of the Posterior Commissure in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.8848</p_value>
            <method>t-test proportion</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Distribution of Non-Specific and Specific Lesions of the Inner Vulvar Ring According to the &quot;Three Rings Vulvoscopy&quot;</title>
        <description>The table shows the distribution of non-specific and specific lesions of the vulva in relation to the individual structures of the Inner vulvar ring according to the &quot;Three Rings Vulvoscopy.&quot; The &quot;INNER vulvar ring&quot; includes clitoris, Hart's line, urethral sulcus, urethral meatus, hymenal remnants, Bartholin's gland opening, and the vestibule.
&quot;Non-Specific Lesions&quot; include non-specific erythema, punctuations, papillae, paleness and smoothness, fissures or sores in the absence of infection and pre/malignancy in any part of the vulva.
&quot;Specific Lesions&quot; comprise eczematous inflammation with thickened, excoriated skin within chronic lichen simplex; hypopigmented or white lesions, fusion or resorption of the labia minora and clitoral hood, loss of vulvar architecture and sclerotic changes in lichen sclerosis; white reticular pattern to extensive erosion with agglutination or resorption of the labia within lichen planus and psoriatic erythematous papules with silver, scaly plaques.</description>
        <time_frame>Three Rings Vulvoscopy, up to 45 minutes for each participant.</time_frame>
        <population>&quot;Three Rings Vulvoscopy&quot; was performed in 328 patients, classified into four groups based on anamnestic data and clinical examination. Localization and specificity of the lesions were mapped into the &quot;TRIV Form Data&quot;. Vulvar lesions in patients with vulvodynia were not relevant for the diagnosis of vulvodynia which was made by Friedrich's criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Distribution of Non-Specific and Specific Lesions of the Inner Vulvar Ring According to the &quot;Three Rings Vulvoscopy&quot;</title>
          <description>The table shows the distribution of non-specific and specific lesions of the vulva in relation to the individual structures of the Inner vulvar ring according to the &quot;Three Rings Vulvoscopy.&quot; The &quot;INNER vulvar ring&quot; includes clitoris, Hart's line, urethral sulcus, urethral meatus, hymenal remnants, Bartholin's gland opening, and the vestibule.
&quot;Non-Specific Lesions&quot; include non-specific erythema, punctuations, papillae, paleness and smoothness, fissures or sores in the absence of infection and pre/malignancy in any part of the vulva.
&quot;Specific Lesions&quot; comprise eczematous inflammation with thickened, excoriated skin within chronic lichen simplex; hypopigmented or white lesions, fusion or resorption of the labia minora and clitoral hood, loss of vulvar architecture and sclerotic changes in lichen sclerosis; white reticular pattern to extensive erosion with agglutination or resorption of the labia within lichen planus and psoriatic erythematous papules with silver, scaly plaques.</description>
          <population>&quot;Three Rings Vulvoscopy&quot; was performed in 328 patients, classified into four groups based on anamnestic data and clinical examination. Localization and specificity of the lesions were mapped into the &quot;TRIV Form Data&quot;. Vulvar lesions in patients with vulvodynia were not relevant for the diagnosis of vulvodynia which was made by Friedrich's criteria.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Non-specific Lesions of the clitoris</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="43"/>
                    <measurement group_id="O3" value="76"/>
                    <measurement group_id="O4" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-specific Lesions of Hart's line</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="68"/>
                    <measurement group_id="O3" value="81"/>
                    <measurement group_id="O4" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-specific Lesions of the Urethral Sulcus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="69"/>
                    <measurement group_id="O3" value="81"/>
                    <measurement group_id="O4" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-specific Lesions of the Urethral Meatus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="45"/>
                    <measurement group_id="O3" value="72"/>
                    <measurement group_id="O4" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-specific Lesions of Hymenal remnants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="37"/>
                    <measurement group_id="O3" value="69"/>
                    <measurement group_id="O4" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-specific Lesions of Bartholin's gland opening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="49"/>
                    <measurement group_id="O3" value="77"/>
                    <measurement group_id="O4" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-specific Lesions of the Vestibule</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="59"/>
                    <measurement group_id="O3" value="80"/>
                    <measurement group_id="O4" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema of the clitoris</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="29"/>
                    <measurement group_id="O4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema of Hart's line</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="52"/>
                    <measurement group_id="O3" value="69"/>
                    <measurement group_id="O4" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema of the Urethral Sulcus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="43"/>
                    <measurement group_id="O4" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema of the Urethral Meatus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema of Hymenal remnants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema of Bartholin's gland opening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="49"/>
                    <measurement group_id="O4" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema of the Vestibule</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="29"/>
                    <measurement group_id="O3" value="45"/>
                    <measurement group_id="O4" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Smoothness of the clitoris</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Smootness of Hart's line</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Smoothness of the Urethral Sulcus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="37"/>
                    <measurement group_id="O4" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Smoothness of the Urethral Meatus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Smoothness of Hymenal remnants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Smoothness of Bartholin's gland opening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Smoothness of the Vestibule</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ischemia of the clitoris</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ischemia of Hart's line</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ischemia of the Urethral Sulcus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="31"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ischemia of the Urethral Meatus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ischemia of Hymenal remnants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ischemia of Bartholin's gland opening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ischemia of the Vestibule</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Punctuation of the clitoris</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Punctuation of Hart's line</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="36"/>
                    <measurement group_id="O3" value="43"/>
                    <measurement group_id="O4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Punctuation of the Urethral Sulcus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Punctuation of the Urethral Meatus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Punctuation of Hymenal remnants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Punctuation of Bartholin's gland opening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Punctuation of the Vestibule</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Papillae of Hart's line</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Papillae of the Urethral Sulcus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Papillae of the Vestibule</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions of the clitoris</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions of Hart's line</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions of the Urethral Sulcus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions of the Urethral Meatus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions of Hymenal remnants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions of Bartholin's gland opening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specific Lesions of the Vestibule</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of the Clitoris in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant for the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Clitoris among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of Hart's Line in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant for the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Hart's Line among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of the Urethral Sulcus in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Urethral Sulcus among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of the Urethral meatus in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Urethral Meatus among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of Hymenal Remnants in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Hymenal Remnants among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of Bartholin's Gland Opening in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Bartholin's Gland Opening among the patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of non-specific lesions of the Vestibule in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Vestibule among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of erythema of the Clitoris in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of erythema of the Clitoris among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of erythema of Hart's Line in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of erythema of Hart's Line among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of erythema of the Urethral Sulcus in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of erythema of the Urethral Sulcus among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of erythema of the Urethral Meatus in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of erythema of the Urethral Meatus among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of erythema of Hymenal Remnants in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of erythema of Hymenal Remnants among patients from different groups?</non_inferiority_desc>
            <p_value>0.0001</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of erythema of Bartholin's Gland Opening in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of erythema of Bartholin's Gland Opening among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of erythema of the Vestibule in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of erythema of the Vestibule among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of smoothness of the Clitoris in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of smoothness of the Clitoris among patients from different groups?</non_inferiority_desc>
            <p_value>0.0023</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of smoothness of the Urethral Sulcus in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of smoothness of the Urethral Sulcus among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of smoothness of Urethral Meatus in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of smoothness of the Urethral Meatus among patients from different groups?</non_inferiority_desc>
            <p_value>0.0235</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of ischemia of the Clitoris in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of ischemia of the Clitoris among patients from different groups?</non_inferiority_desc>
            <p_value>0.0021</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of ischemia of the Urethral Sulcus in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of ischemia of the Urethral Sulcus among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of ischemia of the Urethral Meatus in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of ischemia of the Urethral Meatus among patients from different groups?</non_inferiority_desc>
            <p_value>0.0038</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of ischemia of the Vestibule in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of ischemia of the Vestibule among patients from different groups?</non_inferiority_desc>
            <p_value>0.0019</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of punctuation of Hart's Line in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of punctuation of Hart's Line among patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of punctuation of the Vestibule in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot;. Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of punctuation of the Vestibule among patients from different groups?</non_inferiority_desc>
            <p_value>0.0198</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of papillae of Hart's Line in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of papillae of Hart's Line among patients from different groups?</non_inferiority_desc>
            <p_value>0.0004</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of papillae of the Vestibule in patients classified into four groups based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection and Q-Tip), which were examined by the &quot;Three Rings Vulvoscopy.&quot; Vulvoscopic lesions in patients with vulvodynia were not relevant to the diagnosis of the vulvodynia.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of papillae of the Vestibule among patients from different groups?</non_inferiority_desc>
            <p_value>0.0053</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Clitoris versus non-specific lesions of Hart's Line in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Clitoris versus non-specific lesions of Hart's Line in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0010</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Clitoris versus non-specific lesions of the Urethral Sulcus in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Clitoris versus non-specific lesions of the Urethral Sulcus in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0010</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Clitoris versus non-specific lesions of the Vestibule in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Clitoris versus non-specific lesions of the Vestibule in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Hart's Line versus non-specific lesions of Hymenal Remnants in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Hart's Line versus non-specific lesions of Hymenal Remnants in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0208</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Hart's Line versus non-specific lesions of Bartholin's Gland Opening in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Hart's Line versus non-specific lesions of Bartholin's Gland Opening in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0007</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Urethral Sulcus versus non-specific lesions of Hymenal Remnants in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Urethral Sulcus versus non-specific lesions of Hymenal Remnants in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0208</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Urethral Sulcus versus non-specific lesions of Bartholin's Gland Opening in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Urethral Sulcus versus non-specific lesions of Bartholin's Gland Opening in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0007</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Urethral Meatus versus non-specific lesions of the Vestibule in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Urethral Meatus versus non-specific lesions of the Vestibule in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0040</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Hymenal Remnants versus non-specific lesions of the Vestibule in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Hymenal Remnants versus non-specific lesions of the Vestibule in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0012</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Bartholin's Gland Opening versus non-specific lesions of the Vestibule in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Bartholin's Gland Opening versus non-specific lesions of the Vestibule in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Hart's Line versus non-specific lesions of the Urethral Meatus in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Hart's Line versus non-specific lesions of the Urethral Meatus in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0048</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Hart's Line versus non-specific lesions of Hymenal Remnants in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Hart's Line versus non-specific lesions of Hymenal Remnants in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0007</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Urethral Sulcus versus non-specific lesions of the Urethral Meatus in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Urethral Sulcus versus non-specific lesions of the Urethral Meatus in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0048</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Urethral Sulcus versus non-specific lesions of Hymenal Remnants in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Urethral Sulcus versus non-specific lesions of Hymenal Remnants in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0007</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Urethral Meatus versus non-specific lesions of the Vestibule in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Urethral Meatus versus non-specific lesions of the Vestibule in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0131</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Hymenal Remnants versus non-specific lesions of Bartholin's Gland Opening in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Hymenal Remnants versus non-specific lesions of Bartholin's Gland Opening in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0423</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Hymenal Remnants versus non-specific lesions of the Vestibule in patients with vulvodynia.
The diagnosis of vulvodynia was based on anamnestic data (ISSVD Questionnaire) and clinical examination (Inspection, Q-Tip) following Friedrich's criteria. Vulvoscopic lesions were not relevant to the diagnosis of vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Hymenal Remnants versus non-specific lesions of the Vestibule in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0021</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Clitoris versus non-specific lesions of Hart's Line in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Clitoris versus non-specific lesions of Hart's Line in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Clitoris versus non-specific lesions of the Urethral Sulcus in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Clitoris versus non-specific lesions of the Urethral Sulcus in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Clitoris versus non-specific lesions of the Vestibule in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Clitoris versus non-specific lesions of the Vestibule in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0091</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Hart's Line versus non-specific lesions of the Urethral Meatus in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Hart's Line versus non-specific lesions of the Urethral Meatus in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0002</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Hart's Line versus non-specific lesions of Hymenal Remnants in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Hart's Line versus non-specific lesions of Hymenal Remnants in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Hart's Line versus non-specific lesions of Bartholin's Gland Opening in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Hart's Line versus non-specific lesions of Bartholin's Gland Opening in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0013</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Urethral Sulcus versus non-specific lesions of the Urethral Meatus in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Urethral Sulcus versus non-specific lesions of the Urethral Meatus in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0001</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Urethral Sulcus versus non-specific lesions of Hymenal Remnants in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Urethral Sulcus versus non-specific lesions of Hymenal Remnants in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Urethral Sulcus versus non-specific lesions of Bartholin's Gland Opening in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Urethral Sulcus versus non-specific lesions of Bartholin's Gland Opening in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0008</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of the Urethral Meatus versus non-specific lesions of the Vestibule in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of the Urethral Meatus versus non-specific lesions of the Vestibule in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0251</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of non-specific lesions of Hymenal Remnants versus non-specific lesions of the Vestibule in patients with impaired vulvar skin.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of non-specific lesions of Hymenal Remnants versus non-specific lesions of the Vestibule in patients with impaired vulvar skin?</non_inferiority_desc>
            <p_value>0.0006</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of the Clitoris versus specific lesions of Hart's Line in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesions of the Clitoris versus specific lesions of Hart's Line in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0211</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of the Clitoris versus specific lesions of the Urethral Sulcus in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesions of the Clitoris versus specific lesions of the Urethral Sulcus in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.3067</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of the Clitoris versus specific lesions of the Urethral Meatus in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesions of the Clitoris versus specific lesions of the Urethral Meatus in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0295</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of the Clitoris versus specific lesions of Hymenal Remnants in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesions of the Clitoris versus specific lesions of Hymenal Remnants in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0149</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of the Clitoris versus specific lesions of Bartholin's Gland Opening in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesions of the Clitoris versus specific lesions of Bartholin's Gland Opening in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0007</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of specific lesions of the Clitoris versus specific lesions of the Vestibule in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of specific lesions of the Clitoris versus specific lesions of the Vestibule in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0295</p_value>
            <method>t-test proportion</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Aceto-Whitening Reaction (AWR) in Relation to the Three Vulvar Rings</title>
        <description>The table shows the presence, the quality, and the distribution of the aceto-whitening reaction after 5% acetic acid application (Aceto-Whitening Test), in relation to the three vulvar rings.
The &quot;OUTER Vulvar Ring&quot; includes vulvar skin, the &quot;MIDDLE Vulvar Ring&quot; encompasses the modified mucosa, and the &quot;INNER Vulvar Ring&quot; is presented with glicogenized mucosa.
Acetic acid is thought to cause swelling of the epithelial tissue through reversible coagulation or precipitation of the nuclear proteins and cytokeratins.
Areas of pre-/malignant lesions turn densely white and opaque immediately after application of acetic acid, due to the presence of large numbers of dysplastic cells in the superficial layers of the epithelium.
The acetowhite appearance is not unique to pre-/malignancy; it is also seen in other conditions with increased nuclear protein. The acetowhite reaction varies in intensity, within and between patients.</description>
        <time_frame>Aceto-Whitening Test, up to 10 minutes for each participant.</time_frame>
        <population>The Aceto-Whitening test was performed in 328 patients, classified into four groups based on anamnestic data and clinical examination. Localization and type, as well as the velocity of the AWR, were mapped into the &quot;TRIV Form Data.&quot; Aceto-Whitening of all structures of the Inner Vulvar Ring was named &quot;Ring sign.&quot;</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Aceto-Whitening Reaction (AWR) in Relation to the Three Vulvar Rings</title>
          <description>The table shows the presence, the quality, and the distribution of the aceto-whitening reaction after 5% acetic acid application (Aceto-Whitening Test), in relation to the three vulvar rings.
The &quot;OUTER Vulvar Ring&quot; includes vulvar skin, the &quot;MIDDLE Vulvar Ring&quot; encompasses the modified mucosa, and the &quot;INNER Vulvar Ring&quot; is presented with glicogenized mucosa.
Acetic acid is thought to cause swelling of the epithelial tissue through reversible coagulation or precipitation of the nuclear proteins and cytokeratins.
Areas of pre-/malignant lesions turn densely white and opaque immediately after application of acetic acid, due to the presence of large numbers of dysplastic cells in the superficial layers of the epithelium.
The acetowhite appearance is not unique to pre-/malignancy; it is also seen in other conditions with increased nuclear protein. The acetowhite reaction varies in intensity, within and between patients.</description>
          <population>The Aceto-Whitening test was performed in 328 patients, classified into four groups based on anamnestic data and clinical examination. Localization and type, as well as the velocity of the AWR, were mapped into the &quot;TRIV Form Data.&quot; Aceto-Whitening of all structures of the Inner Vulvar Ring was named &quot;Ring sign.&quot;</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Aceto-Whitening Presence | Positive AWR</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="74"/>
                    <measurement group_id="O3" value="81"/>
                    <measurement group_id="O4" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Semitransparent AWR: Presence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="71"/>
                    <measurement group_id="O3" value="68"/>
                    <measurement group_id="O4" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Coarse AWR: Presence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fast AWR (&lt;30 sec)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Slow AWR (&gt;60 sec)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="24"/>
                    <measurement group_id="O3" value="21"/>
                    <measurement group_id="O4" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Provoked Erythema</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sharply bordered AWR</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="40"/>
                    <measurement group_id="O4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AWR of Outer Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AWR of Middle Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="61"/>
                    <measurement group_id="O3" value="75"/>
                    <measurement group_id="O4" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AWR of Inner Vulvar Ring</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="64"/>
                    <measurement group_id="O3" value="79"/>
                    <measurement group_id="O4" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ring Sign</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="31"/>
                    <measurement group_id="O3" value="67"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening between patients from different groups, with positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening between patients from different groups, with positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of coarse AWR between patients from different groups and positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of coarse AWR between patients from different groups and positive AWR?</non_inferiority_desc>
            <p_value>0.0071</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of slow AWR occurrence between patients from different groups and positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of slow AWR between patients from different groups and positive AWR?</non_inferiority_desc>
            <p_value>0.0010</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of provoked erythema among patients from different groups and positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of provoked erythema among patients from different groups and positive AWR?</non_inferiority_desc>
            <p_value>0.0036</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of sharply bordered AWR between patients from different groups and positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of sharply bordered AWR between patients from different groups and positive AWR?</non_inferiority_desc>
            <p_value>0.0032</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Outer Vulvar Ring between the patients from different groups and positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Outer Vulvar Ring between the patients from different groups and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Middle Vulvar Ring between the patients from different groups and positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Middle Vulvar Ring between the patients from different groups and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Inner Vulvar Ring between the patients from different groups and positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Inner Vulvar Ring between the patients from different groups and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of &quot;Ring sign&quot;, aceto-whitening of all structures of the Inner Vulvar Ring, between the patients from different groups and positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of &quot;Ring sign&quot; between the patients from different groups and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Outer versus Middle Vulvar Ring in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Outer versus Middle Vulvar Ring in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.0856</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Outer versus Inner Vulvar Ring in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Outer versus Inner Vulvar Ring in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.4290</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Middle versus Inner Vulvar Ring in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Middle versus Inner Vulvar Ring in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.0124</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Outer versus Middle Vulvar Ring in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Outer versus Middle Vulvar Ring in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Outer versus Inner Vulvar Ring in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Outer versus Inner Vulvar Ring in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Middle versus Inner Vulvar Ring in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Middle versus Inner Vulvar Ring in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.1918</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Outer versus Middle Vulvar Ring in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Outer versus Middle Vulvar Ring in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Outer versus Inner Vulvar Ring in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Outer versus Inner Vulvar Ring in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Middle versus Inner Vulvar Ring in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Middle versus Inner Vulvar Ring in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.5822</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Outer versus Middle Vulvar Ring in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Outer versus Middle Vulvar Ring in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Outer versus Inner Vulvar Ring in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Outer versus Inner Vulvar Ring in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Middle versus Inner Vulvar Ring in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Middle versus Inner Vulvar Ring in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.4975</p_value>
            <method>t-test proportion</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Velocity of the Aceto-Whitening Reaction (Mean ± SD)</title>
        <description>The table shows the velocity (Mean ± SD) of the aceto-whitening occurrence after 5% acetic acid application (AWR - aceto-whitening reaction) in patients with positive AWR classified into four groups based on anamnestic data and clinical examination.
Acetic acid is thought to cause swelling of the epithelial tissue through reversible coagulation or precipitation of the nuclear proteins and cytokeratins.
Areas of pre-/malignant lesions turn densely white and opaque immediately after application of acetic acid, due to their higher concentration of abnormal nuclear protein and the presence of large numbers of dysplastic cells in the superficial layers of the epithelium.
The acetowhite appearance is not unique to pre-/malignancy; it is also seen in other conditions with increased nuclear protein like immature squamous metaplasia, regeneration, inflammation, HPV-infection, hyperkeratosis, etc. The acetowhite reaction varies in intensity, within and between patients.</description>
        <time_frame>Aceto-Whitening Test, up to 10 minutes for each participant.</time_frame>
        <population>The velocity of the AWR was measured with a stopwatch and noted into the &quot;TRIV Form Data&quot; only in the patients with a positive test.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Velocity of the Aceto-Whitening Reaction (Mean ± SD)</title>
          <description>The table shows the velocity (Mean ± SD) of the aceto-whitening occurrence after 5% acetic acid application (AWR - aceto-whitening reaction) in patients with positive AWR classified into four groups based on anamnestic data and clinical examination.
Acetic acid is thought to cause swelling of the epithelial tissue through reversible coagulation or precipitation of the nuclear proteins and cytokeratins.
Areas of pre-/malignant lesions turn densely white and opaque immediately after application of acetic acid, due to their higher concentration of abnormal nuclear protein and the presence of large numbers of dysplastic cells in the superficial layers of the epithelium.
The acetowhite appearance is not unique to pre-/malignancy; it is also seen in other conditions with increased nuclear protein like immature squamous metaplasia, regeneration, inflammation, HPV-infection, hyperkeratosis, etc. The acetowhite reaction varies in intensity, within and between patients.</description>
          <population>The velocity of the AWR was measured with a stopwatch and noted into the &quot;TRIV Form Data&quot; only in the patients with a positive test.</population>
          <units>second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="81"/>
                <count group_id="O4" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.2" spread="24.3"/>
                    <measurement group_id="O2" value="54.9" spread="21.5"/>
                    <measurement group_id="O3" value="51.6" spread="21.2"/>
                    <measurement group_id="O4" value="65.9" spread="34.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the velocity of the aceto-whitening occurrence (positive AWR) among patients from different groups, in which the AWR was positive.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the velocity of the aceto-whitening occurrence among patients from different groups, in which the AWR was positive?</non_inferiority_desc>
            <p_value>0.0003</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Velocity of Aceto-Whitening Reaction (Median | Range)</title>
        <description>The table shows the velocity (Median | Range) of the aceto-whitening occurrence after 5% acetic acid application (AWR - aceto-whitening reaction) in patients with positive AWR classified into four groups based on anamnestic data and clinical examination.
Acetic acid is thought to cause swelling of the epithelial tissue through reversible coagulation or precipitation of the nuclear proteins and cytokeratins.
Areas of pre-/malignant lesions turn densely white and opaque immediately after application of acetic acid, due to their higher concentration of abnormal nuclear protein and the presence of large numbers of dysplastic cells in the superficial layers of the epithelium.
The acetowhite appearance is not unique to pre-/malignancy; it is also seen in other conditions with increased nuclear protein like immature squamous metaplasia, regeneration, inflammation, HPV-infection, hyperkeratosis, etc. The acetowhite reaction varies in intensity, within and between patients.</description>
        <time_frame>Aceto-Whitening Test, up to 10 minutes for each participant.</time_frame>
        <population>The velocity of the AWR was measured with a stopwatch and noted into the &quot;TRIV Form Data&quot; only in the patients with a positive test.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Velocity of Aceto-Whitening Reaction (Median | Range)</title>
          <description>The table shows the velocity (Median | Range) of the aceto-whitening occurrence after 5% acetic acid application (AWR - aceto-whitening reaction) in patients with positive AWR classified into four groups based on anamnestic data and clinical examination.
Acetic acid is thought to cause swelling of the epithelial tissue through reversible coagulation or precipitation of the nuclear proteins and cytokeratins.
Areas of pre-/malignant lesions turn densely white and opaque immediately after application of acetic acid, due to their higher concentration of abnormal nuclear protein and the presence of large numbers of dysplastic cells in the superficial layers of the epithelium.
The acetowhite appearance is not unique to pre-/malignancy; it is also seen in other conditions with increased nuclear protein like immature squamous metaplasia, regeneration, inflammation, HPV-infection, hyperkeratosis, etc. The acetowhite reaction varies in intensity, within and between patients.</description>
          <population>The velocity of the AWR was measured with a stopwatch and noted into the &quot;TRIV Form Data&quot; only in the patients with a positive test.</population>
          <units>second</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="81"/>
                <count group_id="O4" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.5" lower_limit="30" upper_limit="120"/>
                    <measurement group_id="O2" value="51.5" lower_limit="21" upper_limit="131"/>
                    <measurement group_id="O3" value="49" lower_limit="16" upper_limit="120"/>
                    <measurement group_id="O4" value="58" lower_limit="18" upper_limit="184"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the velocity of the aceto-whitening occurrence among patients with positive AWR from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the velocity of the aceto-whitening occurrence among patients with positive AWR from different groups?</non_inferiority_desc>
            <p_value>0.0004</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the velocity of the aceto-whitening occurrence between patients with vulvar dermatosis and vulvodynia, with positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the velocity of the aceto-whitening occurrence between patients with vulvar dermatosis and vulvodynia, with positive AWR?</non_inferiority_desc>
            <p_value>0.0231</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the velocity of the aceto-whitening occurrence between the patients with normal vulva and impaired vulvar skin, with positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the velocity of the aceto-whitening occurrence between the patients with normal vulva and impaired vulvar skin, with positive AWR?</non_inferiority_desc>
            <p_value>0.0006</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the velocity of the aceto-whitening occurrence between patients with normal vulva and vulvodynia, with positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the velocity of the aceto-whitening occurrence between patients with normal vulva and vulvodynia, with positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Distribution of Aceto-Whitening Reaction in Relation to the Structures of the Outer Vulvar Ring</title>
        <description>The table shows the distribution of aceto-whitening occurrence (AWR) after 5% acetic acid application in relation to the structures of the Outer Vulvar Ring.
The &quot;OUTER Vulvar Ring&quot; is presented with the following structures: Mons Pubis, Labia Majora, and the Perineum.
Acetic acid is thought to cause swelling of the epithelial tissue through reversible coagulation or precipitation of the nuclear proteins and cytokeratins.
Areas of pre-/malignant lesions turn densely white and opaque immediately after application of acetic acid, due to the presence of large numbers of dysplastic cells in the superficial layers of the epithelium.
The acetowhite appearance is not unique to pre-/malignancy; it is also seen in other conditions with increased nuclear protein. The acetowhite reaction varies in intensity, within and between patients.</description>
        <time_frame>Aceto-Whitening Test, up to 10 minutes for each participant.</time_frame>
        <population>We performed the aceto-whitening test with 5% acetic acid application in 328 patients, classified into four groups based on anamnestic data and clinical examination. Localization and type, as well as the velocity of the AWR, were mapped into the &quot;TRIV Form Data&quot;.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Distribution of Aceto-Whitening Reaction in Relation to the Structures of the Outer Vulvar Ring</title>
          <description>The table shows the distribution of aceto-whitening occurrence (AWR) after 5% acetic acid application in relation to the structures of the Outer Vulvar Ring.
The &quot;OUTER Vulvar Ring&quot; is presented with the following structures: Mons Pubis, Labia Majora, and the Perineum.
Acetic acid is thought to cause swelling of the epithelial tissue through reversible coagulation or precipitation of the nuclear proteins and cytokeratins.
Areas of pre-/malignant lesions turn densely white and opaque immediately after application of acetic acid, due to the presence of large numbers of dysplastic cells in the superficial layers of the epithelium.
The acetowhite appearance is not unique to pre-/malignancy; it is also seen in other conditions with increased nuclear protein. The acetowhite reaction varies in intensity, within and between patients.</description>
          <population>We performed the aceto-whitening test with 5% acetic acid application in 328 patients, classified into four groups based on anamnestic data and clinical examination. Localization and type, as well as the velocity of the AWR, were mapped into the &quot;TRIV Form Data&quot;.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>AWR of Mons Pubis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AWR of Labia Majora</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AWR of the Perineum</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Mons Pubis among patients from different groups, with positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Mons Pubis among patients from different groups, with positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Labia Majora among patients from different groups, with positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Labia Majora among patients from different groups, with positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Perineum among patients from different groups, with positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Perineum among patients from different groups, with positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Mons Pubis versus Labia Majora in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Mons Pubis versus Labia Majora in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.0128</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Mons Pubis versus Perineum in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Mons Pubis versus Perineum in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Labia Majora versus Perineum in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Labia Majora versus Perineum in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.0635</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Mons Pubis versus Labia Majora in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Mons Pubis versus Labia Majora in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.0429</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Mons Pubis versus Perineum in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Mons Pubis versus Perineum in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.0011</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Labia Majora versus Perineum in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Labia Majora versus Perineum in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.0936</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Mons Pubis versus Labia Majora in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Mons Pubis versus Labia Majora in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Mons Pubis versus Perineum in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Mons Pubis versus Perineum in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.0429</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Labia Majora versus Perineum in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Labia Majora versus Perineum in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.0429</p_value>
            <method>t-test proportion</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Distribution of Aceto-Whitening Reaction in Relation to the Structures of the Middle Vulvar Ring</title>
        <description>The distribution of aceto-whitening occurrence after 5% acetic acid application (AWR - aceto-whitening reaction) in relation to the structures of the Middle Vulvar Ring.
The &quot;MIDDLE vulvar ring&quot; encompasses the following structures: the anterior commissure with the prepuce of the clitoris, interlabial sulci, labia minora, and the posterior commissure.</description>
        <time_frame>Aceto-Whitening Test, up to 10 minutes for each participant.</time_frame>
        <population>We performed the aceto-whitening test with 5% acetic acid application in 328 patients, classified into four groups based on anamnestic data and clinical examination. Localization and type, as well as the velocity of the AWR, were mapped into the &quot;TRIV Form Data&quot;.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Distribution of Aceto-Whitening Reaction in Relation to the Structures of the Middle Vulvar Ring</title>
          <description>The distribution of aceto-whitening occurrence after 5% acetic acid application (AWR - aceto-whitening reaction) in relation to the structures of the Middle Vulvar Ring.
The &quot;MIDDLE vulvar ring&quot; encompasses the following structures: the anterior commissure with the prepuce of the clitoris, interlabial sulci, labia minora, and the posterior commissure.</description>
          <population>We performed the aceto-whitening test with 5% acetic acid application in 328 patients, classified into four groups based on anamnestic data and clinical examination. Localization and type, as well as the velocity of the AWR, were mapped into the &quot;TRIV Form Data&quot;.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>AWR of the Anterior Commissure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AWR of Interlabial Sulci</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AWR of Labia Minora</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="43"/>
                    <measurement group_id="O4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AWR of the Posterior Commissure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="53"/>
                    <measurement group_id="O3" value="72"/>
                    <measurement group_id="O4" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Anterior Commissure among patients from different groups, with positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Anterior Commissure among patients from different groups, with positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Interlabial Sulci among patients from different groups, with positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Interlabial Sulci among patients from different groups, with positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Labia Minora among patients from different groups, with positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Labia Minora among patients from different groups, with positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Posterior Commissure among patients from different groups, with positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Posterior Commissure among patients from different groups, with positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Anterior Commissure versus Interlabial Sulci in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Anterior Commissure versus Interlabial Sulci in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.0318</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Anterior Commissure versus Labia Minora in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Anterior Commissure versus Labia Minora in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.0318</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Anterior Commissure versus Posterior Commissure in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Anterior Commissure versus Posterior Commissure in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Interlabial Sulci versus Labia Minora in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Interlabial Sulci versus Labia Minora in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Interlabial Sulci versus Posterior Commissure in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Interlabial Sulci versus Posterior Commissure in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.0389</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Labia Minora versus Posterior Commissure in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Labia Minora versus Posterior Commissure in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.0389</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Anterior Commissure versus Interlabial Sulci in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Anterior Commissure versus Interlabial Sulci in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.00001</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Anterior Commissure versus Labia Minora in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Anterior Commissure versus Labia Minora in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Anterior Commissure versus Posterior Commissure in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Anterior Commissure versus Posterior Commissure in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Interlabial Sulci versus Labia Minora in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Interlabial Sulci versus Labia Minora in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.0008</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Interlabial Sulci versus Posterior Commissure in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Interlabial Sulci versus Posterior Commissure in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Labia Minora versus Posterior Commissure in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Labia Minora versus Posterior Commissure in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Anterior Commissure versus Interlabial Sulci in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Anterior Commissure versus Interlabial Sulci in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.0005</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Anterior Commissure versus Labia Minora in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Anterior Commissure versus Labia Minora in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Anterior Commissure versus Posterior Commissure in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Anterior Commissure versus Posterior Commissure in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Interlabial Sulci versus Labia Minora in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Interlabial Sulci versus Labia Minora in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.4505</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Interlabial Sulci versus Posterior Commissure in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Interlabial Sulci versus Posterior Commissure in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Labia Minora versus Posterior Commissure in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Labia Minora versus Posterior Commissure in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Anterior Commissure versus Interlabial Sulci in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Anterior Commissure versus Interlabial Sulci in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Anterior Commissure versus Labia Minora in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Anterior Commissure versus Labia Minora in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.0534</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Anterior Commissure versus Posterior Commissure in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Anterior Commissure versus Posterior Commissure in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Interlabial Sulci versus Labia Minora in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Interlabial Sulci versus Labia Minora in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.0534</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Interlabial Sulci versus Posterior Commissure in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Interlabial Sulci versus Posterior Commissure in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Labia Minora versus Posterior Commissure in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Labia Minora versus Posterior Commissure in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.0005</p_value>
            <method>t-test proportion</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Distribution of Aceto-Whitening Reaction in Relation to the Structures of the Inner Vulvar Ring</title>
        <description>The table shows the distribution of aceto-whitening reaction (AWR) after 5% acetic acid application (AWR - aceto-whitening reaction) in relation to the structures of the Inner Vulvar Ring.
The &quot;INNER Vulvar Ring&quot; is presented with the following structures: the clitoris, Hart's line, the urethral sulcus, the urethral meatus, hymenal remnants, Bartholin's gland opening, and the vestibule.
Acetic acid is thought to cause swelling of the epithelial tissue through reversible coagulation or precipitation of the nuclear proteins and cytokeratins.
Areas of pre-/malignant lesions turn densely white and opaque immediately after application of acetic acid, due to the presence of large numbers of dysplastic cells in the superficial layers of the epithelium.
The acetowhite appearance is not unique to pre-/malignancy; it is also seen in other conditions with increased nuclear protein. The acetowhite reaction varies in intensity, within and between patients.</description>
        <time_frame>Aceto-Whitening Test, up to 10 minutes for each participant.</time_frame>
        <population>We performed the aceto-whitening test with 5% acetic acid application in 328 patients, classified into four groups based on anamnestic data and clinical examination. Localization and type, as well as the velocity of the AWR, were mapped into the &quot;TRIV Form Data&quot;. Aceto-Whitening of all structures of the Inner vulvar ring was named &quot;Ring sign&quot;.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV (some non-specific lesions of the vulva) were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Distribution of Aceto-Whitening Reaction in Relation to the Structures of the Inner Vulvar Ring</title>
          <description>The table shows the distribution of aceto-whitening reaction (AWR) after 5% acetic acid application (AWR - aceto-whitening reaction) in relation to the structures of the Inner Vulvar Ring.
The &quot;INNER Vulvar Ring&quot; is presented with the following structures: the clitoris, Hart's line, the urethral sulcus, the urethral meatus, hymenal remnants, Bartholin's gland opening, and the vestibule.
Acetic acid is thought to cause swelling of the epithelial tissue through reversible coagulation or precipitation of the nuclear proteins and cytokeratins.
Areas of pre-/malignant lesions turn densely white and opaque immediately after application of acetic acid, due to the presence of large numbers of dysplastic cells in the superficial layers of the epithelium.
The acetowhite appearance is not unique to pre-/malignancy; it is also seen in other conditions with increased nuclear protein. The acetowhite reaction varies in intensity, within and between patients.</description>
          <population>We performed the aceto-whitening test with 5% acetic acid application in 328 patients, classified into four groups based on anamnestic data and clinical examination. Localization and type, as well as the velocity of the AWR, were mapped into the &quot;TRIV Form Data&quot;. Aceto-Whitening of all structures of the Inner vulvar ring was named &quot;Ring sign&quot;.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>AWR of the Clitoris</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="35"/>
                    <measurement group_id="O3" value="73"/>
                    <measurement group_id="O4" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AWR of Hart's Line</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="50"/>
                    <measurement group_id="O3" value="79"/>
                    <measurement group_id="O4" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AWR of the Urethral Sulcus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="49"/>
                    <measurement group_id="O3" value="73"/>
                    <measurement group_id="O4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AWR of the Urethral Meatus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="38"/>
                    <measurement group_id="O3" value="70"/>
                    <measurement group_id="O4" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AWR of Hymenal Remnants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="33"/>
                    <measurement group_id="O3" value="69"/>
                    <measurement group_id="O4" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AWR of Bartholin's Gland Opening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="42"/>
                    <measurement group_id="O3" value="75"/>
                    <measurement group_id="O4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AWR of the Vestibule</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="49"/>
                    <measurement group_id="O3" value="76"/>
                    <measurement group_id="O4" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris among patients from different groups, with positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris among patients from different groups, with positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line among patients from different groups, with positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line among patients from different groups, with positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Urethral Sulcus among patients from different groups, with positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Urethral Sulcus among patients from different groups, with positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Urethral Meatus among patients from different groups, with positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Urethral Meatus among patients from different groups, with positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hymenal Remnants among patients from different groups, with positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hymenal Remnants among patients from different groups, with positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Bartholin's Gland Opening among patients from different groups, with positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Bartholin's Gland Opening among patients from different groups, with positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Vestibule among patients from different groups, with positive AWR.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Vestibule among patients from different groups, with positive AWR?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Hart's line in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Hart's line in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.8545</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Urethral Sulcus in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Urethral Sulcus in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.8569</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Urethral Meatus in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Urethral Meatus in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.2478</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Hymenal Remnants in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Hymenal Remnants in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.2478</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Bartholin's Gland Opening in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Bartholin's Gland Opening in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.1627</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Vestibule in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Vestibule in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.5943</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Urethral Sulcus in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Urethral Sulcus in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.7161</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Urethral Meatus in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Urethral Meatus in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.3301</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Hymenal Remnants in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Hymenal Remnants in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.3301</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Bartholin's Gland Opening in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Bartholin's Gland Opening in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.1627</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Vestibule in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Vestibule in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.4742</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Urethral Sulcus versus Urethral Meatus in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Urethral Sulcus versus Urethral Meatus in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.1822</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Urethral Sulcus versus Hymenal Remnants in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Urethral Sulcus versus Hymenal Remnants in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.1822</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hymenal Remnants versus Vestibule in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hymenal Remnants versus Vestibule in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.0927</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Bartholin's Gland Opening versus Vestibule in patients with vulvar dermatosis and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Bartholin's Gland Opening versus Vestibule in patients with vulvar dermatosis and positive AWR?</non_inferiority_desc>
            <p_value>0.0360</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Hart's Line in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Hart's Line in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.0720</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Urethral Sulcus in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Urethral Sulcus in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Urethral Meatus in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Urethral Meatus in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.4833</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Hymenal Remnants in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Hymenal Remnants in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.3594</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Bartholin's Gland Opening in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Bartholin's Gland Opening in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.5987</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Vestibule in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Vestibule in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.4164</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Urethral Sulcus in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Urethral Sulcus in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.0720</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Urethral Meatus in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Urethral Meatus in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.0148</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Hymenal Remnants in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Hymenal Remnants in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.0085</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Bartholin's Gland Opening in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Bartholin's Gland Opening in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.1918</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's line versus Vestibule in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's line versus Vestibule in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.3037</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Urethral Sulcus versus Urethral Meatus in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Urethral Sulcus versus Urethral Meatus in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.4833</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Urethral Sulcus versus Hymenal Remnants in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Urethral Sulcus versus Hymenal Remnants in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.3594</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Hymenal Remnants versus Vestibule in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Hymenal Remnants versus Vestibule in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.0877</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Bartholin's Gland Opening versus Vestibule in patients with vulvodynia and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Bartholin's Gland Opening versus Vestibule in patients with vulvodynia and positive AWR?</non_inferiority_desc>
            <p_value>0.7726</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Hart's Line in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Hart's Line in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.0191</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Urethral Sulcus in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Urethral Sulcus in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.0287</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Urethral Meatus in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Urethral Meatus in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.6374</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Hymenal Remnants in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Hymenal Remnants in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.7512</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Bartholin's Gland Opening in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Bartholin's Gland Opening in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.2734</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Vestibule in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Vestibule in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.0287</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Urethral Sulcus in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Urethral Sulcus in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.8732</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Urethral Meatus in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Urethral Meatus in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.0602</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Hymenal Remnants in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Hymenal Remnants in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.0079</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Bartholin's Gland Opening in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Bartholin's Gland Opening in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.2081</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Vestibule in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Vestibule in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.8732</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Urethral Sulcus versus Urethral Meatus in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Urethral Sulcus versus Urethral Meatus in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.0852</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Urethral Sulcus versus Hymenal Remnants in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Urethral Sulcus versus Hymenal Remnants in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.0125</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hymenal Remnants versus Vestibule in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hymenal Remnants versus Vestibule in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.0125</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Bartholin's Gland Opening versus Vestibule in patients with impaired vulvar skin and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Bartholin's Gland Opening versus Vestibule in patients with impaired vulvar skin and positive AWR?</non_inferiority_desc>
            <p_value>0.2714</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Hart's Line in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Hart's Line in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.1692</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Urethral Sulcus in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Urethral Sulcus in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.0772</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Urethral Meatus in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Urethral Meatus in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.5762</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Hymenal Remnants in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Hymenal Remnants in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.5762</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Bartholin's Gland Opening in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Bartholin's Gland Opening in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of the Clitoris versus Vestibule in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of the Clitoris versus Vestibule in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.0078</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Urethral Sulcus in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Urethral Sulcus in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.6862</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Urethral Meatus in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Urethral Meatus in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.0563</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Hymenal Remnants in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Hymenal Remnants in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.0563</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Bartholin's Gland Opening in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Bartholin's Gland Opening in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.1692</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hart's Line versus Vestibule in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hart's Line versus Vestibule in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.1822</p_value>
            <method>t</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Urethral Sulcus versus Urethral Meatus in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Urethral Sulcus versus Urethral Meatus in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.0220</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Urethral Sulcus versus Hymenal Remnants in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Urethral Sulcus versus Hymenal Remnants in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.0220</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Hymenal Remnants versus Vestibule in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Hymenal Remnants versus Vestibule in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.0220</p_value>
            <method>t-test proportion</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of aceto-whitening of Bartholin's Gland Opening versus Vestibule in patients with normal vulva and positive AWR.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of aceto-whitening of Bartholin's Gland Opening versus Vestibule in patients with normal vulva and positive AWR?</non_inferiority_desc>
            <p_value>0.0078</p_value>
            <method>t-test proportion</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Histopathological Characteristics of Vulvar Specimens in Patients With And Without Vulvar Discomfort</title>
        <description>The table shows the distribution of histopathological findings of vulvar epidermis among patients with and without vulvar discomfort, classified into four groups based on anamnestic data, clinical examination and &quot;Three Rings Vulvoscopy.&quot; Histopathological characteristics of vulvar epidermis included hyperkeratosis, parakeratosis, acanthosis, and epidermal atrophy. In the vulvar dermis, there were evaluated presence of inflammatory infiltrates (monocytes, lymphocytes, mastocytes), collagen fibers, hyalinization, hyperpigmentation, elongated dermal papillae, blood vessels, sebaceous glands, and nerve fibers.</description>
        <time_frame>Histopathological Examination, up to 30 minutes for each vulvar sample.</time_frame>
        <population>We performed a biopsy of the vulva in 164 symptomatic patients during the routine clinical care to histopathologically confirm or exclude a skin disorder. Vulvar specimens from 164 asymptomatic patients were granted from the women undergoing planned labiaplasty.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Vulva</title>
            <description>Patients without vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire) and without finding any clinical and colposcopy vulvar lesion.</description>
          </group>
          <group group_id="O2">
            <title>Impaired Vulvar Skin</title>
            <description>Patients without vulvar symptoms (ISSVD Vulvodynia Pattern Questionnaire) but with some non-specific vulvar lesions found clinically and with TRIV.</description>
          </group>
          <group group_id="O3">
            <title>Vulvodynia</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant for diagnosis of vulvodynia.</description>
          </group>
          <group group_id="O4">
            <title>Vulvar Dermatosis</title>
            <description>Patients with vulvar discomfort (ISSVD Vulvodynia Pattern Questionnaire), clinical and vulvoscopy (TRIV) finding of lesions specific for dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Histopathological Characteristics of Vulvar Specimens in Patients With And Without Vulvar Discomfort</title>
          <description>The table shows the distribution of histopathological findings of vulvar epidermis among patients with and without vulvar discomfort, classified into four groups based on anamnestic data, clinical examination and &quot;Three Rings Vulvoscopy.&quot; Histopathological characteristics of vulvar epidermis included hyperkeratosis, parakeratosis, acanthosis, and epidermal atrophy. In the vulvar dermis, there were evaluated presence of inflammatory infiltrates (monocytes, lymphocytes, mastocytes), collagen fibers, hyalinization, hyperpigmentation, elongated dermal papillae, blood vessels, sebaceous glands, and nerve fibers.</description>
          <population>We performed a biopsy of the vulva in 164 symptomatic patients during the routine clinical care to histopathologically confirm or exclude a skin disorder. Vulvar specimens from 164 asymptomatic patients were granted from the women undergoing planned labiaplasty.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="82"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hyperkeratosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Parakeratosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Acanthosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Epidermal Atrophy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inflammatory Infiltrates</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="52"/>
                    <measurement group_id="O3" value="65"/>
                    <measurement group_id="O4" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mononuclear Infiltrates</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="46"/>
                    <measurement group_id="O3" value="61"/>
                    <measurement group_id="O4" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lymphocytes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mastocytes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Collagen Fibers</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hyalinization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hyperpigmentation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elongated Dermal Papillae</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blood Vessels</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="53"/>
                    <measurement group_id="O4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sebaceous Glands</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="48"/>
                    <measurement group_id="O3" value="61"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nerve Fibers</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="68"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of hyperkeratosis in vulvar specimens of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of hyperkeratosis in vulvar specimens of patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of parakeratosis in vulvar specimens of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of parakeratosis in vulvar specimens of patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of acanthosis in vulvar specimens of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of acanthosis in vulvar specimens of patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of epidermal atrophy in vulvar specimens of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of epidermal atrophy in vulvar specimens of patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of inflammatory infiltrates in vulvar specimens of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of inflammatory infiltrates in vulvar specimens of patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of mononuclear inflammatory infiltrates in vulvar specimens of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of mononuclear inflammatory infiltrates in vulvar specimens of patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of lymphocytes (infiltrates) in vulvar specimens of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of lymphocytes in vulvar specimens of patients from different groups?</non_inferiority_desc>
            <p_value>0.0105</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of mastocytes in vulvar specimens of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of mastocytes in vulvar specimens of patients from different groups?</non_inferiority_desc>
            <p_value>0.0064</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of collagen fibers in vulvar specimens of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of collagen fibers in vulvar specimens of patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of hyalinization in vulvar specimens of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of hyalinization in vulvar specimens of patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of hyperpigmentation in vulvar specimens of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of hyperpigmentation in vulvar specimens of patients from different groups?</non_inferiority_desc>
            <p_value>0.0342</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of elongated dermal papillae in vulvar specimens of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of elongated dermal papillae in vulvar specimens of patients from different groups?</non_inferiority_desc>
            <p_value>0.0148</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of blood vessels in vulvar specimens of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of blood vessels in vulvar specimens of patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of sebaceous glands in vulvar specimens of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of sebaceous glands in vulvar specimens of patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of nerve fibers in vulvar specimens of patients from different groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of nerve fibers in vulvar specimens of patients from different groups?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Histopathological Features of the Vulvar Epidermis and Vulvar Discomfort in Patients With Vulvar Dermatosis</title>
        <description>The table shows the relationship between histopathological features of the vulvar epidermis (normal versus abnormal) and single vulvar symptoms from the categories of the dull (&quot;slow&quot;) and sharp (&quot;fast&quot;) pain of the vulva in 82 patients with vulvar dermatosis.
The dull pain comprises sensations of burning, stinging, soreness, irritation,itching, inflammation and aching.
The fast pain includes sensations like sticking and stabbing, paper-cut or knife-like pain.</description>
        <time_frame>Histopathological Examination, up to 30 minutes for each vulvar sample.</time_frame>
        <population>We performed a biopsy of the vulva in 82 symptomatic patients with vulvar dermatosis diagnosed anamnestically and by clinical examination during the routine clinical care, to confirm the diagnosis on histopathology.</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvar Dermatosis With Normal Epidermis</title>
            <description>Histopathological Finding of Normal Epidermis among the various vulvar complaints in patients with vulvar dermatosis.</description>
          </group>
          <group group_id="O2">
            <title>Vulvar Dermatosis With Abnormal Epidermis</title>
            <description>Histopathological Finding of Abnormal Epidermis among the various vulvar complaints in patients with vulvar dermatosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Histopathological Features of the Vulvar Epidermis and Vulvar Discomfort in Patients With Vulvar Dermatosis</title>
          <description>The table shows the relationship between histopathological features of the vulvar epidermis (normal versus abnormal) and single vulvar symptoms from the categories of the dull (&quot;slow&quot;) and sharp (&quot;fast&quot;) pain of the vulva in 82 patients with vulvar dermatosis.
The dull pain comprises sensations of burning, stinging, soreness, irritation,itching, inflammation and aching.
The fast pain includes sensations like sticking and stabbing, paper-cut or knife-like pain.</description>
          <population>We performed a biopsy of the vulva in 82 symptomatic patients with vulvar dermatosis diagnosed anamnestically and by clinical examination during the routine clinical care, to confirm the diagnosis on histopathology.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dull / Slow Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Burning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stinging</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Soreness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Irritation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Itching</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inflammation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aching</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sharp / Fast Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Knife-Like Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Paper-Cuts Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stabbing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sticking</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar complaints depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar complaints depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of symptoms of the dull (slow) pain of the vulva (burning, stinging, soreness, irritation, itching, inflammation, aching) depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of symptoms of the dull pain of the vulva on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>1.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of vulvar burning depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar burning depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.3533</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of vulvar stinging depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stinging depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.5641</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of vulvar soreness depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar soreness depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.9684</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of vulvar irritation depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar irritation depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.8599</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of vulvar itching depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar itching depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.9402</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of the feeling of vulvar inflammation depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the feeling of vulvar inflammation depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.8389</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of vulvar aching depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar aching depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.7617</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the sharp (fast) pain of the vulva (knife-like pain, paper-cuts pain, stabbing, sticking) depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the sharp pain of the vulva depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.4613</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of the vulvar knife-like pain depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar knife-like pain depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.0331</p_value>
            <method>Chi-squared, Corrected</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of the vulvar paper-cuts pain depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar paper-cuts pain depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.9402</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of vulvar pain like stabbing depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar pain like stabbing depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.9139</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of the vulvar pain like sticking depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar pain like sticking depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvar dermatosis?</non_inferiority_desc>
            <p_value>0.8925</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Histopathological Features of the Vulvar Epidermis and Vulvar Complaints in Patients With Vulvodynia</title>
        <description>The table shows the relationship between histopathological features of the vulvar epidermis (normal versus abnormal), and single vulvar symptoms from the categories of the dull (&quot;slow&quot;) and sharp (&quot;fast&quot;) pain of the vulva in 82 patients with vulvodynia diagnosed anamnestically and clinically following Friedrich's criteria.
The &quot;dull&quot; pain comprises sensations of burning, stinging, soreness, irritation, itching, inflammation and aching. The &quot;fast&quot; pain includes sensations like sticking and stabbing, paper-cut or knife-like pain.</description>
        <time_frame>Histopathological Examination, up to 30 minutes for each vulvar sample.</time_frame>
        <population>We performed a biopsy of the vulva in 82 symptomatic patients with vulvodynia diagnosed anamnestically and by clinical examination following Friedrich's criteria during the routine clinical care, to exclude other skin diseases on histopathology.</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvodynia With Normal Epidermis</title>
            <description>Histopathological Finding of Normal Epidermis among the various vulvar complaints in patients with vulvodynia.</description>
          </group>
          <group group_id="O2">
            <title>Vulvodynia With Abnormal Epidermis</title>
            <description>Histopathological Finding of Abnormal Epidermis among the various vulvar complaints in patients with vulvodynia.</description>
          </group>
        </group_list>
        <measure>
          <title>Histopathological Features of the Vulvar Epidermis and Vulvar Complaints in Patients With Vulvodynia</title>
          <description>The table shows the relationship between histopathological features of the vulvar epidermis (normal versus abnormal), and single vulvar symptoms from the categories of the dull (&quot;slow&quot;) and sharp (&quot;fast&quot;) pain of the vulva in 82 patients with vulvodynia diagnosed anamnestically and clinically following Friedrich's criteria.
The &quot;dull&quot; pain comprises sensations of burning, stinging, soreness, irritation, itching, inflammation and aching. The &quot;fast&quot; pain includes sensations like sticking and stabbing, paper-cut or knife-like pain.</description>
          <population>We performed a biopsy of the vulva in 82 symptomatic patients with vulvodynia diagnosed anamnestically and by clinical examination following Friedrich's criteria during the routine clinical care, to exclude other skin diseases on histopathology.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dull / Slow Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Burning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stinging</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Soreness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Irritation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Itching</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inflammation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aching</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sharp / Fast Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Knife-Like Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Paper-Cuts Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stabbing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sticking</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of vulvar complaints depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar complaints depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0000</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of symptoms of the dull (slow) pain depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of symptoms of the dull pain depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.6921</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of vulvar burning depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar burning on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.1848</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of vulvar stinging depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar stinging depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.9048</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of vulvar soreness depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar soreness depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.3953</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of vulvar irritation depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar irritation depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0921</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of vulvar itching depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar itching depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.6734</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of the feeling of vulvar inflammation depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the feeling of vulvar inflammation depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.3458</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of vulvar aching depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar aching depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.5304</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of symptoms of the sharp (fast) pain depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of symptoms of the sharp pain depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0012</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of vulvar knife-like pain depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar knife-like pain depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0002</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of vulvar paper-cuts pain depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar paper-cuts pain depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0218</p_value>
            <method>Chi-squared, Corrected</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of vulvar pain like stabbing depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar pain like stabbing depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.0297</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The incidence of vulvar pain like sticking depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of vulvar pain like sticking depending on the histopathology of the epidermis (normal versus abnormal) in patients with vulvodynia?</non_inferiority_desc>
            <p_value>0.6468</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Histopathological Features of Vulvar Dermis in Patients With Vulvar Dermatosis Depending On The Duration of Vulvar Discomfort</title>
        <description>The table shows the relationship between histopathological features of the vulvar dermis depending on the duration of vulvar discomfort (less or more than 24 months) in 82 consecutive patients with vulvar dermatosis.
Histopathological characteristics of vulvar dermis included inflammatory infiltrates (mononuclear, lymphocytes, mastocytes), collagen fibers, hyalinization, hyperpigmentation, elongated dermal papillae, blood vessels, sebaceous glands, and nerve fibers.</description>
        <time_frame>Histopathological Examination, up to 30 minutes for each vulvar sample.</time_frame>
        <population>We performed a biopsy of the vulva in 82 symptomatic patients with vulvar dermatosis diagnosed anamnestically and by clinical examination during the routine clinical care, to confirm the diagnosis on histopathology.</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvar Dermatosis 1</title>
            <description>Patients with duration of symptoms of the vulvar dermatosis less than 24 months.</description>
          </group>
          <group group_id="O2">
            <title>Vulvar Dermatosis 2</title>
            <description>Patients with duration of symptoms of the vulvar dermatosis more than 24 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Histopathological Features of Vulvar Dermis in Patients With Vulvar Dermatosis Depending On The Duration of Vulvar Discomfort</title>
          <description>The table shows the relationship between histopathological features of the vulvar dermis depending on the duration of vulvar discomfort (less or more than 24 months) in 82 consecutive patients with vulvar dermatosis.
Histopathological characteristics of vulvar dermis included inflammatory infiltrates (mononuclear, lymphocytes, mastocytes), collagen fibers, hyalinization, hyperpigmentation, elongated dermal papillae, blood vessels, sebaceous glands, and nerve fibers.</description>
          <population>We performed a biopsy of the vulva in 82 symptomatic patients with vulvar dermatosis diagnosed anamnestically and by clinical examination during the routine clinical care, to confirm the diagnosis on histopathology.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Inflammatory Infiltrates</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mononuclear Inflammatory Infiltrates</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lymphocytes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mastocytes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Collagen Fibers</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hyalinization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hyperpigmentation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elongated Dermal Papillae</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blood Vessels</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sebaceous Glands</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nerve Fibers</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of inflammatory infiltrates in vulvar specimens from patients with vulvar dermatosis depending on the duration of vulvar discomfort.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the finding of inflammatory infiltrates in vulvar specimens from patients with vulvar dermatosis depending on the duration of vulvar discomfort for less or more than 24 months?</non_inferiority_desc>
            <p_value>0.2045</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of mononuclear inflammatory infiltrates in vulvar specimens from patients with vulvar dermatosis depending on the duration of vulvar discomfort.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the finding of mononuclear inflammatory infiltrates in vulvar specimens from patients with vulvar dermatosis depending on the duration of vulvar discomfort for less or more than 24 months?</non_inferiority_desc>
            <p_value>0.7469</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of lymphocytes in vulvar specimens from patients with vulvar dermatosis depending on the duration of vulvar discomfort.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the finding of lymphocytes in vulvar specimens from patients with vulvar dermatosis depending on the duration of vulvar discomfort for less or more than 24 months?</non_inferiority_desc>
            <p_value>0.4271</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of collagen fibers in vulvar specimens from patients with vulvar dermatosis depending on the duration of vulvar discomfort.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the finding of collagen fibers in vulvar specimens from patients with vulvar dermatosis depending on the duration of vulvar discomfort for less or more than 24 months?</non_inferiority_desc>
            <p_value>0.3607</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of hyalinization in vulvar specimens from patients with vulvar dermatosis depending on the duration of vulvar discomfort.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the finding of hyalinization in vulvar specimens from patients with vulvar dermatosis depending on the duration of vulvar discomfort for less or more than 24 months?</non_inferiority_desc>
            <p_value>0.8672</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Histopathological Features of the Vulvar Dermis in Patients With Vulvodynia Depending on The Duration of Vulvar Discomfort</title>
        <description>The table shows the relationship between histopathological features of the vulvar dermis depending on the duration of vulvar discomfort (less or more than 24 months) in 82 patients with vulvodynia, diagnosed anamnestically and clinically following Friedrich's criteria.
Histopathological characteristics of vulvar dermis included inflammatory infiltrates (mononuclear, lymphocytes, mastocytes), collagen fibers, hyalinization, hyperpigmentation, elongated dermal papillae, blood vessels, sebaceous glands, and nerve fibers.</description>
        <time_frame>Histopathological Examination, up to 30 minutes for each vulvar sample.</time_frame>
        <population>We performed a biopsy of the vulva in 82 symptomatic patients with vulvodynia diagnosed anamnestically and by clinical examination following Friedrich's criteria during the routine clinical care, to exclude other skin diseases.</population>
        <group_list>
          <group group_id="O1">
            <title>Vulvodynia 1</title>
            <description>Patients with duration of symptoms of the vulvodynia less than 24 months.</description>
          </group>
          <group group_id="O2">
            <title>Vulvodynia 2</title>
            <description>Patients with duration of symptoms of vulvodynia more than 24 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Histopathological Features of the Vulvar Dermis in Patients With Vulvodynia Depending on The Duration of Vulvar Discomfort</title>
          <description>The table shows the relationship between histopathological features of the vulvar dermis depending on the duration of vulvar discomfort (less or more than 24 months) in 82 patients with vulvodynia, diagnosed anamnestically and clinically following Friedrich's criteria.
Histopathological characteristics of vulvar dermis included inflammatory infiltrates (mononuclear, lymphocytes, mastocytes), collagen fibers, hyalinization, hyperpigmentation, elongated dermal papillae, blood vessels, sebaceous glands, and nerve fibers.</description>
          <population>We performed a biopsy of the vulva in 82 symptomatic patients with vulvodynia diagnosed anamnestically and by clinical examination following Friedrich's criteria during the routine clinical care, to exclude other skin diseases.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Inflammatory Infiltrates</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mononuclear Inflammatory Infiltrates</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lymphocytes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mastocytes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Collagen Fibers</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hyalinization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hyperpigmentation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elongated Dermal Papillae</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blood Vessels</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sebaceous Glands</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nerve Fibers</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of inflammatory infiltrates in vulvar specimens from patients with vulvodynia depending on the duration of vulvar discomfort.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the finding of inflammatory infiltrates in vulvar specimens from patients with vulvodynia depending on the duration of vulvar discomfort for less or more than 24 months?</non_inferiority_desc>
            <p_value>0.0045</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of mononuclear inflammatory infiltrates in vulvar specimens from patients with vulvodynia depending on the duration of vulvar discomfort.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the finding of mononuclear inflammatory infiltrates in vulvar specimens from patients with vulvodynia depending on the duration of vulvar discomfort for less or more than 24 months?</non_inferiority_desc>
            <p_value>0.0032</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of collagen fibers in vulvar specimens from patients with vulvodynia depending on the duration of vulvar discomfort.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the finding of collagen fibers in vulvar specimens from patients with vulvodynia depending on the duration of vulvar discomfort for less or more than 24 months?</non_inferiority_desc>
            <p_value>0.1067</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of hyalinization in vulvar specimens from patients with vulvodynia depending on the duration of vulvar discomfort.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of inflammatory cells in vulvar specimens from patients with vulvodynia depending on the duration of vulvar discomfort for less or more than 24 months?</non_inferiority_desc>
            <p_value>0.8672</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of blood vessels in vulvar specimens from patients with vulvodynia depending on the duration of vulvar discomfort.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of blood vessels in vulvar specimens from patients with vulvodynia depending on the duration of vulvar discomfort for less or more than 24 months?</non_inferiority_desc>
            <p_value>0.0219</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of sebaceous glands in vulvar specimens from patients with vulvodynia depending on the duration of vulvar discomfort.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of sebaceous glands in vulvar specimens from patients with vulvodynia depending on the duration of vulvar discomfort for less or more than 24 months?</non_inferiority_desc>
            <p_value>0.8213</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Parameter: The difference in the incidence of the histopathological finding of nerve fibers in vulvar specimens from patients with vulvodynia depending on the duration of vulvar discomfort.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Question: Is there a difference in the incidence of the finding of nerve fibers in vulvar specimens from patients with vulvodynia depending on the duration of vulvar discomfort for less or more than 24 months?</non_inferiority_desc>
            <p_value>0.0613</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>We collected the adverse event data from hospital admission up to 2 years after TRIV for each participant.</time_frame>
      <desc>Agency for Medicinal Products And Medical Devices of Croatia (HALMED), Ministry of Health of Republic Croatia</desc>
      <group_list>
        <group group_id="E1">
          <title>Normal Vulva</title>
          <description>Patients without vulvar discomfort and any vulvar lesion undergoing planned labioplasty, before surgery.</description>
        </group>
        <group group_id="E2">
          <title>Impaired Vulvar Skin</title>
          <description>Patients without vulvar symptoms with some non-specific lesions of the vulva found by clinical examination, undergoing planned labioplasty, before surgery.</description>
        </group>
        <group group_id="E3">
          <title>Vulvodynia</title>
          <description>Patients with vulvar discomfort, who clinically fulfilled Friedrich's criteria. Non-specific lesions found with TRIV were not relevant to the diagnosis of vulvodynia.</description>
        </group>
        <group group_id="E4">
          <title>Vulvar Dermatosis</title>
          <description>Patients with vulvar discomfort and vulvar lesions specific for dermatosis found by clinical examination.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="82"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="82"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="82"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="82"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="82"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="82"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="82"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="82"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="82"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="82"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="82"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="82"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Vesna Harni</name_or_title>
      <organization>Ginekološka poliklinika Dr. Vesna Harni</organization>
      <phone>0038512923648</phone>
      <email>vesnaharni@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

